<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32668736</article-id>
<article-id pub-id-type="pmc">7404044</article-id>
<article-id pub-id-type="doi">10.3390/ijms21144946</article-id>
<article-id pub-id-type="publisher-id">ijms-21-04946</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Crosstalk of Brain and Bone—Clinical Observations and Their Molecular Bases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Otto</surname>
<given-names>Ellen</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-04946">1</xref>
<xref ref-type="author-notes" rid="fn1-ijms-21-04946">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Knapstein</surname>
<given-names>Paul-Richard</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-21-04946">2</xref>
<xref ref-type="author-notes" rid="fn1-ijms-21-04946">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jahn</surname>
<given-names>Denise</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-04946">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Appelt</surname>
<given-names>Jessika</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-04946">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Frosch</surname>
<given-names>Karl-Heinz</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-21-04946">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6529-6864</contrib-id>
<name>
<surname>Tsitsilonis</surname>
<given-names>Serafeim</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-21-04946">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8925-7288</contrib-id>
<name>
<surname>Keller</surname>
<given-names>Johannes</given-names>
</name>
<xref ref-type="aff" rid="af2-ijms-21-04946">2</xref>
<xref ref-type="corresp" rid="c1-ijms-21-04946">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-21-04946"><label>1</label>Julius Wolff Institute for Biomechanics and Musculoskeletal Regeneration, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany; <email>ellen.otto@charite.de</email> (E.O.); <email>denise.jahn@charite.de</email> (D.J.); <email>jessika.appelt@charite.de</email> (J.A.); <email>serafeim.tsitsilonis@charite.de</email> (S.T.)</aff>
<aff id="af2-ijms-21-04946"><label>2</label>Clinic of Trauma, Hand and Reconstructive Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; <email>p.knapstein@uke.de</email> (P.-R.K.); <email>k.frosch@uke.de</email> (K.-H.F.)</aff>
<author-notes>
<corresp id="c1-ijms-21-04946"><label>*</label>Correspondence: <email>j.keller@uke.de</email></corresp>
<fn id="fn1-ijms-21-04946">
<label>†</label>
<p>These authors contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>7</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>7</month>
<year>2020</year>
</pub-date>
<volume>21</volume>
<issue>14</issue>
<elocation-id>4946</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>6</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>7</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© 2020 by the authors.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>As brain and bone disorders represent major health issues worldwide, substantial clinical investigations demonstrated a bidirectional crosstalk on several levels, mechanistically linking both apparently unrelated organs. While multiple stress, mood and neurodegenerative brain disorders are associated with osteoporosis, rare genetic skeletal diseases display impaired brain development and function. Along with brain and bone pathologies, particularly trauma events highlight the strong interaction of both organs. This review summarizes clinical and experimental observations reported for the crosstalk of brain and bone, followed by a detailed overview of their molecular bases. While brain-derived molecules affecting bone include central regulators, transmitters of the sympathetic, parasympathetic and sensory nervous system, bone-derived mediators altering brain function are released from bone cells and the bone marrow. Although the main pathways of the brain-bone crosstalk remain ‘efferent’, signaling from brain to bone, this review emphasizes the emergence of bone as a crucial ‘afferent’ regulator of cerebral development, function and pathophysiology. Therefore, unraveling the physiological and pathological bases of brain-bone interactions revealed promising pharmacologic targets and novel treatment strategies promoting concurrent brain and bone recovery.</p>
</abstract>
<kwd-group>
<kwd>brain</kwd>
<kwd>bone</kwd>
<kwd>interaction</kwd>
<kwd>clinical and experimental studies</kwd>
<kwd>molecular signaling</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-21-04946" sec-type="intro">
<title>1. Introduction</title>
<p>While the brain is regarded as the principal coordinator of body homeostasis by regulating organ activity and their crosstalk, bone features hematopoietic, endocrine metabolic and storage functions along with its predominant mechanical role. Although brain and bone seem apparently unrelated, exceptional clinical and experimental evidence propose a bilateral dependence of both organs [<xref ref-type="bibr" rid="B1-ijms-21-04946">1</xref>,<xref ref-type="bibr" rid="B2-ijms-21-04946">2</xref>]. The effect of brain on bone homeostasis and regeneration, transmitted via the ‘efferent’ nervous system, is well established [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>,<xref ref-type="bibr" rid="B4-ijms-21-04946">4</xref>,<xref ref-type="bibr" rid="B5-ijms-21-04946">5</xref>] whereas the understanding of the ‘afferent’ effect of bone on brain function and development is still evolving [<xref ref-type="bibr" rid="B6-ijms-21-04946">6</xref>,<xref ref-type="bibr" rid="B7-ijms-21-04946">7</xref>,<xref ref-type="bibr" rid="B8-ijms-21-04946">8</xref>]. Therefore, multiple stress, mood and neurodegenerative brain pathologies were previously correlated with bone loss, while only a limited number of genetic skeletal diseases was associated with the modulation of brain development and function. Trauma in particular was discovered to effect brain and bone concurrently.</p>
<p>In this review, we first recapitulate clinical observations and confirming experimental studies, demonstrating brain-bone interconnection. Thereafter, we provide a detailed overview of the molecular bases regarding these bilateral interactions. Based on this mechanistic understanding, we review promising therapeutic targets for disorders affecting brain and bone.</p>
</sec>
<sec id="sec2-ijms-21-04946">
<title>2. Clinical Observations</title>
<p>In the clinical setting, the ‘efferent’ effect of brain on bone remodeling is eventually reflected in bone gain or loss, the latter being the most common. Loss of bone density, strength and microarchitecture leads to the degenerative skeletal disorder osteoporosis, which occurs when the physiological homeostasis is disturbed and bone resorption of osteoclasts exceeds bone formation by osteoblasts. Osteoporosis represents the most common cause for fractures in the aging population, posing a major clinical issue and a significant socioeconomic burden [<xref ref-type="bibr" rid="B9-ijms-21-04946">9</xref>]. Bone mineral density (BMD) is assessed through dual-energy x-ray absorptiometry (DXA) in which osteoporosis is defined at T-score −2.5 or less standard deviations below the average of young and healthy adults [<xref ref-type="bibr" rid="B10-ijms-21-04946">10</xref>]. Osteoporosis has been associated with a great variety of brain dysfunctions such as epilepsy [<xref ref-type="bibr" rid="B11-ijms-21-04946">11</xref>], schizophrenia [<xref ref-type="bibr" rid="B12-ijms-21-04946">12</xref>], shift work [<xref ref-type="bibr" rid="B13-ijms-21-04946">13</xref>], post-traumatic stress disorder [<xref ref-type="bibr" rid="B14-ijms-21-04946">14</xref>], depression [<xref ref-type="bibr" rid="B15-ijms-21-04946">15</xref>] as well as major neurodegenerative diseases including stroke [<xref ref-type="bibr" rid="B16-ijms-21-04946">16</xref>], Alzheimer’s [<xref ref-type="bibr" rid="B17-ijms-21-04946">17</xref>] and Parkinson’s disease [<xref ref-type="bibr" rid="B18-ijms-21-04946">18</xref>]. Interestingly, trauma to the central nervous system such as traumatic brain [<xref ref-type="bibr" rid="B19-ijms-21-04946">19</xref>] and spinal cord injury positively affect bone regeneration (for a detailed review please see Reference [<xref ref-type="bibr" rid="B20-ijms-21-04946">20</xref>]). Finally, complex regional pain syndrome following trauma or surgery was reported to affect brain and bone concurrently [<xref ref-type="bibr" rid="B21-ijms-21-04946">21</xref>].</p>
<p>The ‘afferent’ effect of bone on brain function is more difficult to elucidate and far less understood. None the less, rare genetic skeletal disorders are associated with changes of brain activity, potentially caused by interconnecting molecular mechanisms. Furthermore, peripheral bone injury was discovered to negatively modulate or even exacerbate traumatic brain injury [<xref ref-type="bibr" rid="B22-ijms-21-04946">22</xref>]. In combination with growing molecular knowledge on bone-derived mediators, these clinical observations provided a first understanding of the skeletal capacity to modulate brain development and function.</p>
<sec id="sec2dot1-ijms-21-04946">
<title>2.1. Efferent ‘Brain-Bone’</title>
<p>Neuropsychological dysfunction, caused by shift work, post-traumatic stress and depression as well as the major neurodegenerative pathologies, are associated with bone loss and elevated fracture risk (<xref ref-type="table" rid="ijms-21-04946-t001">Table 1</xref>) [<xref ref-type="bibr" rid="B23-ijms-21-04946">23</xref>]. Considering the impact of brain dysfunction on bone however, direct interactions have to be distinguished from secondary effects following cognitive impairment and long hospitalization which commonly lead to reduced physical activity and altered mechanical loading [<xref ref-type="bibr" rid="B24-ijms-21-04946">24</xref>]. Malnourishment, lifestyle behavior and psychotropic medication represent additional factors causing bone loss, the latter particularly implied for epilepsy [<xref ref-type="bibr" rid="B11-ijms-21-04946">11</xref>] and schizophrenia [<xref ref-type="bibr" rid="B12-ijms-21-04946">12</xref>].</p>
<p>Growing evidence provides a strong correlation between shift work and osteoporosis [<xref ref-type="bibr" rid="B13-ijms-21-04946">13</xref>,<xref ref-type="bibr" rid="B25-ijms-21-04946">25</xref>,<xref ref-type="bibr" rid="B26-ijms-21-04946">26</xref>], as working nights are accompanied by numerous endocrinological changes [<xref ref-type="bibr" rid="B27-ijms-21-04946">27</xref>] such as reduced levels of melatonin [<xref ref-type="bibr" rid="B28-ijms-21-04946">28</xref>,<xref ref-type="bibr" rid="B29-ijms-21-04946">29</xref>,<xref ref-type="bibr" rid="B30-ijms-21-04946">30</xref>] and elevated levels of stress-induced cortisol [<xref ref-type="bibr" rid="B31-ijms-21-04946">31</xref>]. These alterations were associated with an increase in body mass index [<xref ref-type="bibr" rid="B31-ijms-21-04946">31</xref>], elevated risk for cardiovascular diseases [<xref ref-type="bibr" rid="B32-ijms-21-04946">32</xref>], diabetes [<xref ref-type="bibr" rid="B33-ijms-21-04946">33</xref>,<xref ref-type="bibr" rid="B34-ijms-21-04946">34</xref>] and low BMD. As bone turnover markers were identified to mirror diurnal oscillations [<xref ref-type="bibr" rid="B35-ijms-21-04946">35</xref>], bone remodeling is considered to follow central and peripheral circadian control [<xref ref-type="bibr" rid="B36-ijms-21-04946">36</xref>,<xref ref-type="bibr" rid="B37-ijms-21-04946">37</xref>]. Therefore, chronic inadequate sleep [<xref ref-type="bibr" rid="B38-ijms-21-04946">38</xref>] and a disturbance in the expression of circadian clock genes have been observed to alter the skeletal phenotype [<xref ref-type="bibr" rid="B37-ijms-21-04946">37</xref>,<xref ref-type="bibr" rid="B39-ijms-21-04946">39</xref>,<xref ref-type="bibr" rid="B40-ijms-21-04946">40</xref>].</p>
<p>Post-traumatic stress disorder represents another chronic psychological stress condition associated with bone loss, which poses an elevated risk for osteoporosis in civilian [<xref ref-type="bibr" rid="B14-ijms-21-04946">14</xref>] as well as military patients [<xref ref-type="bibr" rid="B41-ijms-21-04946">41</xref>]. Although malnutrition could not be excluded, the negative effect on bone mass was proposed to be mediated by elevated serum levels of proinflammatory cytokines such as tumor necrosis factor α (TNFα), interleukin 1 (IL1) and interleukin 6 (IL6) [<xref ref-type="bibr" rid="B42-ijms-21-04946">42</xref>] known to stimulate bone resorption [<xref ref-type="bibr" rid="B43-ijms-21-04946">43</xref>], as well as through hormones released in response to chronic psychological stress [<xref ref-type="bibr" rid="B44-ijms-21-04946">44</xref>]. Stress signaling is predominantly mediated through the hypothalamic-pituitary-adrenal (HPA) axis, whereby pituitary-released adrenocorticotrophic hormone stimulates glucocorticoid synthesis in the adrenal cortex. Along with their important homeostatic, metabolic and immunologic functions, glucocorticoids were shown to directly inhibit osteoblastogenesis [<xref ref-type="bibr" rid="B45-ijms-21-04946">45</xref>], which results in reduced bone mass and higher fracture risk [<xref ref-type="bibr" rid="B46-ijms-21-04946">46</xref>]. Experimental evidence reported an additional negative effect of glucocorticoids on endochondral ossification in the growth plate, constraining longitudinal and appositional bone growth in adolescent mice [<xref ref-type="bibr" rid="B47-ijms-21-04946">47</xref>]. Chronic psychosocial stress was also shown to modulate the immune response through β-adrenoreceptor signaling, resulting in impaired fracture healing [<xref ref-type="bibr" rid="B48-ijms-21-04946">48</xref>].</p>
<p>Major depressive disorder (MDD) refers to a psychiatric condition also associated with low BMD [<xref ref-type="bibr" rid="B49-ijms-21-04946">49</xref>] and higher fracture risk [<xref ref-type="bibr" rid="B50-ijms-21-04946">50</xref>,<xref ref-type="bibr" rid="B51-ijms-21-04946">51</xref>,<xref ref-type="bibr" rid="B52-ijms-21-04946">52</xref>]. Apart from reduced physical activity and psychotropic medication, bone loss of patients suffering from MDD was proposed to result from inflammatory, metabolic and HPA axis dysregulations [<xref ref-type="bibr" rid="B53-ijms-21-04946">53</xref>] with high levels of cortisol and catecholamines [<xref ref-type="bibr" rid="B54-ijms-21-04946">54</xref>,<xref ref-type="bibr" rid="B55-ijms-21-04946">55</xref>] as well as lower levels of steroids [<xref ref-type="bibr" rid="B56-ijms-21-04946">56</xref>,<xref ref-type="bibr" rid="B57-ijms-21-04946">57</xref>]. MDD is thought to impair bone and brain in a bidirectional manner, as low BMD and elevated fracture risk potentially result in pain conditions, further deteriorating depression [<xref ref-type="bibr" rid="B15-ijms-21-04946">15</xref>]. MDD itself was additionally identified to negatively affect fracture healing through a direct inhibition of osteoblast differentiation [<xref ref-type="bibr" rid="B57-ijms-21-04946">57</xref>].</p>
<p>Patients suffering from major neurodegenerative diseases including stroke, Alzheimer’s and Parkinson’s disease are commonly diagnosed with osteoporosis, resulting in high morbidity and mortality [<xref ref-type="bibr" rid="B58-ijms-21-04946">58</xref>,<xref ref-type="bibr" rid="B59-ijms-21-04946">59</xref>,<xref ref-type="bibr" rid="B60-ijms-21-04946">60</xref>]. First, ischemic or hemorrhagic stroke leads to cell death and breakdown of the blood-brain barrier (BBB) [<xref ref-type="bibr" rid="B61-ijms-21-04946">61</xref>]. Poststroke fracture is a common complication [<xref ref-type="bibr" rid="B62-ijms-21-04946">62</xref>,<xref ref-type="bibr" rid="B63-ijms-21-04946">63</xref>], which poses a substantial disadvantage for stroke recovery [<xref ref-type="bibr" rid="B63-ijms-21-04946">63</xref>] as a result of immobilization, elevated bone resorption, hypercalcemia and hypovitaminosis D [<xref ref-type="bibr" rid="B64-ijms-21-04946">64</xref>]. Interestingly, within the first few days following an acute stroke event, patients already display elevated serum concentrations of bone turnover markers including osteoprotegerin, sclerostin [<xref ref-type="bibr" rid="B65-ijms-21-04946">65</xref>], dickkopf-related protein 1 [<xref ref-type="bibr" rid="B66-ijms-21-04946">66</xref>] and osteopontin [<xref ref-type="bibr" rid="B67-ijms-21-04946">67</xref>,<xref ref-type="bibr" rid="B68-ijms-21-04946">68</xref>], suggesting direct correlation of stroke and bone loss. However, hypoxic conditions following stroke were shown to activate angiogenesis and osteogenetic precursor cells, resulting in heterotopic ossification in various parts of the body [<xref ref-type="bibr" rid="B69-ijms-21-04946">69</xref>]. While vascular endothelial growth factor (VEGF) signaling is essential for adequate callus formation, hypoxic induction of VEGF further promotes brain edema [<xref ref-type="bibr" rid="B70-ijms-21-04946">70</xref>,<xref ref-type="bibr" rid="B71-ijms-21-04946">71</xref>]. Thus, experimental fracture, induced shortly before stroke, increased neuroinflammation and further exacerbated ischemic cerebral injury causing substantial secondary damage in a murine stroke-model [<xref ref-type="bibr" rid="B72-ijms-21-04946">72</xref>].</p>
<p>Second, Alzheimer’s disease (AD), a chronic neurodegenerative disease, is also closely associated with osteoporosis and an increased fracture risk [<xref ref-type="bibr" rid="B73-ijms-21-04946">73</xref>,<xref ref-type="bibr" rid="B74-ijms-21-04946">74</xref>,<xref ref-type="bibr" rid="B75-ijms-21-04946">75</xref>]. Patients with less brain atrophy show better bone quality [<xref ref-type="bibr" rid="B76-ijms-21-04946">76</xref>], indicating central mechanisms of AD contributing to bone loss [<xref ref-type="bibr" rid="B7-ijms-21-04946">7</xref>]. Further, patients suffering from AD or mild cognitive impairments display higher levels of osteopontin [<xref ref-type="bibr" rid="B77-ijms-21-04946">77</xref>], which correlates with cognitive decline [<xref ref-type="bibr" rid="B78-ijms-21-04946">78</xref>] and reduced BMD [<xref ref-type="bibr" rid="B79-ijms-21-04946">79</xref>], while AD progression is linked to serum levels of the bone turnover markers osteopontin, osteocalcin and sclerostin [<xref ref-type="bibr" rid="B8-ijms-21-04946">8</xref>]. In AD, an accumulation of extracellular amyloid-β (Aβ) plaques and intracellular tau inclusions causing cell degeneration has been observed [<xref ref-type="bibr" rid="B80-ijms-21-04946">80</xref>]. In turn, Aβ was identified to increase osteoclast activation and bone resorption [<xref ref-type="bibr" rid="B81-ijms-21-04946">81</xref>]. Thus, targeting of Aβ plaques may evolve as a promising therapeutic approach to prevent cognitive decline and bone loss in patients with AD [<xref ref-type="bibr" rid="B82-ijms-21-04946">82</xref>].</p>
<p>Third, in line with stroke and AD, patients with Parkinson’s disease (PD) additionally display reduced BMD [<xref ref-type="bibr" rid="B18-ijms-21-04946">18</xref>]. While the pathogenesis of PD includes oxidative stress, disturbances of iron metabolism [<xref ref-type="bibr" rid="B83-ijms-21-04946">83</xref>] and aggregation of α-synuclein protein [<xref ref-type="bibr" rid="B84-ijms-21-04946">84</xref>,<xref ref-type="bibr" rid="B85-ijms-21-04946">85</xref>], the associated bone loss already occurs during early stages of disease development. As a result, the majority of PD patients are prone not only to neurological impairment and postural imbalance but also an increased fracture risk [<xref ref-type="bibr" rid="B18-ijms-21-04946">18</xref>,<xref ref-type="bibr" rid="B86-ijms-21-04946">86</xref>]. Along with correlating vitamin D deficiency, reduced body weight [<xref ref-type="bibr" rid="B87-ijms-21-04946">87</xref>] and female gender [<xref ref-type="bibr" rid="B88-ijms-21-04946">88</xref>], recent evidence propose a direct effect of PD on bone through degeneration of dopaminergic neurons, resulting in accelerated osteoclastogenesis and suppressed bone formation [<xref ref-type="bibr" rid="B89-ijms-21-04946">89</xref>].</p>
</sec>
<sec id="sec2dot2-ijms-21-04946">
<title>2.2. Afferent ‘Bone-Brain’</title>
<p>Although most clinical observations primarily highlight the impact of neurologic disorders on bone integrity, a limited number of genetic bone pathologies are accompanied by structural and cognitive brain impairment, pointing towards an ‘afferent’ bone-brain effect. In this regard, cleidocranial dysplasia (CCD) represents an autosomal dominant skeletal disorder caused by the haploinsufficiency of <italic>RUNX2</italic> (also called <italic>CBFA1</italic>), which is a key transcription factor of osteoblast differentiation. CCD is characterized by skeletal anomalies including brachycephalic skull, collarbones partly or completely missing, midfacial hypoplasia and delayed tooth eruption [<xref ref-type="bibr" rid="B90-ijms-21-04946">90</xref>]. Some patients with CCD additionally suffer from a developmental delay of the brain or late-onset progressive cognitive decline [<xref ref-type="bibr" rid="B91-ijms-21-04946">91</xref>]. This might potentially be explained by dysfunctional osteoblasts and an insufficient secretion of the osteoblast-derived hormone osteocalcin [<xref ref-type="bibr" rid="B92-ijms-21-04946">92</xref>], which was shown to exert neuroprotective effects [<xref ref-type="bibr" rid="B6-ijms-21-04946">6</xref>].</p>
<p>Similar to CCD, Coffin-Lowry syndrome (CLS) refers to a genetic skeletal disorder associated with brain malfunction. CLS represents an X-linked disease, caused by loss-of-function mutations in the gene <italic>RPS6KA3</italic> encoding for the growth-factor-regulated protein kinase RSK2, which phosphorylates activating transcription factor 4 (ATF4, also called CREB-2) [<xref ref-type="bibr" rid="B93-ijms-21-04946">93</xref>]. Although clinical manifestation is highly heterogeneous, CLS patients show profound growth retardation with facial, hand and skeletal malformations as well as serious psychomotor impairments [<xref ref-type="bibr" rid="B94-ijms-21-04946">94</xref>]. While the inactivation of RSK2 was associated with severe impaired spatial learning and long-term spatial memory deficit [<xref ref-type="bibr" rid="B95-ijms-21-04946">95</xref>], long-term potentiation requires the RSK2 substrate ATF4 [<xref ref-type="bibr" rid="B96-ijms-21-04946">96</xref>]. The skeletal malformations are also presumed to be caused by the lack of ATF4, which was shown to regulate osteoblast differentiation and function [<xref ref-type="bibr" rid="B94-ijms-21-04946">94</xref>,<xref ref-type="bibr" rid="B97-ijms-21-04946">97</xref>] as well as to stimulate osteocalcin expression [<xref ref-type="bibr" rid="B98-ijms-21-04946">98</xref>]. Therefore, brain and bone dysfunction of patients suffering from CLS may be explained by altered ATF4 activity [<xref ref-type="bibr" rid="B1-ijms-21-04946">1</xref>].</p>
<p>Other skeletal disorders, such as the <italic>SOST</italic> gene mutations sclerosteosis and van Buchem disease, are associated with raised intracranial pressure and cranial nerve entrapment [<xref ref-type="bibr" rid="B99-ijms-21-04946">99</xref>,<xref ref-type="bibr" rid="B100-ijms-21-04946">100</xref>], while hereditary multiple exostoses (HME) [<xref ref-type="bibr" rid="B101-ijms-21-04946">101</xref>] correlates with symptoms of autism [<xref ref-type="bibr" rid="B102-ijms-21-04946">102</xref>] and frontotemporal dementia [<xref ref-type="bibr" rid="B103-ijms-21-04946">103</xref>]. Although multiple genetic diseases with concurrent skeletal and mental deficits (selection see <xref ref-type="app" rid="app1-ijms-21-04946">Supplementary Table S1</xref>) show individually altered brain and bone dysfunction, further evidence of bidirectional molecular interaction is warranted.</p>
</sec>
<sec id="sec2dot3-ijms-21-04946">
<title>2.3. Trauma Affecting Brain and Bone</title>
<p>Clinical studies involving physically injured patients revealed a strong crosslink of brain and bone. In response to general trauma or surgical injury, complex regional pain syndrome (CRPS) was observed to effect the nervous system and bone concurrently [<xref ref-type="bibr" rid="B21-ijms-21-04946">21</xref>]. Although not directly affecting brain function, CRPS is characterized by autonomic, sensory and motoric abnormalities with clinical features of neurogenic inflammation, maladaptive neuroplasticity and nociceptive sensitization accompanied by sensory impairments, potentially leading to anxiety and depression [<xref ref-type="bibr" rid="B104-ijms-21-04946">104</xref>,<xref ref-type="bibr" rid="B105-ijms-21-04946">105</xref>,<xref ref-type="bibr" rid="B106-ijms-21-04946">106</xref>]. In bone, CRPS results in loss of BMD and increased periarticular bone turnover with osteoprotegerin proposed as a potential biomarker [<xref ref-type="bibr" rid="B107-ijms-21-04946">107</xref>].</p>
<p>Different to general trauma, the external physical insult to the head, causing an alteration of brain function among other brain pathologies, is termed traumatic brain injury (TBI) [<xref ref-type="bibr" rid="B108-ijms-21-04946">108</xref>]. Depending on force severity, TBI results in temporary to permanent neurologic dysfunctions as well as a disruption of the circadian rhythm, behavioral and cognitive impairments, with generally increased mortality and morbidity [<xref ref-type="bibr" rid="B109-ijms-21-04946">109</xref>,<xref ref-type="bibr" rid="B110-ijms-21-04946">110</xref>,<xref ref-type="bibr" rid="B111-ijms-21-04946">111</xref>]. During primary TBI, the meninges are commonly damaged causing cerebral hematoma, edema, ischemia and necrosis, leading to a disruption of the BBB [<xref ref-type="bibr" rid="B110-ijms-21-04946">110</xref>,<xref ref-type="bibr" rid="B112-ijms-21-04946">112</xref>]. Subsequent metabolic disturbance, apoptosis, oxidative stress and neuroinflammation are defined as secondary injury, potentially lasting for weeks [<xref ref-type="bibr" rid="B113-ijms-21-04946">113</xref>] with wide-ranging systemic effects on the immune system and other organ function including bone [<xref ref-type="bibr" rid="B114-ijms-21-04946">114</xref>]. Clinical TBI studies reported an ‘efferent’ effect on the intact bone, showing patients suffering from isolated TBI to exhibit an elevated fracture risk and reduced BMD [<xref ref-type="bibr" rid="B19-ijms-21-04946">19</xref>,<xref ref-type="bibr" rid="B115-ijms-21-04946">115</xref>,<xref ref-type="bibr" rid="B116-ijms-21-04946">116</xref>]. Although immobilization represents a contributing factor, experimental studies confirmed the negative effect of TBI on bone quality and mineral density without changes in movement [<xref ref-type="bibr" rid="B117-ijms-21-04946">117</xref>,<xref ref-type="bibr" rid="B118-ijms-21-04946">118</xref>]. This alteration in bone metabolism is stated to be caused by the elevated BBB permeability, peripheral inflammatory response as well as endocrine and sympathetic outflow modulation of the secondary injury [<xref ref-type="bibr" rid="B114-ijms-21-04946">114</xref>,<xref ref-type="bibr" rid="B119-ijms-21-04946">119</xref>]. Recent evidence implies that the inflammatory stress on bone and its marrow following TBI activates nuclear factor ‘kappa-light-chain-enhancer’ of activated B-cells (NF-κB), which in turn induces osteoclastic differentiation resulting in elevated bone resorption [<xref ref-type="bibr" rid="B120-ijms-21-04946">120</xref>]. Along with the negative impact on bone metabolism, patients suffering from TBI were furthermore identified to frequently sustain heterotopic ossification (HO) [<xref ref-type="bibr" rid="B121-ijms-21-04946">121</xref>,<xref ref-type="bibr" rid="B122-ijms-21-04946">122</xref>]. Such musculoskeletal ectopic deposition of lamellar bone in non-osseous tissue is commonly acquired after neurological, soft or bone tissue trauma [<xref ref-type="bibr" rid="B119-ijms-21-04946">119</xref>], especially following combined TBI and fracture or high severity injury [<xref ref-type="bibr" rid="B123-ijms-21-04946">123</xref>]. Although it has been agreed that neurological HO, initiated by simultaneous central and peripheral nervous injury, represents endochondral ossification, the underlying molecular and cellular mechanisms still remain to be elucidated [<xref ref-type="bibr" rid="B122-ijms-21-04946">122</xref>,<xref ref-type="bibr" rid="B124-ijms-21-04946">124</xref>,<xref ref-type="bibr" rid="B125-ijms-21-04946">125</xref>]. Recently established TBI models sustaining HO potentially provide the foundation for investigations of the pathogenesis while unraveling promising therapeutic targets [<xref ref-type="bibr" rid="B126-ijms-21-04946">126</xref>,<xref ref-type="bibr" rid="B127-ijms-21-04946">127</xref>].</p>
<p>In contrast to isolated brain injury, patients suffering from TBI with concomitant fracture however were identified to exhibit accelerated bone healing and enhanced callus formation [<xref ref-type="bibr" rid="B128-ijms-21-04946">128</xref>,<xref ref-type="bibr" rid="B129-ijms-21-04946">129</xref>,<xref ref-type="bibr" rid="B130-ijms-21-04946">130</xref>,<xref ref-type="bibr" rid="B131-ijms-21-04946">131</xref>,<xref ref-type="bibr" rid="B132-ijms-21-04946">132</xref>,<xref ref-type="bibr" rid="B133-ijms-21-04946">133</xref>,<xref ref-type="bibr" rid="B134-ijms-21-04946">134</xref>]. Similar to the physiologic bone remodeling, bone healing represents a complex process, consisting of the pro- and anti-inflammatory phase, followed by the soft callus, hard callus and the remodeling phases [<xref ref-type="bibr" rid="B135-ijms-21-04946">135</xref>,<xref ref-type="bibr" rid="B136-ijms-21-04946">136</xref>]. Although continues attempts were made to unravel the underlying molecular bases of this positive ‘efferent’ TBI effect on bone regeneration [<xref ref-type="bibr" rid="B137-ijms-21-04946">137</xref>], the exact mechanisms still remain to be elucidated. Clinical studies monitored the systemic regulation of trauma patients suffering from fracture and TBI, to identify potential osteogenic humoral factors [<xref ref-type="bibr" rid="B138-ijms-21-04946">138</xref>]. Therefore, proliferation was significantly increased when treating osteoblasts with serum [<xref ref-type="bibr" rid="B139-ijms-21-04946">139</xref>] or cerebrospinal fluid of TBI patients [<xref ref-type="bibr" rid="B140-ijms-21-04946">140</xref>], pointing towards centrally released osteogenic factors entering the circulation following TBI [<xref ref-type="bibr" rid="B138-ijms-21-04946">138</xref>]. For further investigation, experimental studies reproduced the phenomenon [<xref ref-type="bibr" rid="B141-ijms-21-04946">141</xref>], reporting an increased bone volume, elevated mineral density and higher rates of gap bridging in mice with TBI and concomitant fracture [<xref ref-type="bibr" rid="B142-ijms-21-04946">142</xref>]. As today, different theories have been postulated, considering a complex modulation of the inflammatory response, participating hormones, neuropeptides and neurotransmitters [<xref ref-type="bibr" rid="B114-ijms-21-04946">114</xref>,<xref ref-type="bibr" rid="B119-ijms-21-04946">119</xref>,<xref ref-type="bibr" rid="B137-ijms-21-04946">137</xref>,<xref ref-type="bibr" rid="B143-ijms-21-04946">143</xref>]. Most recent evidence proposed a non-humoral pathway with dominance of neuronal mechanisms and neuroinflammation [<xref ref-type="bibr" rid="B144-ijms-21-04946">144</xref>]. Similar to TBI, isolated spinal cord injury (SCI) was associated with reduced BMD and osteoporosis [<xref ref-type="bibr" rid="B145-ijms-21-04946">145</xref>], predominantly observed within the trabecular metaphysical-epiphyseal areas of the distal femur and proximal tibia [<xref ref-type="bibr" rid="B146-ijms-21-04946">146</xref>,<xref ref-type="bibr" rid="B147-ijms-21-04946">147</xref>,<xref ref-type="bibr" rid="B148-ijms-21-04946">148</xref>,<xref ref-type="bibr" rid="B149-ijms-21-04946">149</xref>]. Further, patients suffering from SCI also frequently show HO as well as accelerated and enhanced callus formation [<xref ref-type="bibr" rid="B20-ijms-21-04946">20</xref>], which was reproduced in vitro utilizing serum of SCI patients [<xref ref-type="bibr" rid="B150-ijms-21-04946">150</xref>,<xref ref-type="bibr" rid="B151-ijms-21-04946">151</xref>].</p>
<p>Despite the positive effect of trauma on bone regeneration, the ‘afferent’ bone-brain interaction of peripheral injury such as fracture was discovered to negatively modulate and potentially further deteriorate TBI [<xref ref-type="bibr" rid="B22-ijms-21-04946">22</xref>]. While a neurological impact of fracture healing is considered to be constrained by the BBB, trauma patients suffering from TBI and concomitant skeletal injury show higher functional deficits and mortality rates [<xref ref-type="bibr" rid="B151-ijms-21-04946">151</xref>]. Clinical multitrauma studies identified systemic inflammatory changes [<xref ref-type="bibr" rid="B152-ijms-21-04946">152</xref>,<xref ref-type="bibr" rid="B153-ijms-21-04946">153</xref>,<xref ref-type="bibr" rid="B154-ijms-21-04946">154</xref>] with the capacity to modulate the neuroinflammatory response following TBI [<xref ref-type="bibr" rid="B22-ijms-21-04946">22</xref>]. Such alterations were strongly supported by experimental evidence, reporting concomitant fracture to exacerbate TBI, neuroinflammation [<xref ref-type="bibr" rid="B155-ijms-21-04946">155</xref>] and further deteriorate cerebral edema, motor deficits and neurological recovery [<xref ref-type="bibr" rid="B156-ijms-21-04946">156</xref>].</p>
</sec>
</sec>
<sec id="sec3-ijms-21-04946">
<title>3. Molecular Bases of Brain-Bone Crosstalk</title>
<p>Clinical observations continuously unravel pathophysiological processes and interactions, which reveal potential therapeutic benefit and therefore commonly represent the bases for specific mechanistic research. As a result, the combination of clinical and experimental studies gave rise to a continuously improving understanding of the brain-bone crosstalk. Several mutations in the genes encoding the below referenced mediators were discovered in humans to affect development and metabolism of bone and brain, respectively, to various degrees (<xref ref-type="app" rid="app1-ijms-21-04946">Supplementary Table S2</xref>). In this section, we provide an insight to molecules which directly mediate the signal transmission of these two organs.</p>
<sec id="sec3dot1-ijms-21-04946">
<title>3.1. Brain- and Nerve-Derived Mediators Affecting Bone Cell Function</title>
<sec id="sec3dot1dot1-ijms-21-04946">
<title>3.1.1. Central Regulation</title>
<p>The central nervous system (CNS) is classically known for its major role in coordinating the activity of all parts of the body through neuroendocrine signaling which is primarily funneled by the hypothalamus. Most of these regulatory mediators are either expressed by the hypothalamic nuclei and transported to the posterior pituitary gland or secreted to stimulate hormone release in the anterior pituitary gland. Notably, those hormones, including follicle-stimulating hormone, thyroid-stimulating hormone, prolactin, adrenocorticotrophic hormone, growth hormone, arginine vasopressin, oxytocin and pineal gland-derived melatonin were all discovered to represent potent regulators of skeletal integrity (<xref ref-type="fig" rid="ijms-21-04946-f001">Figure 1</xref>, <xref ref-type="table" rid="ijms-21-04946-t002">Table 2</xref>) [<xref ref-type="bibr" rid="B4-ijms-21-04946">4</xref>,<xref ref-type="bibr" rid="B170-ijms-21-04946">170</xref>].</p>
<p>Growing evidence supports an estrogen-independent, direct effect of <bold>follicular stimulating hormone</bold> (FSH) on extragonadal tissue, particularly bone and fat [<xref ref-type="bibr" rid="B171-ijms-21-04946">171</xref>,<xref ref-type="bibr" rid="B172-ijms-21-04946">172</xref>,<xref ref-type="bibr" rid="B173-ijms-21-04946">173</xref>,<xref ref-type="bibr" rid="B174-ijms-21-04946">174</xref>]. Although this matter remains intensively discussed [<xref ref-type="bibr" rid="B175-ijms-21-04946">175</xref>,<xref ref-type="bibr" rid="B176-ijms-21-04946">176</xref>,<xref ref-type="bibr" rid="B177-ijms-21-04946">177</xref>,<xref ref-type="bibr" rid="B178-ijms-21-04946">178</xref>,<xref ref-type="bibr" rid="B179-ijms-21-04946">179</xref>], osteoclasts and their precursor cells have been shown to express FSH receptors, allowing FSH to directly stimulate osteoclast formation, function and survival [<xref ref-type="bibr" rid="B173-ijms-21-04946">173</xref>,<xref ref-type="bibr" rid="B174-ijms-21-04946">174</xref>]. Bone resorption is additionally promoted indirectly following the upregulation of pro-resorptive cytokines in proportion to FSH receptor expression [<xref ref-type="bibr" rid="B179-ijms-21-04946">179</xref>]. Especially during late perimenopause, when estrogen levels are still unaltered although ovarian failure is impending, a sharp increase of serum FSH levels was associated with an enhanced rate of bone loss and visceral adiposity onset, proposing FSH as a potential key player in osteoporosis and obesity in women across the menopausal transition [<xref ref-type="bibr" rid="B171-ijms-21-04946">171</xref>,<xref ref-type="bibr" rid="B178-ijms-21-04946">178</xref>]. Therefore, FSH-neutralizing antibodies were tested in pre-clinical experiments, which lead to increased bone mass and reduced body fat [<xref ref-type="bibr" rid="B171-ijms-21-04946">171</xref>,<xref ref-type="bibr" rid="B180-ijms-21-04946">180</xref>].</p>
<p>In line with FSH, <bold>thyroid stimulating hormone</bold> (TSH) was shown to directly affect bone remodeling through binding to the TSH receptor expressed in both osteoblast and osteoclast precursors, independent of thyroid T3 and T4 [<xref ref-type="bibr" rid="B181-ijms-21-04946">181</xref>]. TSH was identified to negatively regulate osteoclastogenesis trough binding to TSH receptor directly but also indirectly by suppressing the synthesis of pro-osteoclastic signals [<xref ref-type="bibr" rid="B181-ijms-21-04946">181</xref>,<xref ref-type="bibr" rid="B182-ijms-21-04946">182</xref>] such as the cytokine TNFα, a critical mediator of the antiresorptive effects of TSH [<xref ref-type="bibr" rid="B183-ijms-21-04946">183</xref>]. However, TSH was not only observed to reduce bone loss but also to restore bone mass, bone volume, microarchitecture and strength [<xref ref-type="bibr" rid="B184-ijms-21-04946">184</xref>]. In osteoblasts, TSH induces the synthesis of noncanonical Wnt5a, resulting in osteoblastogenesis and stimulation of osteoprotegerin (OPG) synthesis, which in turn reduces bone resorption through an inhibition of receptor activator of nuclear factor κB ligand (RANKL) signaling [<xref ref-type="bibr" rid="B185-ijms-21-04946">185</xref>]. However, TSH receptor activation was demonstrated to suppress osteoblast differentiation and the expression of collagen type 1 by impairing the Wnt pathway and decreasing VEGF concentrations [<xref ref-type="bibr" rid="B181-ijms-21-04946">181</xref>]. Although these studies define TSH as a single and independent control molecule in bone formation as well as resorption, further investigation are required to unravel the underlying molecular pathophysiology and its therapeutic potential.</p>
<p>Lactotrophic cell-derived prolactin (PRL) is predominantly known for its pivotal role in lactation, mammary development and reproduction, additionally participating in bone homeostasis [<xref ref-type="bibr" rid="B186-ijms-21-04946">186</xref>]. Interestingly, G protein-coupled PRL receptors are only expressed on osteoblasts but not osteoclasts [<xref ref-type="bibr" rid="B187-ijms-21-04946">187</xref>], with a variable response based on PRL concentration levels. Although PRL is essential for bone growth and homeostasis [<xref ref-type="bibr" rid="B187-ijms-21-04946">187</xref>], patients with pathological high PRL concentrations show increased bone resorption and suppressed bone formation activity, which eventually leads to osteoporosis [<xref ref-type="bibr" rid="B188-ijms-21-04946">188</xref>]. On a mechanistic level, several studies observed PRL to reduce osteocalcin and alkaline phosphate activity [<xref ref-type="bibr" rid="B189-ijms-21-04946">189</xref>], to decrease OPG expression [<xref ref-type="bibr" rid="B190-ijms-21-04946">190</xref>,<xref ref-type="bibr" rid="B191-ijms-21-04946">191</xref>] and to inhibit osteoblastic proliferation as well as bone mineralization [<xref ref-type="bibr" rid="B192-ijms-21-04946">192</xref>]. Besides these direct effects, hyperprolactinemia is also proposed to negatively act on bone in an indirect manner, involving hypogonadism, hypercalcemia and an enhanced secretion of parathyroid hormone-related peptide (PTHrP) [<xref ref-type="bibr" rid="B188-ijms-21-04946">188</xref>]. As PRL treatment however showed a positive effect on bone formation in infant rats [<xref ref-type="bibr" rid="B193-ijms-21-04946">193</xref>] and a decreased RANKL/OPG ratio in human fetal osteoblasts [<xref ref-type="bibr" rid="B192-ijms-21-04946">192</xref>], the effect of PRL on bone is proposed to be dependent on the developmental stage [<xref ref-type="bibr" rid="B194-ijms-21-04946">194</xref>] and warrants further mechanistic understanding.</p>
<p>Adrenocorticotrophic hormone (ACTH), the key mediator of corticosteroid-release from the adrenal gland, represents an important co-regulator of immune responses, vascular tone, central metabolism and bone turnover [<xref ref-type="bibr" rid="B194-ijms-21-04946">194</xref>,<xref ref-type="bibr" rid="B195-ijms-21-04946">195</xref>]. Chronically elevated levels of glucocorticoids are a well-established cause for osteoporosis and presumbly osteonecrosis due to their inhibitory impact on bone-forming osteoblasts [<xref ref-type="bibr" rid="B47-ijms-21-04946">47</xref>,<xref ref-type="bibr" rid="B196-ijms-21-04946">196</xref>]. Zaidi et al. propose that ACTH in interaction with VEGF supports the prevention of glucocorticoid-induced osteonecrosis [<xref ref-type="bibr" rid="B170-ijms-21-04946">170</xref>,<xref ref-type="bibr" rid="B194-ijms-21-04946">194</xref>,<xref ref-type="bibr" rid="B195-ijms-21-04946">195</xref>]. Additional studies described the expression of ACTH by monocytes/macrophages [<xref ref-type="bibr" rid="B197-ijms-21-04946">197</xref>], which acts cortisol-independent on melanocortin 2 receptors (MC2R) expressed by osteoblastic cells [<xref ref-type="bibr" rid="B195-ijms-21-04946">195</xref>]. Therefore, local and pituitary-derived ACTH features the capacity to regulate bone cells directly [<xref ref-type="bibr" rid="B170-ijms-21-04946">170</xref>] in a concentration-dependent manner [<xref ref-type="bibr" rid="B195-ijms-21-04946">195</xref>].</p>
<p>While most anterior pituitary gland-derived hormones show a divergent, rather negative effect on bone remodeling, growth hormone (GH) also known as somatotropin, is a peptide hormone crucial for human development, stimulating cell reproduction and regeneration as well as the regulation of longitudinal bone growth [<xref ref-type="bibr" rid="B198-ijms-21-04946">198</xref>]. GH was shown to induce a net gain of bone mass [<xref ref-type="bibr" rid="B198-ijms-21-04946">198</xref>], with in vivo studies demonstrating the capacity of GH to stimulate the proliferation of osteoblastic-cells [<xref ref-type="bibr" rid="B199-ijms-21-04946">199</xref>]. Although the majority of experimental evidence implies GH to exert primarily insulin-like growth factor 1 (IGF-1)-dependent skeletal effects, the group of Zaidi et al. currently challenge this view by proposing the direct effect of GH on bone cells [<xref ref-type="bibr" rid="B170-ijms-21-04946">170</xref>,<xref ref-type="bibr" rid="B194-ijms-21-04946">194</xref>].</p>
<p>In contrast to all neurohormones previously discussed, arginine-vasopressin (AVP) commonly known as antidiuretic hormone, is a peptide hormone released from the posterior pituitary gland, which has also been reported to regulate bone metabolism [<xref ref-type="bibr" rid="B4-ijms-21-04946">4</xref>]. In bone, AVP receptors (Avpr1α/2) are expressed by osteoblasts and osteoclasts, allowing AVP-binding to reduce osteoblastogenesis as well as to increase osteoclastogenesis [<xref ref-type="bibr" rid="B200-ijms-21-04946">200</xref>]. As patients with chronic hyponatremia show severe osteoporosis and high fracture risk, their elevated AVP levels were suggested to mobilize sodium from skeletal cells which increases bone resorption [<xref ref-type="bibr" rid="B170-ijms-21-04946">170</xref>,<xref ref-type="bibr" rid="B194-ijms-21-04946">194</xref>]. Additionally, AVP was shown to promote the production of corticotropin-releasing hormone, which in turn facilitates the release of ACTH [<xref ref-type="bibr" rid="B201-ijms-21-04946">201</xref>].</p>
<p>Oxytocin (OT), also released from the posterior pituitary gland, is known for its role in lactation, parturition [<xref ref-type="bibr" rid="B157-ijms-21-04946">157</xref>,<xref ref-type="bibr" rid="B202-ijms-21-04946">202</xref>], social behavior, as well as in energy and bone homeostasis [<xref ref-type="bibr" rid="B203-ijms-21-04946">203</xref>,<xref ref-type="bibr" rid="B204-ijms-21-04946">204</xref>]. Interestingly, OT and AVP were observed to interact with each other’s G protein-coupled receptors in order to control bone metabolism [<xref ref-type="bibr" rid="B203-ijms-21-04946">203</xref>]. As opposed to AVP, OT shows a rather anabolic effect on bone [<xref ref-type="bibr" rid="B204-ijms-21-04946">204</xref>], promoting osteoblastogenesis while moderately inhibiting osteoclast activity [<xref ref-type="bibr" rid="B205-ijms-21-04946">205</xref>]. OT receptor expression was identified in osteoblasts [<xref ref-type="bibr" rid="B206-ijms-21-04946">206</xref>] and osteoclasts [<xref ref-type="bibr" rid="B207-ijms-21-04946">207</xref>] while bone marrow cells were shown to produce OT themselves, implying an autocrine/paracrine regulation of bone formation [<xref ref-type="bibr" rid="B204-ijms-21-04946">204</xref>]. Notably, OT synthesis and OT receptor expression were positively regulated by estrogen signaling [<xref ref-type="bibr" rid="B208-ijms-21-04946">208</xref>], explaining the observed sex differences in experimental and clinical studies [<xref ref-type="bibr" rid="B171-ijms-21-04946">171</xref>].</p>
<p>Different to all pituitary-derived hormones, melatonin is primarily released from the pineal gland into the cerebrospinal fluid [<xref ref-type="bibr" rid="B158-ijms-21-04946">158</xref>,<xref ref-type="bibr" rid="B209-ijms-21-04946">209</xref>] and physiologically involved in the synchronization of circadian and seasonal rhythms including the sleep-wake cycle with further regulation of the blood pressure and temperature homeostasis [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>]. In bone, both osteoblasts and osteoclasts were observed to express melatonin receptors [<xref ref-type="bibr" rid="B210-ijms-21-04946">210</xref>]. As bone remodeling is commonly known to follow circadian rhythmic, melatonin was early discovered to support osteoblastic differentiation [<xref ref-type="bibr" rid="B211-ijms-21-04946">211</xref>] and type 1 collagen synthesis [<xref ref-type="bibr" rid="B212-ijms-21-04946">212</xref>]. As a result melatonin was identified to inhibit adipogenesis and promote osteogenesis [<xref ref-type="bibr" rid="B213-ijms-21-04946">213</xref>], which was further confirmed by the observation of melatonin to induce the expression of bone morphogenetic proteins, alkaline phosphatases, osteocalcin, OPG and the suppression of RANKL [<xref ref-type="bibr" rid="B159-ijms-21-04946">159</xref>]. While in vivo studies led to contradictory results [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>], clinical observation showed a gain of BMD following melatonin supplementation in postmenopausal women with osteopenia [<xref ref-type="bibr" rid="B214-ijms-21-04946">214</xref>], fueling continuous discussions on melatonin’s therapeutic potential [<xref ref-type="bibr" rid="B159-ijms-21-04946">159</xref>,<xref ref-type="bibr" rid="B215-ijms-21-04946">215</xref>,<xref ref-type="bibr" rid="B216-ijms-21-04946">216</xref>].</p>
<p>Complementary to all these neurohormones involved in the central regulation of bone remodeling, further neuropeptides and -transmitters, the endocannabinoid system as well as the central clock (<xref ref-type="fig" rid="ijms-21-04946-f001">Figure 1</xref>) play an important role in bone homeostasis. While the control of energy homeostasis is generally divided among anabolic-active AgRP/NPY and catabolic-active POMC/CART neurons, their impact on bone metabolism appears to be more complex [<xref ref-type="bibr" rid="B4-ijms-21-04946">4</xref>]. The multifunctional and orexigenic neuropeptide Y (NPY) is predominantly expressed in the arcuate nucleus (ARC) [<xref ref-type="bibr" rid="B217-ijms-21-04946">217</xref>], regulating energy metabolism through induced food intake and increased fat storage [<xref ref-type="bibr" rid="B218-ijms-21-04946">218</xref>]. In the peripheral nervous system (PNS), NPY is mainly expressed by neurons of the sympathetic nervous system were it plays a major role in bone metabolism through its receptors Y1 and Y2 [<xref ref-type="bibr" rid="B219-ijms-21-04946">219</xref>,<xref ref-type="bibr" rid="B220-ijms-21-04946">220</xref>]. When binding to Y1 expressed by osteoblasts [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>], NPY inhibits bone formation, proliferation of mesenchymal stem cells and osteoprogenitors [<xref ref-type="bibr" rid="B222-ijms-21-04946">222</xref>] and promotes energy storage in white adipose tissue [<xref ref-type="bibr" rid="B223-ijms-21-04946">223</xref>], while binding to Y2 reduces bone mass and osteoblast activity through central modulation [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>,<xref ref-type="bibr" rid="B220-ijms-21-04946">220</xref>,<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. During chronic stress however, NPY was reported to feature protective effects on bone [<xref ref-type="bibr" rid="B224-ijms-21-04946">224</xref>], which is potentially explained by a centrally-mediated decrease in sympathetic tone [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>].</p>
<p>The neuropeptide agouti-related peptide (AgRP) is co-expressed with NPY. AgRP represents one of the most potent and long-lasting appetite stimulators, in addition to its modulatory impact on metabolism and energy expenditure [<xref ref-type="bibr" rid="B225-ijms-21-04946">225</xref>,<xref ref-type="bibr" rid="B226-ijms-21-04946">226</xref>]. Interestingly, it has been proposed that altered AgRP neuronal activities affect bone homeostasis independent of metabolic shifts or leptin signaling [<xref ref-type="bibr" rid="B227-ijms-21-04946">227</xref>,<xref ref-type="bibr" rid="B228-ijms-21-04946">228</xref>]. In this regard, enhanced AgRP neuronal activity was reported to lower sympathetic tone, which favors increased bone mass due to elevated osteoblast activity [<xref ref-type="bibr" rid="B229-ijms-21-04946">229</xref>,<xref ref-type="bibr" rid="B230-ijms-21-04946">230</xref>].</p>
<p>Cocaine amphetamine regulated transcript (CART), an anorexic neuropeptide precursor protein also involved in the regulation of food intake and energy expenditure [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>,<xref ref-type="bibr" rid="B231-ijms-21-04946">231</xref>,<xref ref-type="bibr" rid="B232-ijms-21-04946">232</xref>,<xref ref-type="bibr" rid="B233-ijms-21-04946">233</xref>,<xref ref-type="bibr" rid="B234-ijms-21-04946">234</xref>], is released in the ventral tegmental area of the brain according to the serum levels of leptin [<xref ref-type="bibr" rid="B234-ijms-21-04946">234</xref>]. While low hypothalamic CART expression was associated with increased bone resorption through higher levels of RANKL, elevated CART expression resulted in increased bone mass phenotype [<xref ref-type="bibr" rid="B217-ijms-21-04946">217</xref>,<xref ref-type="bibr" rid="B233-ijms-21-04946">233</xref>]. Although the pituitary gland and pancreatic islets additionally release CART into the system [<xref ref-type="bibr" rid="B234-ijms-21-04946">234</xref>], no direct effect on osteoblast gene expression was observed [<xref ref-type="bibr" rid="B233-ijms-21-04946">233</xref>].</p>
<p>Proopiomelanocortin (POMC) is a large precursor protein for multiple peptide hormones including ACTH, melanocyte-stimulating hormones (MSHs) and beta-endorphin [<xref ref-type="bibr" rid="B235-ijms-21-04946">235</xref>]. The melanocortin peptides ACTH and α-, β- and γ-MSH bind with varying affinity to five known melanocortin receptors (MCRs) belonging to the group of G protein-coupled receptors [<xref ref-type="bibr" rid="B236-ijms-21-04946">236</xref>]. While all POMC peptides feature immunomodulatory capacity attenuating inflammatory processes [<xref ref-type="bibr" rid="B236-ijms-21-04946">236</xref>], melanocortins were particularly identified to show osteo- and chondro-protective effects [<xref ref-type="bibr" rid="B237-ijms-21-04946">237</xref>,<xref ref-type="bibr" rid="B238-ijms-21-04946">238</xref>,<xref ref-type="bibr" rid="B239-ijms-21-04946">239</xref>,<xref ref-type="bibr" rid="B240-ijms-21-04946">240</xref>]. Therefore, α-MSH is proposed to potentially delay the process of inflammatory and degenerative joint diseases [<xref ref-type="bibr" rid="B240-ijms-21-04946">240</xref>]. Additionally, single nucleotide polymorphisms (SNPs) in the promoter region of the POMC gene were associated with low BMD [<xref ref-type="bibr" rid="B241-ijms-21-04946">241</xref>]. Female mice lacking estrogen receptors in POMC neurons display an increase in cortical bone mass and mechanical strength [<xref ref-type="bibr" rid="B242-ijms-21-04946">242</xref>], which implies a negative effect of estrogen on bone mass through POMC neurons.</p>
<p>Neuromedin U (NMU), a neuropeptide predominantly expressed in the pituitary and gastrointestinal tract [<xref ref-type="bibr" rid="B243-ijms-21-04946">243</xref>], is involved in the regulation of smooth muscle contraction, blood pressure, feeding, energy homeostasis, nociception and stress response [<xref ref-type="bibr" rid="B244-ijms-21-04946">244</xref>]. A central, leptin-dependent, regulation of bone remodeling by NMU was demonstrated in NMU-deficient mice which showed higher bone mass due to increased bone formation [<xref ref-type="bibr" rid="B245-ijms-21-04946">245</xref>]. In rats, NMU was reported to regulate the corticotropin releasing hormone as a stress response in the pituitary gland [<xref ref-type="bibr" rid="B243-ijms-21-04946">243</xref>,<xref ref-type="bibr" rid="B246-ijms-21-04946">246</xref>]. In this regard, elevated concentration of both ACTH and corticosterone were observed following NMU injections [<xref ref-type="bibr" rid="B247-ijms-21-04946">247</xref>]. Furthermore, NMU stimulates the release of vasopressin and enhances the secretion of steroids from rat adrenal cortex [<xref ref-type="bibr" rid="B247-ijms-21-04946">247</xref>]. Taken together, these observations point out potential treatment indications of NMU receptor agonists, which could target bone loss diseases or stress-related disorders without inducing unwanted body weight gain [<xref ref-type="bibr" rid="B248-ijms-21-04946">248</xref>,<xref ref-type="bibr" rid="B249-ijms-21-04946">249</xref>].</p>
<p>The vasoactive intestinal peptide (VIP) is synthesized in various tissues including the pancreas, gastrointestinal tract as well as the hypothalamus and the autonomic nervous system. VIP is commonly associated with the sympathetic (SNS) as well as the parasympathetic nervous system (PSNS) [<xref ref-type="bibr" rid="B250-ijms-21-04946">250</xref>], as ACh and VIP are often co-released from parasympathetic nerve fibers [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>] in the periosteum and epiphysis of bone [<xref ref-type="bibr" rid="B251-ijms-21-04946">251</xref>,<xref ref-type="bibr" rid="B252-ijms-21-04946">252</xref>,<xref ref-type="bibr" rid="B253-ijms-21-04946">253</xref>]. G protein-coupled VIP receptors are expressed in both osteoblasts [<xref ref-type="bibr" rid="B254-ijms-21-04946">254</xref>] and osteoclasts [<xref ref-type="bibr" rid="B255-ijms-21-04946">255</xref>]. VIP was reported to directly suppress receptor activator of nuclear factor κB (RANK) in osteoclasts and RANKL in osteoblasts, while it increases the expression of OPG [<xref ref-type="bibr" rid="B256-ijms-21-04946">256</xref>,<xref ref-type="bibr" rid="B257-ijms-21-04946">257</xref>] causing an anti-resorptive effect.</p>
<p>The central regulation of bone homeostasis is furthermore controlled by important neurotransmitters of the CNS, including the monoamine serotonin and dopamine as well as the excitatory neurotransmitter glutamate (<xref ref-type="fig" rid="ijms-21-04946-f001">Figure 1</xref>). In bone, different subtypes of G protein-coupled serotonin receptors are expressed by osteoblasts and osteoclasts [<xref ref-type="bibr" rid="B258-ijms-21-04946">258</xref>]. Gut-derived serotonin was reported to decrease osteoblast proliferation in a low-density lipoprotein receptor-related protein 5 (<italic>Lrp5</italic>)-dependent manner [<xref ref-type="bibr" rid="B259-ijms-21-04946">259</xref>], as well as to promote maturation of osteoclasts resulting in elevated bone resorption [<xref ref-type="bibr" rid="B260-ijms-21-04946">260</xref>]. In fact, it has not been clarified whether <italic>Lrp5</italic> signaling via the serotonin or Wnt pathway is more crucial [<xref ref-type="bibr" rid="B261-ijms-21-04946">261</xref>]. Overall, the impact of serotonin on bone metabolism is proposed to be origin-dependent, whereby peripherally produced serotonin inhibits and central serotonin enhances bone formation [<xref ref-type="bibr" rid="B262-ijms-21-04946">262</xref>]. These findings are supported by clinical data showing an acceleration of postmenopausal bone loss and reduction in bone mass accrual following the use of selective serotonin reuptake inhibitors (SSRIs) [<xref ref-type="bibr" rid="B263-ijms-21-04946">263</xref>,<xref ref-type="bibr" rid="B264-ijms-21-04946">264</xref>,<xref ref-type="bibr" rid="B265-ijms-21-04946">265</xref>].</p>
<p>Dopamine (DA), a member of the catecholamine family, is widely expressed in the CNS and some peripheral areas, which binds to five different dopamine receptors (DR<sub>1</sub>-DR<sub>5</sub>). Signaling of DR<sub>1</sub> [<xref ref-type="bibr" rid="B266-ijms-21-04946">266</xref>], DR<sub>2</sub> [<xref ref-type="bibr" rid="B267-ijms-21-04946">267</xref>], DR<sub>3</sub> and DR<sub>5</sub> [<xref ref-type="bibr" rid="B268-ijms-21-04946">268</xref>] was evidenced to enhance osteoblastic proliferation and bone mineralization as well as to suppress osteoclastogenesis [<xref ref-type="bibr" rid="B269-ijms-21-04946">269</xref>]. The inhibition of these receptors by atypical antipsychotics leads to bone loss [<xref ref-type="bibr" rid="B270-ijms-21-04946">270</xref>,<xref ref-type="bibr" rid="B271-ijms-21-04946">271</xref>]. Dopamine represents another important molecule of bone homeostasis which gains further importance in diseases with dopamine decline such as AD, PD, depression or schizophrenia, while it demonstrates that the clinical use of neuroleptics potentially affects bone mass [<xref ref-type="bibr" rid="B271-ijms-21-04946">271</xref>].</p>
<p>The excitatory neurotransmitter glutamate (GLU) activates ionotropic and metabotropic receptors. All mature bone cells feature glutamate receptors, with N-methyl-D-aspartate (NMDA) receptor being the most commonly expressed by osteoblasts [<xref ref-type="bibr" rid="B272-ijms-21-04946">272</xref>] and osteoclasts [<xref ref-type="bibr" rid="B273-ijms-21-04946">273</xref>,<xref ref-type="bibr" rid="B274-ijms-21-04946">274</xref>]. Glutamate inhibits osteoclast activity [<xref ref-type="bibr" rid="B275-ijms-21-04946">275</xref>] while promoting osteoblast differentiation and function [<xref ref-type="bibr" rid="B276-ijms-21-04946">276</xref>]. In addition, it was shown that not only bone is innervated densely by glutamate-containing nerve fibers [<xref ref-type="bibr" rid="B277-ijms-21-04946">277</xref>] but osteoblasts themselves secret glutamate through exocytosis [<xref ref-type="bibr" rid="B278-ijms-21-04946">278</xref>]. Intracellularly, the enzyme glutamine synthase converts active glutamate into inactive glutamine, thus regulating the concentration of glutamate. Interestingly, the basal expression of glutamine synthase itself was shown to be regulated positively by glucocorticoids and negatively by Wnt signaling or Vitamin D [<xref ref-type="bibr" rid="B279-ijms-21-04946">279</xref>], establishing glutamine synthase as a key player in the regulation of osteoblastogenesis.</p>
<p>The central regulation of bone remodeling is further controlled by the <bold>circadian clock</bold> [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>] as well as the endocannabinoid system [<xref ref-type="bibr" rid="B280-ijms-21-04946">280</xref>]. As the majority of homeostatic and metabolic functions are under circadian control, bone represents no exception, with central and peripheral circadian rhythms controlling bone remodeling. The central pacemaker is located in the hypothalamic suprachiasmatic nucleus, continuously synchronized with the daily light-dark cycle. The heterodimer of pacemaker transcription factors <italic>Bmal1</italic> and <italic>Clock</italic> regulate the gene expression of downstream targets such as periods (<italic>Per1–3</italic>) and cryptochromes (<italic>Cry1</italic>, <italic>Cry2</italic>) [<xref ref-type="bibr" rid="B281-ijms-21-04946">281</xref>]. A cyclic expression oscillation of these genes was discovered to regulate glucocorticoids by elevating the hypothalamic secretion of ACTH [<xref ref-type="bibr" rid="B282-ijms-21-04946">282</xref>] as well as the sympathetic outflow [<xref ref-type="bibr" rid="B283-ijms-21-04946">283</xref>,<xref ref-type="bibr" rid="B284-ijms-21-04946">284</xref>], both associated with a negative effect on bone mass. Although continuously synchronized with the central pacemaker, the existence of peripheral clocks was revealed following the observation of time dependent gene expression within different cell types [<xref ref-type="bibr" rid="B36-ijms-21-04946">36</xref>,<xref ref-type="bibr" rid="B285-ijms-21-04946">285</xref>]. In bone, circadian expression oscillation was primarily reported for osteoblast activity [<xref ref-type="bibr" rid="B286-ijms-21-04946">286</xref>,<xref ref-type="bibr" rid="B287-ijms-21-04946">287</xref>,<xref ref-type="bibr" rid="B288-ijms-21-04946">288</xref>] but also identified in osteoclasts and osteocytes [<xref ref-type="bibr" rid="B289-ijms-21-04946">289</xref>,<xref ref-type="bibr" rid="B290-ijms-21-04946">290</xref>] as well as mesenchymal stem cells [<xref ref-type="bibr" rid="B291-ijms-21-04946">291</xref>]. A further mechanistic understanding of the circadian system and bone remodeling relationship is thus expected to identify novel therapeutic strategies to treat major bone diseases such as osteoporosis.</p>
<p>Cannabinoid signaling is transduced by two cannabinoid receptors (CB1 and CB2), with CB1 predominantly expressed in presynaptic neurons of the CNS and PNS [<xref ref-type="bibr" rid="B292-ijms-21-04946">292</xref>,<xref ref-type="bibr" rid="B293-ijms-21-04946">293</xref>] and CB2 in peripheral tissues [<xref ref-type="bibr" rid="B294-ijms-21-04946">294</xref>]. CB2 receptors expressed in osteoblasts and osteoclasts [<xref ref-type="bibr" rid="B295-ijms-21-04946">295</xref>,<xref ref-type="bibr" rid="B296-ijms-21-04946">296</xref>,<xref ref-type="bibr" rid="B297-ijms-21-04946">297</xref>] were identified to promote bone formation as well as to represses RANKL, thereby inhibiting bone resorption [<xref ref-type="bibr" rid="B298-ijms-21-04946">298</xref>]. In clinical studies, genetic variants of the <italic>CNR2</italic> gene, encoding for CB2 receptors, were associated with low BMD and osteoporosis [<xref ref-type="bibr" rid="B299-ijms-21-04946">299</xref>]. In contrast, centrally expressed CB1 receptors are considered to decrease the sympathetic outflow by modulating adrenergic signaling [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. In this regard, CB1 receptors are proposed to transmit retrograde signals which inhibit the release of the sympathetic nervous system transmitter norepinephrine and thereby stimulate bone formation [<xref ref-type="bibr" rid="B300-ijms-21-04946">300</xref>,<xref ref-type="bibr" rid="B301-ijms-21-04946">301</xref>]. As a result, CB1/CB2 agonists and antagonists are under investigation for their therapeutic capacity in bone regeneration [<xref ref-type="bibr" rid="B302-ijms-21-04946">302</xref>]. Additionally, the phytocannabinoid cannabidiol was identified to stimulate collagen crosslinks and stabilize callus formation by stimulating lysyl-hydroxylase activity in osteoblasts while respecting the BBB, which promotes cannabidiol as a treatment option for osteoporosis [<xref ref-type="bibr" rid="B302-ijms-21-04946">302</xref>] and impaired fracture healing [<xref ref-type="bibr" rid="B303-ijms-21-04946">303</xref>].</p>
</sec>
<sec id="sec3dot1dot2-ijms-21-04946">
<title>3.1.2. SNS and PSNS</title>
<p>The autonomic nervous system integrates input from the internal and external microenvironment to ensure essential body function and homeostasis, also in adaption to stressors [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. The autonomic nervous system is separated into the sympathetic (SNS) and parasympathetic nervous system (PSNS), which are both substantially involved in the regulation of bone homeostasis [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>,<xref ref-type="bibr" rid="B4-ijms-21-04946">4</xref>,<xref ref-type="bibr" rid="B5-ijms-21-04946">5</xref>,<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>].</p>
<p>The SNS, commonly known to prepare for alert situations [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>], signals through the neurotransmitter norepinephrine (NE) which activates G protein-coupled α- and β-adrenergic receptors at effector organs. Noradrenergic fibers were identified within the periosteum, branching into the bone marrow and mineralized bone alongside blood vessels [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. Although the expression of subtypes from both α- and β-adrenergic receptors were detected in both osteoblasts and osteoclast [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>], osteoblastic β-adrenergic receptors are considered as the major transducers of sympathetic signaling in bone remodeling [<xref ref-type="bibr" rid="B304-ijms-21-04946">304</xref>]. The activation of β2-adrenergic receptors was identified to inhibit osteoblast function and further shown to induce the release of osteoblast-derived RANKL, thus promoting osteoclast formation [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>,<xref ref-type="bibr" rid="B233-ijms-21-04946">233</xref>].</p>
<p>As the SNS is considered a negative regulator of bone mass, the PSNS is proposed to counterbalance this impact. In contrast to the SNS, the PSNS emerges from cranial nerves as well as the sacral spinal cord, innervating the rostral and caudal part of the body, respectively. The PSNS promotes restive and digestive responses with a rather positive effect on bone remodeling, signaling through acetylcholine (ACh) at muscarinic and nicotinic cholinergic receptors [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. Although parasympathetic nerve fibers were discovered within the bone microenvironment [<xref ref-type="bibr" rid="B305-ijms-21-04946">305</xref>], specific density and pattern of the cholinergic bone innervation still remains to be determined [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. The expression of both cholinergic receptor types was identified in osteoclasts and osteoblasts, with osteoclasts being the predominant target of cholinergic signaling inducing an overall inhibitory effect [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. Notably, ACh inhibition [<xref ref-type="bibr" rid="B306-ijms-21-04946">306</xref>] and central muscarinic receptor deletion studies [<xref ref-type="bibr" rid="B307-ijms-21-04946">307</xref>] revealed a significant ACh regulation on CNS-mediated bone remodeling. Exclusively the deletion of muscarinic ACh receptor 3 (M3R), which is expressed in different areas of the brain, resulted in significant lower bone formation with elevated bone resorption, identical to the phenotype observed following adrenergic agonists treatment [<xref ref-type="bibr" rid="B308-ijms-21-04946">308</xref>]. Therefore, cholinergic signaling is proposed to promote bone mass accrual through the central decrease of sympathetic activity [<xref ref-type="bibr" rid="B307-ijms-21-04946">307</xref>].</p>
<p>Historically, the skeletal innervation of the autonomic nervous system was first identified histologically, while its crucial function for bone remodeling started with the discovery of leptin [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>]. Leptin represents an adipocyte-derived hormone, encoded by the <italic>Ob</italic> (<italic>Lep</italic>) gene. In bone, leptin was discovered to modulate bone metabolism through hypothalamic signaling, leading to an increase in cortical bone and a decrease in trabecular bone [<xref ref-type="bibr" rid="B308-ijms-21-04946">308</xref>,<xref ref-type="bibr" rid="B309-ijms-21-04946">309</xref>]. Along with its direct impact on the hypothalamus, leptin was observed to bind to hypothalamic receptors, which regulate bone metabolism through the SNS [<xref ref-type="bibr" rid="B310-ijms-21-04946">310</xref>,<xref ref-type="bibr" rid="B311-ijms-21-04946">311</xref>]. The impact of leptin on bone mass is also related to the intake of energy and IGF-1 pathway [<xref ref-type="bibr" rid="B312-ijms-21-04946">312</xref>]. Partially opposing the influence of leptin, the second adipocyte-derived hormone adiponectin was observed to signal in neurons of the locus coeruleus, which decreases the sympathetic tone and therefore leads to an increase in bone mass.</p>
</sec>
<sec id="sec3dot1dot3-ijms-21-04946">
<title>3.1.3. Sensory Innervation</title>
<p>Along with the SNS and PSNS, the sensory nervous system (SeNS) represents the third arm of the autonomic nervous system involved in the regulation of skeletal homeostasis [<xref ref-type="bibr" rid="B4-ijms-21-04946">4</xref>]. A network of sensory nerve fibers was identified in compartments of trabecular bone, with rich innervation throughout the periosteum [<xref ref-type="bibr" rid="B313-ijms-21-04946">313</xref>,<xref ref-type="bibr" rid="B314-ijms-21-04946">314</xref>]. The impact of sensory innervation on bone emerged from denervation studies using capsaicin to disrupt sensory neurons [<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>,<xref ref-type="bibr" rid="B5-ijms-21-04946">5</xref>]. The loss of sensory nerves caused elevated bone resorption with no influence on bone formation, overall resulting in reduced BMD [<xref ref-type="bibr" rid="B315-ijms-21-04946">315</xref>,<xref ref-type="bibr" rid="B316-ijms-21-04946">316</xref>].</p>
<p>Sensory nerves express calcitonin gene-related peptide and substance P as their main neurotransmitters [<xref ref-type="bibr" rid="B221-ijms-21-04946">221</xref>] which substantially regulate bone homeostasis (<xref ref-type="fig" rid="ijms-21-04946-f001">Figure 1</xref>). Calcitonin gene-related peptide (CGRP) represents a neuropeptide occurring as two major isoforms (α and β), both encoded by different genes while sharing similar biological activities [<xref ref-type="bibr" rid="B317-ijms-21-04946">317</xref>]. CGRP, expressed in both the CNS and PNS, primarily functions as a potent vasodilator. In bone, CGRP-positive nerve fibers were reported in the periosteum, epiphyseal trabecular bone and within the bone marrow itself [<xref ref-type="bibr" rid="B250-ijms-21-04946">250</xref>]. CGRP receptor expression was demonstrated in osteoblasts and bone marrow stromal cells, mediating the stimulatory effect of CGRP on osteoblast proliferation and differentiation [<xref ref-type="bibr" rid="B254-ijms-21-04946">254</xref>,<xref ref-type="bibr" rid="B318-ijms-21-04946">318</xref>,<xref ref-type="bibr" rid="B319-ijms-21-04946">319</xref>]. Additionally, CGRP was identified to inhibit osteoclast differentiation and activity in vitro [<xref ref-type="bibr" rid="B320-ijms-21-04946">320</xref>]. In bone regeneration, CGRP plasma levels were observed to be elevated in patients with long-bone fracture [<xref ref-type="bibr" rid="B321-ijms-21-04946">321</xref>], similar to rabbits suffering from fracture with concomitant traumatic brain injury [<xref ref-type="bibr" rid="B322-ijms-21-04946">322</xref>].</p>
<p>Substance P (SP) represents another sensory neuropeptide, which is released from sensory nerve endings. SP is synthesized from the tachykinin 1 (<italic>TAC1</italic>) gene and signals through neurokinin 1 receptors [<xref ref-type="bibr" rid="B323-ijms-21-04946">323</xref>]. Physiologically, SP is known for its initiating role in neurogenic inflammation, which can be further potentiated by CGRP [<xref ref-type="bibr" rid="B323-ijms-21-04946">323</xref>]. Following CNS injury, SP was reported to be substantially elevated [<xref ref-type="bibr" rid="B324-ijms-21-04946">324</xref>] and associated with the promotion of brain edema, injury of neurons, crucial BBB disruption and subsequent poor functional outcome [<xref ref-type="bibr" rid="B325-ijms-21-04946">325</xref>]. In bone, both osteoblasts and osteoclasts were shown to express neurokinin 1 receptors [<xref ref-type="bibr" rid="B318-ijms-21-04946">318</xref>,<xref ref-type="bibr" rid="B326-ijms-21-04946">326</xref>]. Although current evidence of SP on bone formation remains inconsistent [<xref ref-type="bibr" rid="B327-ijms-21-04946">327</xref>], SP is proposed to stimulate osteoblast proliferation and differentiation in a dose-dependent manner while simultaneously promoting the formation and activity of osteoclasts [<xref ref-type="bibr" rid="B328-ijms-21-04946">328</xref>]. In vivo, SP-deficiency was observed to cause a minor reduction in bone resorption but a major impairment of bone formation and mineralization [<xref ref-type="bibr" rid="B328-ijms-21-04946">328</xref>]. In bone repair, SP is considered an important regulator of angiogenesis which promotes fracture healing [<xref ref-type="bibr" rid="B329-ijms-21-04946">329</xref>], while the antagonization of its receptor neurokinin 1 results in reduced callus formation and biomechanical strength [<xref ref-type="bibr" rid="B330-ijms-21-04946">330</xref>,<xref ref-type="bibr" rid="B331-ijms-21-04946">331</xref>].</p>
<p>Different to the neuropeptides CGRP and SP, semaphorins represent a group of soluble and membrane-associated proteins, originally identified to regulate axonal guidance and growth [<xref ref-type="bibr" rid="B332-ijms-21-04946">332</xref>]. Different semaphorins are considered to be involved in bone homeostasis, such as semaphorin 3A (sema3A), sema4D, sema6D and sema7A [<xref ref-type="bibr" rid="B333-ijms-21-04946">333</xref>,<xref ref-type="bibr" rid="B334-ijms-21-04946">334</xref>]. Osteoblast-derived sema3A, particularly important for sensory neuronal development, was discovered to feature significant osteoprotective properties by promoting osteoblast function and suppressing osteoclastic activity [<xref ref-type="bibr" rid="B335-ijms-21-04946">335</xref>]. While studying conditional sem3A-deficient mice, only the depletion of sema3A in sensory neurons resulted in a lower BMD phenotype but not the inactivation of osteoblastic sema3A [<xref ref-type="bibr" rid="B336-ijms-21-04946">336</xref>]. These results contradict direct regulatory effects of sema3A on osteoblasts, indicating an indirect modulation of bone remodeling through sensory nerve development [<xref ref-type="bibr" rid="B1-ijms-21-04946">1</xref>,<xref ref-type="bibr" rid="B2-ijms-21-04946">2</xref>,<xref ref-type="bibr" rid="B4-ijms-21-04946">4</xref>,<xref ref-type="bibr" rid="B334-ijms-21-04946">334</xref>,<xref ref-type="bibr" rid="B335-ijms-21-04946">335</xref>,<xref ref-type="bibr" rid="B337-ijms-21-04946">337</xref>].</p>
<p>In summary, these observations highlight the importance of the nervous system in bone homeostasis and regeneration. While SNS activity results in a suppression of bone formation, PSNS and SeNS activity are proposed to counterbalance this effect by promoting bone formation and reducing bone resorption [<xref ref-type="bibr" rid="B1-ijms-21-04946">1</xref>,<xref ref-type="bibr" rid="B2-ijms-21-04946">2</xref>,<xref ref-type="bibr" rid="B3-ijms-21-04946">3</xref>]. The neuronal regulation of bone mass by SeNS-derived peptides exhibit exceptional features with notable future therapeutic potential.</p>
</sec>
</sec>
<sec id="sec3dot2-ijms-21-04946">
<title>3.2. Bone-Derived Mediators Acting on the Central Nervous System</title>
<p>Recent studies revealed a bidirectional dependence of brain and bone through bone cell-derived modulators that directly affect behavioral and cognitive function. The main bone-derived mediator affecting the brain represents osteocalcin (OCN), which is encoded by the <italic>BGLAP</italic> gene and exclusively synthesized by osteoblasts. Undercarboxylated, bioactive OCN, initially considered as an inhibitor of bone mineralization [<xref ref-type="bibr" rid="B337-ijms-21-04946">337</xref>], participates in systemic body regulation and homeostasis [<xref ref-type="bibr" rid="B338-ijms-21-04946">338</xref>] primarily regulating insulin secretion, muscle adaptation as well as testosterone production in the testis [<xref ref-type="bibr" rid="B6-ijms-21-04946">6</xref>]. In addition, OCN was recently discovered to transverse the BBB to enter the CNS, where it promotes spatial learning and memory while preventing anxiety-like behavior or even depression [<xref ref-type="bibr" rid="B6-ijms-21-04946">6</xref>]. Cognitive function and circulating levels of OCN are proposed to inversely correlate with age while maternal osteocalcin regulates embryonic brain development by enhancing monoamine neurotransmitters and their synthesis [<xref ref-type="bibr" rid="B339-ijms-21-04946">339</xref>]. Although the treatment capacity of OCN in neurodegenerative disorders remains to be elucidated [<xref ref-type="bibr" rid="B340-ijms-21-04946">340</xref>], models of movement disorders such as PD demonstrated a neuroprotective effect of OCN [<xref ref-type="bibr" rid="B341-ijms-21-04946">341</xref>], while OCN was reported to improve insulin sensitivity and muscle strength [<xref ref-type="bibr" rid="B342-ijms-21-04946">342</xref>]. Interestingly, the hormonal role of osteocalcin was currently challenged by two individually performed experimental studies [<xref ref-type="bibr" rid="B343-ijms-21-04946">343</xref>,<xref ref-type="bibr" rid="B344-ijms-21-04946">344</xref>] that generated novel murine osteocalcin-knockout strains which lacked the previously postulated endocrine dysregulation. Therefore, both OCN-deficient mice strains with a <italic>Bglap</italic>/<italic>Bglap2</italic> double-knockout allele displayed regular bone quantity, glucose metabolism, fertility [<xref ref-type="bibr" rid="B343-ijms-21-04946">343</xref>] and muscle mass [<xref ref-type="bibr" rid="B344-ijms-21-04946">344</xref>]. Bone microstructure analyses of the two studies revealed an increase in cortical bone carbonate-to-phosphate ratio and collagen maturity [<xref ref-type="bibr" rid="B343-ijms-21-04946">343</xref>] but also the disruption of the biological apatite crystallographic orientation which resulted in reduced bone strength [<xref ref-type="bibr" rid="B344-ijms-21-04946">344</xref>]. The impact of OCN-deficiency on cognition and brain development within the new models remains to be elucidated.</p>
<p>Another bone-derived mediator, lipocalin 2 (LCN2), also known as neutrophil gelatinase-associated lipocalin, is a glycoprotein which regulates energy metabolism by mediating insulin secretion and improving glucose tolerance as well as insulin sensitivity [<xref ref-type="bibr" rid="B345-ijms-21-04946">345</xref>]. Similar to osteocalcin, the predominantly osteoblast-derived LCN2 was recently discovered to cross the BBB in order to activate the anorexigenic pathway by binding to the melanocortin 4 receptor (MC4R) in the hypothalamus [<xref ref-type="bibr" rid="B346-ijms-21-04946">346</xref>]. Therefore, the suppression of appetite by LCN2 is referred to as an endocrine function of bone [<xref ref-type="bibr" rid="B346-ijms-21-04946">346</xref>].</p>
<p>Along with the osteoblast-derived OCN and LCN2, the osteocyte-specific sclerostin was additionally identified to affect brain function. Sclerostin, a glycoprotein encoded by the <italic>SOST</italic> gene, antagonizes Wnt signaling by binding to the Lrp4/5/6 [<xref ref-type="bibr" rid="B347-ijms-21-04946">347</xref>], which interrupts the Wnt/β-catenin pathway resulting in elevated bone resorption and reduced bone formation [<xref ref-type="bibr" rid="B348-ijms-21-04946">348</xref>]. Therefore, the inhibition of sclerostin was proposed as a therapeutic approach in the treatment of bone loss [<xref ref-type="bibr" rid="B349-ijms-21-04946">349</xref>], which led to the development and approval in the US and Europe of the monoclonal sclerostin-antibody Romosozumab for severe osteoporosis [<xref ref-type="bibr" rid="B350-ijms-21-04946">350</xref>,<xref ref-type="bibr" rid="B351-ijms-21-04946">351</xref>,<xref ref-type="bibr" rid="B352-ijms-21-04946">352</xref>,<xref ref-type="bibr" rid="B353-ijms-21-04946">353</xref>]. In the brain, Wnt/β-catenin signaling is essential for neurogenesis, neuronal survival, synaptic plasticity, BBB integrity [<xref ref-type="bibr" rid="B82-ijms-21-04946">82</xref>] and further associated with the pathophysiology of AD [<xref ref-type="bibr" rid="B354-ijms-21-04946">354</xref>]. As <italic>SOST</italic>/sclerostin is expressed by several other tissues in physiological and pathogenic conditions [<xref ref-type="bibr" rid="B355-ijms-21-04946">355</xref>], additional studies are required to elucidate whether pharmacologic inhibition of sclerostin may also affect Wnt/β-catenin signaling in the brain [<xref ref-type="bibr" rid="B8-ijms-21-04946">8</xref>].</p>
<p>Similar to sclerostin, dickkopf-related protein 1 (DKK1) represents another antagonist of Wnt signaling. In bone, DKK1 binds to Lrp6 also antagonizing the Wnt/β-catenin pathway [<xref ref-type="bibr" rid="B356-ijms-21-04946">356</xref>], whereby over-expression of DKK1 results in osteopenia [<xref ref-type="bibr" rid="B357-ijms-21-04946">357</xref>]. During early embryogenesis, DKK1 is released from the endoderm in order to control cell death and differentiation [<xref ref-type="bibr" rid="B358-ijms-21-04946">358</xref>]. As a result, over-expression of DKK1 leads to synaptic loss and neuronal apoptosis, making it a common marker for neuronal death in neurodegenerative diseases [<xref ref-type="bibr" rid="B359-ijms-21-04946">359</xref>]. In the aging brain, Wnt signaling was identified to generally diminish [<xref ref-type="bibr" rid="B360-ijms-21-04946">360</xref>], while DKK1 remained up-regulated [<xref ref-type="bibr" rid="B361-ijms-21-04946">361</xref>]. Such an elevation of DKK1 was clinically and experimentally reported for individuals suffering from AD, further supporting the hypothesis that Wnt signaling dysfunction contributes to the pathology of AD [<xref ref-type="bibr" rid="B362-ijms-21-04946">362</xref>]. Along with its positive effect on bone, restoring the Wnt/β-catenin signaling is regarded as a promising future therapeutic approach to treat neurodegenerative diseases [<xref ref-type="bibr" rid="B354-ijms-21-04946">354</xref>,<xref ref-type="bibr" rid="B359-ijms-21-04946">359</xref>,<xref ref-type="bibr" rid="B362-ijms-21-04946">362</xref>,<xref ref-type="bibr" rid="B363-ijms-21-04946">363</xref>,<xref ref-type="bibr" rid="B364-ijms-21-04946">364</xref>,<xref ref-type="bibr" rid="B365-ijms-21-04946">365</xref>].</p>
<p>In addition to the molecular mediators secreted by bone, bone marrow-derived cells were identified to enter the systemic circulation and migrate into the injured brain [<xref ref-type="bibr" rid="B8-ijms-21-04946">8</xref>]. In preclinical studies, bone marrow-derived microglia-like cells were shown to modulate amyloid pathology by restricting Aβ plaque formation and by supporting Aβ plaque clearance, which improved cognitive impairment [<xref ref-type="bibr" rid="B366-ijms-21-04946">366</xref>,<xref ref-type="bibr" rid="B367-ijms-21-04946">367</xref>,<xref ref-type="bibr" rid="B368-ijms-21-04946">368</xref>]. Therefore, recent attempts employed hematopoietic stem cells mobilized from bone marrow into the peripheral blood for autologous microglia-like cell preparation [<xref ref-type="bibr" rid="B369-ijms-21-04946">369</xref>], using specific antibodies to convert bone marrow cells into trafficking microglia-like cells [<xref ref-type="bibr" rid="B367-ijms-21-04946">367</xref>]. Additionally, the systemic transplantation of bone marrow-derived macrophages reduced neuroinflammation with a limited reversion of Aβ deposition [<xref ref-type="bibr" rid="B370-ijms-21-04946">370</xref>]. In summary, growing evidence of experimental AD studies demonstrates the capacity of bone marrow-derived microglia and macrophages to enter the CNS and to suppress the progression of brain degeneration, which provides a promising therapeutic tool for AD patients [<xref ref-type="bibr" rid="B8-ijms-21-04946">8</xref>,<xref ref-type="bibr" rid="B371-ijms-21-04946">371</xref>].</p>
</sec>
<sec id="sec3dot3-ijms-21-04946">
<title>3.3. Mediators Affecting Both Brain and Bone Function</title>
<p>Both brain and bone share common regulatory factors which are locally synthesized in both organ systems. These mediators include irisin, osteopontin (OPN) and RANKL as well as the growth factors brain-derived neurotrophic factor (BDNF), IGF-1 and bone morphogenic proteins (BMPs). Irisin, a cleaved product of the precursor type 1 membrane protein, is described as an exercise-induced myokine [<xref ref-type="bibr" rid="B372-ijms-21-04946">372</xref>,<xref ref-type="bibr" rid="B373-ijms-21-04946">373</xref>] with the capacity to change visceral adipose tissue into brown adipose tissue, highlighting its potential role in preventing obesity or even metabolic syndrome [<xref ref-type="bibr" rid="B374-ijms-21-04946">374</xref>,<xref ref-type="bibr" rid="B375-ijms-21-04946">375</xref>]. In the brain, irisin was discovered to feature neuroprotective effects following ischemic stroke [<xref ref-type="bibr" rid="B376-ijms-21-04946">376</xref>] through the activation of phagocytotic cells [<xref ref-type="bibr" rid="B377-ijms-21-04946">377</xref>], while rescuing synaptic plasticity and memory defects in models of AD [<xref ref-type="bibr" rid="B375-ijms-21-04946">375</xref>,<xref ref-type="bibr" rid="B377-ijms-21-04946">377</xref>,<xref ref-type="bibr" rid="B378-ijms-21-04946">378</xref>]. In bone, irisin showed osteoanabolic effects by enhancing osteoblastic activity and reducing the number of osteoclasts [<xref ref-type="bibr" rid="B372-ijms-21-04946">372</xref>]. Furthermore, irisin was proposed to upregulate <italic>RUNX2</italic> and Wnt/β-catenin signaling, potentially transmitted by the suppression of the Wnt antagonist sclerostin [<xref ref-type="bibr" rid="B373-ijms-21-04946">373</xref>]. As a result, irisin represents a notable pharmacologic target currently under discussion in osteoporosis-associated neurodegenerative diseases and metabolic research [<xref ref-type="bibr" rid="B7-ijms-21-04946">7</xref>,<xref ref-type="bibr" rid="B374-ijms-21-04946">374</xref>].</p>
<p>OPN represents a glycoprotein encoded by the <italic>SPP1</italic> gene, which is expressed in a variety of tissues including brain and bone. OPN is one of the non-collagenous proteins present in bone matrix, supporting bone demineralization by anchoring osteoclasts to bone mineral matrix which enhances the process of bone resorption [<xref ref-type="bibr" rid="B379-ijms-21-04946">379</xref>,<xref ref-type="bibr" rid="B380-ijms-21-04946">380</xref>]. Therefore, patients with high serum OPN levels are associated with low BMD [<xref ref-type="bibr" rid="B381-ijms-21-04946">381</xref>]. Besides bone tissue, OPN is a multifunctional molecule with high expression in inflammatory diseases, where it serves as a proinflammatory cytokine [<xref ref-type="bibr" rid="B382-ijms-21-04946">382</xref>]. In the brain, OPN is proposed to protect neurons and to regulate repair processes in various brain disorders such as ischemia, stroke, TBI and neurodegenerative diseases [<xref ref-type="bibr" rid="B77-ijms-21-04946">77</xref>,<xref ref-type="bibr" rid="B383-ijms-21-04946">383</xref>,<xref ref-type="bibr" rid="B384-ijms-21-04946">384</xref>,<xref ref-type="bibr" rid="B385-ijms-21-04946">385</xref>].</p>
<p>RANKL is encoded by the <italic>TNFSF11</italic> gene, also expressed in various tissues including brain and bone. In the CNS, RANKL/RANK are particularly present in the lateral septal nucleus of the hypothalamus, controlling the central regulation of fever and gender specific body temperature in females [<xref ref-type="bibr" rid="B386-ijms-21-04946">386</xref>], whereas in bone, RANKL represents the key mediator for activation, differentiation, fusion and survival of osteoclasts [<xref ref-type="bibr" rid="B387-ijms-21-04946">387</xref>]. For therapeutic treatment of bone loss diseases, the RANKL-neutralizing monoclonal antibody Denosumab [<xref ref-type="bibr" rid="B387-ijms-21-04946">387</xref>,<xref ref-type="bibr" rid="B388-ijms-21-04946">388</xref>] was developed, which is fully approved in the US and Europe. Recently, Denosumab was reported to improve chronic social defeat stress in mice [<xref ref-type="bibr" rid="B389-ijms-21-04946">389</xref>,<xref ref-type="bibr" rid="B390-ijms-21-04946">390</xref>], which is proposed as novel treatment indication in patients suffering from depression.</p>
<p>The growth factor BDNF is secreted in the CNS and PNS. In the brain, BDNF supports neurodevelopment, synaptic plasticity, neuronal differentiation and survival while its reduced levels are associated with neuronal dysfunction and degeneration in disorders such as depression, AD and PD [<xref ref-type="bibr" rid="B391-ijms-21-04946">391</xref>]. Interestingly, the central inactivation of BDNF expression leads to gender-dependent increased bone mass [<xref ref-type="bibr" rid="B392-ijms-21-04946">392</xref>], obesity and leptin resistance [<xref ref-type="bibr" rid="B393-ijms-21-04946">393</xref>].</p>
<p>IGF-1, a polypeptide hormone structurally similar to insulin, is primarily synthesized in the liver in response to growth hormone signaling [<xref ref-type="bibr" rid="B394-ijms-21-04946">394</xref>]. In the brain, IGF-1 was discovered to perform pleiotropic actions during development, alterations of neuronal excitability and enhancement of nerve cell metabolism, posing anti-apoptotic properties [<xref ref-type="bibr" rid="B395-ijms-21-04946">395</xref>]. In bone, the growth hormone/IGF-1 axis stimulates growth directly by activating chondrocyte proliferation and osteoblast differentiation [<xref ref-type="bibr" rid="B396-ijms-21-04946">396</xref>,<xref ref-type="bibr" rid="B397-ijms-21-04946">397</xref>], while the reduction of IGF-1 serum levels and insulin-deficiency of type 1 diabetes were associated with osteoporosis [<xref ref-type="bibr" rid="B397-ijms-21-04946">397</xref>].</p>
<p>Expressed in most body tissues, BMPs represent the largest subgroup of the transforming growth factor beta (TGFβ) family, regulating various developmental processes [<xref ref-type="bibr" rid="B398-ijms-21-04946">398</xref>]. In the brain, BMPs are involved in neurogenesis with differential expression levels in adults [<xref ref-type="bibr" rid="B399-ijms-21-04946">399</xref>,<xref ref-type="bibr" rid="B400-ijms-21-04946">400</xref>], indicating their participation in age-related neuronal dysfunction [<xref ref-type="bibr" rid="B401-ijms-21-04946">401</xref>]. Therefore, BMPs are discussed for therapeutic protection of the white matter [<xref ref-type="bibr" rid="B402-ijms-21-04946">402</xref>]. In bone, BMPs enhance endochondral ossification and skeletal regeneration [<xref ref-type="bibr" rid="B400-ijms-21-04946">400</xref>]. Interestingly, statins, commonly known for their application in cardiovascular diseases, were shown to promote osteogenesis via the BMP pathway by inhibiting osteoclastogenesis and apoptosis of osteoblasts [<xref ref-type="bibr" rid="B403-ijms-21-04946">403</xref>,<xref ref-type="bibr" rid="B404-ijms-21-04946">404</xref>,<xref ref-type="bibr" rid="B405-ijms-21-04946">405</xref>], which highlights their osteoanabolic and anti-resorptive treatment capacity [<xref ref-type="bibr" rid="B406-ijms-21-04946">406</xref>,<xref ref-type="bibr" rid="B407-ijms-21-04946">407</xref>].</p>
</sec>
</sec>
<sec id="sec4-ijms-21-04946" sec-type="conclusions">
<title>4. Conclusions</title>
<p>Several clinical observations provide key evidence for a bidirectional communication between brain and bone tissue, which is strongly supported by experimental studies that unraveled the underlying mechanistic pathways and identified molecular mediators involved in this crosstalk. The majority of brain-bone crosstalk is ’efferent,’ as the nervous system tightly modulates bone metabolism and regeneration. Thus, bone is regulated by multiple transmitters of both the CNS and PNS. Although evidence of the bone’s regulatory capacity is continuously growing, this ‘afferent’ loop has long been underestimated. Skeletal tissue emerged as a crucial modulator of cerebral development, function and pathologies. Investigating the diverse physiological and pathological interactions of brain and bone has thus revealed a variety of promising pharmacologic targets, supporting anabolic treatment strategies in bone and neuroprotective effects in brain pathologies. Future therapeutic approaches however need to consider the intense and dynamic brain-bone crosstalk as well as genetic and neuropsychological comorbidities of affected patients, potentially requiring additional monitoring or even individualized treatment regimes.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Tobias Thiele for his graphical support.</p>
</ack>
<app-group>
<app id="app1-ijms-21-04946">
<title>Supplementary Materials</title>
<p>The following are available online at <uri xlink:href="https://www.mdpi.com/1422-0067/21/14/4946/s1">https://www.mdpi.com/1422-0067/21/14/4946/s1</uri>.</p>
<supplementary-material content-type="local-data" id="ijms-21-04946-s001">
<media xlink:href="ijms-21-04946-s001.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</app>
</app-group>
<notes>
<title>Author Contributions</title>
<p>Conceptualization, E.O., P.-R.K., J.K.; writing—original draft preparation, E.O., P.-R.K., J.K.; writing—review and editing, E.O., P.-R.K., D.J., J.A., K.-H.F., S.T., J.K.; visualization, E.O., P.-R.K.; supervision, J.K.; funding acquisition, S.T., J.K. All authors have read and agreed to the published version of the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>This work was funded in part by the German Research Foundation (DFG KE 2179/2-1 and TS 303/2-1), the Else-Kröner-Fresenius Stiftung (EKFS 2017_A22) and the Berlin Institute of Health. We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charité—Universitätsmedizin Berlin.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-ijms-21-04946">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamouni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schreiweis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Oury</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Bone, brain &amp; beyond</article-title>
<source/>Rev. Endocr. Metab. Disord.
          <year>2015</year>
<volume>16</volume>
<fpage>99</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1007/s11154-015-9312-5</pub-id>
<pub-id pub-id-type="pmid">25771889</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-21-04946">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rousseaud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Moriceau</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramos-Brossier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Oury</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Bone-brain crosstalk and potential associated diseases</article-title>
<source/>Horm. Mol. Biol. Clin. Investig.
          <year>2016</year>
<volume>28</volume>
<fpage>69</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1515/hmbci-2016-0030</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-21-04946">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dimitri</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The Central Nervous System and Bone Metabolism: An Evolving Story</article-title>
<source/>Calcif. Tissue Int.
          <year>2017</year>
<volume>100</volume>
<fpage>476</fpage>
<lpage>485</lpage>
<pub-id pub-id-type="doi">10.1007/s00223-016-0179-6</pub-id>
<pub-id pub-id-type="pmid">27501818</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-21-04946">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Idelevich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Brain to bone: What is the contribution of the brain to skeletal homeostasis?</article-title>
<source/>Bone
          <year>2018</year>
<volume>115</volume>
<fpage>31</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2018.05.018</pub-id>
<pub-id pub-id-type="pmid">29777919</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-21-04946">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maryanovich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Frenette</surname>
<given-names>P.S.</given-names>
</name>
</person-group>
<article-title>Neural regulation of bone and bone marrow</article-title>
<source/>Cold Spring Harb. Perspect. Med.
          <year>2018</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.1101/cshperspect.a031344</pub-id>
<pub-id pub-id-type="pmid">29500307</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-21-04946">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Obri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khrimian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Oury</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Osteocalcin in the brain: From embryonic development to age-related decline in cognition</article-title>
<source/>Nat. Rev. Endocrinol.
          <year>2018</year>
<volume>14</volume>
<fpage>174</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1038/nrendo.2017.181</pub-id>
<pub-id pub-id-type="pmid">29376523</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-21-04946">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frame</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bretland</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Dengler-Crish</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Mechanistic complexities of bone loss in Alzheimer’s disease: A review</article-title>
<source/>Connect. Tissue Res.
          <year>2020</year>
<volume>61</volume>
<fpage>4</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1080/03008207.2019.1624734</pub-id>
<pub-id pub-id-type="pmid">31184223</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-21-04946">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bonser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Papadimitriou</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Mastaglia</surname>
<given-names>F.L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The potential influence of bone-derived modulators on the progression of Alzheimer’s disease</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2019</year>
<volume>69</volume>
<fpage>59</fpage>
<lpage>70</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-181249</pub-id>
<pub-id pub-id-type="pmid">30932886</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-21-04946">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tatangelo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Watts</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Connaughton</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Abimanyi-Ochom</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Borgström</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Shore-Lorenti</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stuart</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Iuliano-Burns</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The Cost of Osteoporosis, Osteopenia, and Associated Fractures in Australia in 2017</article-title>
<source/>J. Bone Miner. Res.
          <year>2019</year>
<volume>34</volume>
<fpage>616</fpage>
<lpage>625</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.3640</pub-id>
<pub-id pub-id-type="pmid">30615801</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-21-04946">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siris</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Adler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bilezikian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bolognese</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dawson-Hughes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Favus</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Jan De Beur</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Khosla</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>N.E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The clinical diagnosis of osteoporosis: A position statement from the National Bone Health Alliance Working Group</article-title>
<source/>Osteoporos. Int.
          <year>2014</year>
<volume>25</volume>
<fpage>1439</fpage>
<lpage>1443</lpage>
<pub-id pub-id-type="doi">10.1007/s00198-014-2655-z</pub-id>
<pub-id pub-id-type="pmid">24577348</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-21-04946">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petty</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Wilding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wark</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics—A Review</article-title>
<source/>Curr. Osteoporos. Rep.
          <year>2016</year>
<volume>14</volume>
<fpage>54</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1007/s11914-016-0302-7</pub-id>
<pub-id pub-id-type="pmid">26879819</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-21-04946">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kishimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>De Hert</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Manu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Correll</surname>
<given-names>C.U.</given-names>
</name>
</person-group>
<article-title>Osteoporosis and fracture risk in people with schizophrenia</article-title>
<source/>Curr. Opin. Psychiatry
          <year>2012</year>
<volume>25</volume>
<fpage>415</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.1097/YCO.0b013e328355e1ac</pub-id>
<pub-id pub-id-type="pmid">22744405</pub-id>
</element-citation>
</ref>
<ref id="B13-ijms-21-04946">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bukowska-Damska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Skowronska-Jozwiak</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Peplonska</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Night shift work and osteoporosis: Evidence and hypothesis</article-title>
<source/>Chronobiol. Int.
          <year>2019</year>
<volume>36</volume>
<fpage>171</fpage>
<lpage>180</lpage>
<pub-id pub-id-type="doi">10.1080/07420528.2018.1528553</pub-id>
<pub-id pub-id-type="pmid">30311808</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-21-04946">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Liou</surname>
<given-names>Y.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Post-traumatic stress disorder and risk of osteoporosis: A nationwide longitudinal study</article-title>
<source/>Stress Heal.
          <year>2018</year>
<volume>34</volume>
<fpage>440</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1002/smi.2806</pub-id>
<pub-id pub-id-type="pmid">29656531</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-21-04946">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aloumanis</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mavroudis</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>The “depressive” face of osteoporosis and the “osteoporotic” face of depression</article-title>
<source/>Hormones
          <year>2013</year>
<volume>12</volume>
<fpage>350</fpage>
<lpage>362</lpage>
<pub-id pub-id-type="doi">10.1007/BF03401301</pub-id>
<pub-id pub-id-type="pmid">24121377</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-21-04946">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cisari</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Invernizzi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bevilacqua</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Osteoporosis after stroke: A review of the causes and potential treatments</article-title>
<source/>Cerebrovasc. Dis.
          <year>2009</year>
<volume>28</volume>
<fpage>191</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1159/000226578</pub-id>
<pub-id pub-id-type="pmid">19571530</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-21-04946">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>R.Y.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease and osteoporosis</article-title>
<source/>Tzu Chi Med. J.
          <year>2017</year>
<volume>29</volume>
<fpage>138</fpage>
<lpage>142</lpage>
</element-citation>
</ref>
<ref id="B18-ijms-21-04946">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Invernizzi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Carda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Viscontini</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Cisari</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Osteoporosis in Parkinson’s disease</article-title>
<source/>Park. Relat. Disord.
          <year>2009</year>
<volume>15</volume>
<fpage>339</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2009.02.009</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-21-04946">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Comiskey</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Prevalence of and risk factors for osteoporosis in adults with acquired brain injury</article-title>
<source/>Ir. J. Med. Sci.
          <year>2016</year>
<volume>185</volume>
<fpage>473</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1007/s11845-016-1399-5</pub-id>
<pub-id pub-id-type="pmid">26787314</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-21-04946">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>The effects of spinal cord injury on bone healing in patients with femoral fractures</article-title>
<source/>J. Spinal Cord Med.
          <year>2014</year>
<volume>37</volume>
<fpage>414</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1179/2045772313Y.0000000155</pub-id>
<pub-id pub-id-type="pmid">24621032</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-21-04946">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borchers</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Gershwin</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Complex regional pain syndrome: A comprehensive and critical review</article-title>
<source/>Autoimmun. Rev.
          <year>2014</year>
<volume>13</volume>
<fpage>242</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1016/j.autrev.2013.10.006</pub-id>
<pub-id pub-id-type="pmid">24161450</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-21-04946">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonald</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Agoston</surname>
<given-names>D.V.</given-names>
</name>
<name>
<surname>Shultz</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>The effect of concomitant peripheral injury on traumatic brain injury pathobiology and outcome</article-title>
<source/>J. Neuroinflammation
          <year>2016</year>
<volume>13</volume>
<pub-id pub-id-type="doi">10.1186/s12974-016-0555-1</pub-id>
<pub-id pub-id-type="pmid">27117191</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-21-04946">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dennison</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Compston</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Flahive</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Siris</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Gehlbach</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Boonen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chapurlat</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Díez-Pérez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>F.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)</article-title>
<source/>Bone
          <year>2012</year>
<volume>50</volume>
<fpage>1288</fpage>
<lpage>1293</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2012.02.639</pub-id>
<pub-id pub-id-type="pmid">22426498</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-21-04946">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Spatz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cloutier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Palme</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Christiansen</surname>
<given-names>B.A.</given-names>
</name>
<name>
<surname>Bouxsein</surname>
<given-names>M.L.</given-names>
</name>
</person-group>
<article-title>Partial reductions in mechanical loading yield proportional changes in bone density, bone architecture, and muscle mass</article-title>
<source/>J. Bone Miner. Res.
          <year>2013</year>
<volume>28</volume>
<fpage>875</fpage>
<lpage>885</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.1814</pub-id>
<pub-id pub-id-type="pmid">23165526</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-21-04946">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feskanich</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hankinson</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Schernhammer</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>Nightshift work and fracture risk: The Nurses’ Health Study</article-title>
<source/>Osteoporos. Int.
          <year>2009</year>
<volume>20</volume>
<fpage>537</fpage>
<lpage>542</lpage>
<pub-id pub-id-type="doi">10.1007/s00198-008-0729-5</pub-id>
<pub-id pub-id-type="pmid">18766292</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-21-04946">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quevedo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zuniga</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Low bone mineral density in rotating-shift workers</article-title>
<source/>J. Clin. Densitom.
          <year>2010</year>
<volume>13</volume>
<fpage>467</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="doi">10.1016/j.jocd.2010.07.004</pub-id>
<pub-id pub-id-type="pmid">21029978</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-21-04946">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weibel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brandenberger</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Disturbances in Hormonal Profiles of Night Workers during Their Usual Sleep and Work Times</article-title>
<source/>J. Biol. Rhythms
          <year>1998</year>
<volume>13</volume>
<fpage>202</fpage>
<lpage>208</lpage>
<pub-id pub-id-type="doi">10.1177/074873098129000048</pub-id>
<pub-id pub-id-type="pmid">9615284</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-21-04946">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumont</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lanctt</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cadieux-Viau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Paquet</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Melatonin production and light exposure of rotating night workers</article-title>
<source/>Chronobiol. Int.
          <year>2012</year>
<volume>29</volume>
<fpage>203</fpage>
<lpage>210</lpage>
<pub-id pub-id-type="doi">10.3109/07420528.2011.647177</pub-id>
<pub-id pub-id-type="pmid">22324558</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-21-04946">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulhôa</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Marqueze</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Burgos</surname>
<given-names>L.G.A.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>C.R.C.</given-names>
</name>
</person-group>
<article-title>Shift work and endocrine disorders</article-title>
<source/>Int. J. Endocrinol.
          <year>2015</year>
<volume>2015</volume>
<pub-id pub-id-type="doi">10.1155/2015/826249</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-21-04946">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schernhammer</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Rosner</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Willet</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Laden</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Colditz</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Hankinson</surname>
<given-names>S.E.</given-names>
</name>
</person-group>
<article-title>Epidemiology of urinary melatonin in women and its relation to other hormones and night work</article-title>
<source/>Cancer Epidemiol. Biomarkers Prev.
          <year>2004</year>
<volume>13</volume>
<fpage>936</fpage>
<lpage>943</lpage>
<pub-id pub-id-type="pmid">15184249</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-21-04946">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manenschijn</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Van Kruysbergen</surname>
<given-names>R.G.P.M.</given-names>
</name>
<name>
<surname>De Jong</surname>
<given-names>F.H.</given-names>
</name>
<name>
<surname>Koper</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Van Rossum</surname>
<given-names>E.F.C.</given-names>
</name>
</person-group>
<article-title>Shift work at young age is associated with elevated long-term cortisol levels and body mass index</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>2011</year>
<volume>96</volume>
<fpage>1862</fpage>
<lpage>1865</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2011-1551</pub-id>
<pub-id pub-id-type="pmid">21880805</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-21-04946">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pimenta</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Kac</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Campos e Souza</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Maria de Barros Almeida Ferreira</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Maria de Fátima Silqueira</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Night-shift work and cardiovascular risk among employees of a public university</article-title>
<source/>Rev. da Assoc. Médica Bras. (English Ed.)
          <year>2012</year>
<volume>58</volume>
<fpage>168</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1016/S0104-4230(12)70177-X</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-21-04946">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strohmaier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Devore</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Schernhammer</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>A Review of Data of Findings on Night Shift Work and the Development of DM and CVD Events: A Synthesis of the Proposed Molecular Mechanisms</article-title>
<source/>Curr. Diab. Rep.
          <year>2018</year>
<volume>18</volume>
<pub-id pub-id-type="doi">10.1007/s11892-018-1102-5</pub-id>
<pub-id pub-id-type="pmid">30343445</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-21-04946">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schernhammer</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F.B.</given-names>
</name>
</person-group>
<article-title>Rotating night shift work and risk of type 2 diabetes: Two prospective cohort studies in women</article-title>
<source/>PLoS Med.
          <year>2011</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.1371/journal.pmed.1001141</pub-id>
<pub-id pub-id-type="pmid">22162955</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-21-04946">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ohtsuka-Isoya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shinoda</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Circadian rhythms in serum bone markers and their relation to the effect of etidronate in rats</article-title>
<source/>Chronobiol. Int.
          <year>2003</year>
<volume>20</volume>
<fpage>325</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1081/CBI-120019343</pub-id>
<pub-id pub-id-type="pmid">12723888</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-21-04946">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schibler</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Sassone-Corsi</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>A web of circadian pacemakers</article-title>
<source/>Cell
          <year>2002</year>
<volume>111</volume>
<fpage>919</fpage>
<lpage>922</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)01225-4</pub-id>
<pub-id pub-id-type="pmid">12507418</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-21-04946">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maronde</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schilling</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Seitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schinke</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schmutz</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>van der Horst</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Amling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Albrecht</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>The clock genes Period 2 and Cryptochrome 2 differentially balance bone formation</article-title>
<source/>PLoS ONE
          <year>2010</year>
<volume>5</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0011527</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-21-04946">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Everson</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Folley</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Toth</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Chronically inadequate sleep results in abnormal bone formation and abnormal bone marrow in rats</article-title>
<source/>Exp. Biol. Med.
          <year>2012</year>
<volume>237</volume>
<fpage>1101</fpage>
<lpage>1109</lpage>
<pub-id pub-id-type="doi">10.1258/ebm.2012.012043</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-21-04946">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Kohrt</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Buxton</surname>
<given-names>O.M.</given-names>
</name>
<name>
<surname>Everson</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Orwoll</surname>
<given-names>E.S.</given-names>
</name>
<name>
<surname>Shea</surname>
<given-names>S.A.</given-names>
</name>
</person-group>
<article-title>The importance of the circadian system &amp; sleep for bone health</article-title>
<source/>Metabolism
          <year>2018</year>
<volume>84</volume>
<fpage>28</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2017.12.002</pub-id>
<pub-id pub-id-type="pmid">29229227</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-21-04946">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swanson</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Shea</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Wolfe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cain</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Munch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vujović</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Czeisler</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Buxton</surname>
<given-names>O.M.</given-names>
</name>
<name>
<surname>Orwoll</surname>
<given-names>E.S.</given-names>
</name>
</person-group>
<article-title>Bone turnover markers after sleep restriction and circadian disruption: A mechanism for sleep-related bone loss in humans</article-title>
<source/>J. Clin. Endocrinol. Metab.
          <year>2017</year>
<volume>102</volume>
<fpage>3722</fpage>
<lpage>3730</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2017-01147</pub-id>
<pub-id pub-id-type="pmid">28973223</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-21-04946">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El-Gabalawy</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Blaney</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sumner</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Pietrzak</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Physical health conditions associated with full and subthreshold PTSD in U.S. military veterans: Results from the National Health and Resilience in Veterans Study</article-title>
<source/>J. Affect. Disord.
          <year>2018</year>
<volume>227</volume>
<fpage>849</fpage>
<lpage>853</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2017.11.058</pub-id>
<pub-id pub-id-type="pmid">29689700</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-21-04946">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toft</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bramness</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Abebe</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Wampold</surname>
<given-names>B.E.</given-names>
</name>
<name>
<surname>Tilden</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hestad</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Neupane</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>PTSD patients show increasing cytokine levels during treatment despite reduced psychological distress</article-title>
<source/>Neuropsychiatr. Dis. Treat.
          <year>2018</year>
<volume>14</volume>
<fpage>2367</fpage>
<lpage>2378</lpage>
<pub-id pub-id-type="doi">10.2147/NDT.S173659</pub-id>
<pub-id pub-id-type="pmid">30271153</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-21-04946">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeilschifter</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chenu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mundy</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Roodman</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro</article-title>
<source/>J. Bone Miner. Res.
          <year>1989</year>
<volume>4</volume>
<fpage>113</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.5650040116</pub-id>
<pub-id pub-id-type="pmid">2785743</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-21-04946">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daskalakis</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Lehrner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yehuda</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Endocrine Aspects of Post-traumatic Stress Disorder and Implications for Diagnosis and Treatment</article-title>
<source/>Endocrinol. Metab. Clin. N. Am.
          <year>2013</year>
<volume>42</volume>
<fpage>503</fpage>
<lpage>513</lpage>
<pub-id pub-id-type="doi">10.1016/j.ecl.2013.05.004</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-21-04946">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasan</surname>
<given-names>K.M.M.</given-names>
</name>
<name>
<surname>Rahman</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Arif</surname>
<given-names>K.M.T.</given-names>
</name>
<name>
<surname>Sobhani</surname>
<given-names>M.E.</given-names>
</name>
</person-group>
<article-title>Psychological stress and aging: Role of glucocorticoids (GCs)</article-title>
<source/>Age
          <year>2012</year>
<volume>34</volume>
<fpage>1421</fpage>
<lpage>1433</lpage>
<pub-id pub-id-type="doi">10.1007/s11357-011-9319-0</pub-id>
<pub-id pub-id-type="pmid">21971999</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-21-04946">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinstein</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Jilka</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Michael Parfitt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Manolagas</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts end osteocytes by glucocorticoids potential mechanisms of their deleterious effects on bone</article-title>
<source/>J. Clin. Investig.
          <year>1998</year>
<volume>102</volume>
<fpage>274</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1172/JCI2799</pub-id>
<pub-id pub-id-type="pmid">9664068</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-21-04946">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foertsch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Haffner-Luntzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kroner</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Erber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Reber</surname>
<given-names>S.O.</given-names>
</name>
<name>
<surname>Ignatius</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Chronic psychosocial stress disturbs long-bone growth in adolescent mice</article-title>
<source/>DMM Dis. Model. Mech.
          <year>2017</year>
<volume>10</volume>
<fpage>1399</fpage>
<lpage>1409</lpage>
<pub-id pub-id-type="doi">10.1242/dmm.030916</pub-id>
<pub-id pub-id-type="pmid">28982680</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-21-04946">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haffner-Luntzer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Foertsch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Prystaz</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tschaffon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mödinger</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bahney</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Marcucio</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Miclau</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ignatius</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic psychosocial stress compromises the immune response and endochondral ossification during bone fracture healing via β-AR signaling</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2019</year>
<volume>116</volume>
<fpage>8615</fpage>
<lpage>8622</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1819218116</pub-id>
<pub-id pub-id-type="pmid">30948630</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-21-04946">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schweiger</surname>
<given-names>J.U.</given-names>
</name>
<name>
<surname>Schweiger</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Hüppe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kahl</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Greggersen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fassbinder</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Bone density and depressive disorder: A meta-analysis</article-title>
<source/>Brain Behav.
          <year>2016</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1002/brb3.489</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-21-04946">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cizza</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Major depressive disorder is a risk factor for low bone mass, central obesity, and other medical conditions</article-title>
<source/>Dialogues Clin. Neurosci.
          <year>2011</year>
<volume>13</volume>
<fpage>73</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="pmid">21485748</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-21-04946">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cizza</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Primma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Coyle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gourgiotis</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Csako</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Depression and osteoporosis: A research synthesis with meta-analysis</article-title>
<source/>Horm. Metab. Res.
          <year>2010</year>
<volume>42</volume>
<fpage>467</fpage>
<lpage>482</lpage>
<pub-id pub-id-type="doi">10.1055/s-0030-1252020</pub-id>
<pub-id pub-id-type="pmid">20455194</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-21-04946">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yirmiya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bab</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis</article-title>
<source/>Biol. Psychiatry
          <year>2009</year>
<volume>66</volume>
<fpage>423</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2009.03.016</pub-id>
<pub-id pub-id-type="pmid">19446797</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-21-04946">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lembke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lazzeroni</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Schatzberg</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>HPA axis in major depression: Cortisol, clinical symptomatology and genetic variation predict cognition</article-title>
<source/>Mol. Psychiatry
          <year>2017</year>
<volume>22</volume>
<fpage>527</fpage>
<lpage>536</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.120</pub-id>
<pub-id pub-id-type="pmid">27528460</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-21-04946">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yirmiya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Goshen</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bajayo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kreisel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Feldman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trembovler</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Csernus</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Shohami</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bab</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Depression induces bone loss through stimulation of the sympathetic nervous system</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2006</year>
<volume>103</volume>
<fpage>16876</fpage>
<lpage>16881</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0604234103</pub-id>
<pub-id pub-id-type="pmid">17075068</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-21-04946">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mezuk</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Eaton</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Golden</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Depression and osteoporosis: Epidemiology and potential mediating pathways</article-title>
<source/>Osteoporos. Int.
          <year>2008</year>
<volume>19</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1007/s00198-007-0449-2</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-21-04946">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schweiger</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Deuschle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heuser</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Lumbar bone mineral density in patients with major depression: Evidence of increased bone loss at follow-up</article-title>
<source/>Am. J. Psychiatry
          <year>2000</year>
<volume>157</volume>
<fpage>118</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1176/ajp.157.1.118</pub-id>
<pub-id pub-id-type="pmid">10618024</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-21-04946">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>The effect of depression on fracture healing and osteoblast differentiation in rats</article-title>
<source/>Neuropsychiatr. Dis. Treat.
          <year>2018</year>
<volume>14</volume>
<fpage>1705</fpage>
<lpage>1713</lpage>
<pub-id pub-id-type="doi">10.2147/NDT.S168653</pub-id>
<pub-id pub-id-type="pmid">29988656</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-21-04946">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Feigin</surname>
<given-names>V.L.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cercy</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>C.O.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Parmar</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Abajobir</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Abate</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Abd-Allah</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016</article-title>
<source/>N. Engl. J. Med.
          <year>2018</year>
<volume>379</volume>
<fpage>2429</fpage>
<lpage>2437</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1804492</pub-id>
<pub-id pub-id-type="pmid">30575491</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-21-04946">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mughal</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Inderjeeth</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Inderjeeth</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Osteoporosis in patients with dementia is associated with high morbidity and mortality: Findings from a single orthogeriatric unit</article-title>
<source/>Aust. J. Gen. Pract.
          <year>2019</year>
<volume>48</volume>
<fpage>53</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.31128/AJGP-04-18-4544</pub-id>
<pub-id pub-id-type="pmid">31256458</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-21-04946">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Posada</surname>
<given-names>I.J.</given-names>
</name>
<name>
<surname>Benito-León</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Louis</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Trincado</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Villarejo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Medrano</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Bermejo-Pareja</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Mortality from Parkinson’s disease: A population-based prospective study (NEDICES)</article-title>
<source/>Mov. Disord.
          <year>2011</year>
<volume>26</volume>
<fpage>2522</fpage>
<lpage>2529</lpage>
<pub-id pub-id-type="doi">10.1002/mds.23921</pub-id>
<pub-id pub-id-type="pmid">21915906</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-21-04946">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abdullahi</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ronaldson</surname>
<given-names>P.T.</given-names>
</name>
</person-group>
<article-title>Blood-brain barrier dysfunction in ischemic stroke: Targeting tight junctions and transporters for vascular protection</article-title>
<source/>Am. J. Physiol. Cell Physiol.
          <year>2018</year>
<volume>315</volume>
<fpage>C343</fpage>
<lpage>C356</lpage>
<pub-id pub-id-type="doi">10.1152/ajpcell.00095.2018</pub-id>
<pub-id pub-id-type="pmid">29949404</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-21-04946">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramnemark</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nyberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Borssén</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Olsson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Fractures after stroke</article-title>
<source/>Osteoporos. Int.
          <year>1998</year>
<volume>8</volume>
<fpage>92</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1007/s001980050053</pub-id>
<pub-id pub-id-type="pmid">9692083</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-21-04946">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lyu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Impact of bone fracture on ischemic stroke recovery</article-title>
<source/>Int. J. Mol. Sci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>1533</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19051533</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-21-04946">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kuno</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kaji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Etoh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oizumi</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Influence of immobilization upon calcium metabolism in the week following hemiplegic stroke</article-title>
<source/>J. Neurol. Sci.
          <year>2000</year>
<volume>175</volume>
<fpage>135</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1016/S0022-510X(00)00298-7</pub-id>
<pub-id pub-id-type="pmid">10831774</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-21-04946">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>X.W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>Y.Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.F.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X.P.</given-names>
</name>
</person-group>
<article-title>High serum levels of sclerostin and Dickkopf-1 are associated with acute ischaemic stroke</article-title>
<source/>Atherosclerosis
          <year>2016</year>
<volume>253</volume>
<fpage>22</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2016.08.003</pub-id>
<pub-id pub-id-type="pmid">27573735</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-21-04946">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Serum Dkk-1 (Dickkopf-1) Is a Potential Biomarker in the Prediction of Clinical Outcomes among Patients with Acute Ischemic Stroke</article-title>
<source/>Arterioscler. Thromb. Vasc. Biol.
          <year>2019</year>
<volume>39</volume>
<fpage>285</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.118.311960</pub-id>
<pub-id pub-id-type="pmid">30580563</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-21-04946">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathold</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wanby</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Brudin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Von</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Alterations in bone turnover markers in patients with noncardio-embolic ischemic stroke</article-title>
<source/>PLoS ONE
          <year>2018</year>
<volume>13</volume>
<fpage>1</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0207348</pub-id>
<pub-id pub-id-type="pmid">30496210</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-21-04946">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beaupre</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Lew</surname>
<given-names>H.L.</given-names>
</name>
</person-group>
<article-title>Bone-density changes after stroke</article-title>
<source/>Am. J. Phys. Med. Rehabil.
          <year>2006</year>
<volume>85</volume>
<fpage>464</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="doi">10.1097/01.phm.0000214275.69286.7a</pub-id>
<pub-id pub-id-type="pmid">16628156</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-21-04946">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wheatley</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Cholok</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Levi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>The traumatic bone: Trauma-induced heterotopic ossification</article-title>
<source/>Transl. Res.
          <year>2017</year>
<volume>186</volume>
<fpage>95</fpage>
<lpage>111</lpage>
<pub-id pub-id-type="doi">10.1016/j.trsl.2017.06.004</pub-id>
<pub-id pub-id-type="pmid">28668522</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-21-04946">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerber</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>T.H.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Kowalski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Werb</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ferrara</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation</article-title>
<source/>Nat. Med.
          <year>1999</year>
<volume>5</volume>
<fpage>623</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="doi">10.1038/9467</pub-id>
<pub-id pub-id-type="pmid">10371499</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-21-04946">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Street</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>DeGuzman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bunting</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peale</surname>
<given-names>F.V.</given-names>
</name>
<name>
<surname>Ferrara</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Steinmetz</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hoeffel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cleland</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Daugherty</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2002</year>
<volume>99</volume>
<fpage>9656</fpage>
<lpage>9661</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.152324099</pub-id>
<pub-id pub-id-type="pmid">12118119</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-21-04946">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Bone fracture pre-ischemic stroke exacerbates ischemic cerebral injury in mice</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<elocation-id>e0153835</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0153835</pub-id>
<pub-id pub-id-type="pmid">27089041</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-21-04946">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Arrighi</surname>
<given-names>H.M.</given-names>
</name>
<name>
<surname>Bullock</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Hip fracture risk and subsequent mortality among Alzheimer’s disease patients in the United Kingdom, 1988–2007</article-title>
<source/>Age Ageing
          <year>2011</year>
<volume>40</volume>
<fpage>49</fpage>
<lpage>54</lpage>
<pub-id pub-id-type="doi">10.1093/ageing/afq146</pub-id>
<pub-id pub-id-type="pmid">21087990</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-21-04946">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>H.F.</given-names>
</name>
</person-group>
<article-title>Alzheimer’s disease and risk of hip fracture: A meta-analysis study</article-title>
<source/>Sci. World J.
          <year>2012</year>
<volume>2012</volume>
<pub-id pub-id-type="doi">10.1100/2012/872173</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-21-04946">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.K.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liliang</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Y.C.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased risk of hip fractures in patients with dementia: A nationwide population-based study</article-title>
<source/>BMC Neurol.
          <year>2014</year>
<volume>14</volume>
<pub-id pub-id-type="doi">10.1186/s12883-014-0175-2</pub-id>
<pub-id pub-id-type="pmid">25213690</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-21-04946">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loskutova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Honea</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Vidoni</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Burns</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Bone density and brain atrophy in early Alzheimer’s disease</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2009</year>
<volume>18</volume>
<fpage>777</fpage>
<lpage>785</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2009-1185</pub-id>
<pub-id pub-id-type="pmid">19661621</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-21-04946">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>X.S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Chi</surname>
<given-names>L.J.</given-names>
</name>
</person-group>
<article-title>Elevated osteopontin levels in mild cognitive impairment and Alzheimer’s disease</article-title>
<source/>Mediators Inflamm.
          <year>2013</year>
<volume>2013</volume>
<pub-id pub-id-type="doi">10.1155/2013/615745</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-21-04946">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Carecchio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chiocchetti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nicola</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Galimberti</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Fenoglio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cappellano</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Monaco</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Scarpini</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dianzani</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer’s disease and its levels correlate with cognitive decline</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2010</year>
<volume>19</volume>
<fpage>1143</fpage>
<lpage>1148</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2010-1309</pub-id>
<pub-id pub-id-type="pmid">20308780</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-21-04946">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fodor</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bondor</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Albu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Simon</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Craciun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muntean</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The value of osteopontin in the assessment of bone mineral density status in postmenopausal women</article-title>
<source/>J. Investig. Med.
          <year>2013</year>
<volume>61</volume>
<fpage>15</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.2310/JIM.0b013e3182761264</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-21-04946">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>McBride</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Narasimhan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Changolkar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gathagan</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Yue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dengler</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Amyloid-β plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation</article-title>
<source/>Nat. Med.
          <year>2018</year>
<volume>24</volume>
<fpage>29</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4443</pub-id>
<pub-id pub-id-type="pmid">29200205</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-21-04946">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Teguh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Amyloid β peptide enhances RANKL-induced osteoclast activation through NF-κB, ERK, and calcium oscillation signaling</article-title>
<source/>Int. J. Mol. Sci.
          <year>2016</year>
<volume>17</volume>
<elocation-id>1683</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms17101683</pub-id>
<pub-id pub-id-type="pmid">27735865</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-21-04946">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Piña-Crespo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease</article-title>
<source/>Mol. Brain
          <year>2019</year>
<volume>12</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1186/s13041-019-0525-5</pub-id>
<pub-id pub-id-type="pmid">30606245</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-21-04946">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gerlach</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Youdim</surname>
<given-names>M.B.H.</given-names>
</name>
<name>
<surname>Double</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Zecca</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Riederer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Becker</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Brain iron pathways and their relevance to Parkinson’s disease</article-title>
<source/>J. Neurochem.
          <year>2001</year>
<volume>79</volume>
<fpage>225</fpage>
<lpage>236</lpage>
<pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00608.x</pub-id>
<pub-id pub-id-type="pmid">11677250</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-21-04946">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fink</surname>
<given-names>A.L.</given-names>
</name>
</person-group>
<article-title>The aggregation and fibrillation of α-synuclein</article-title>
<source/>Acc. Chem. Res.
          <year>2006</year>
<volume>39</volume>
<fpage>628</fpage>
<lpage>634</lpage>
<pub-id pub-id-type="doi">10.1021/ar050073t</pub-id>
<pub-id pub-id-type="pmid">16981679</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-21-04946">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burré</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Südhof</surname>
<given-names>T.C.</given-names>
</name>
</person-group>
<article-title>Definition of a molecular pathway mediating α-synuclein neurotoxicity</article-title>
<source/>J. Neurosci.
          <year>2015</year>
<volume>35</volume>
<fpage>5221</fpage>
<lpage>5232</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4650-14.2015</pub-id>
<pub-id pub-id-type="pmid">25834048</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-21-04946">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kapral</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Alibhai</surname>
<given-names>S.M.H.</given-names>
</name>
<name>
<surname>Cram</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Casaubon</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Prager</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stamplecoski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rashkovan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Austin</surname>
<given-names>P.C.</given-names>
</name>
</person-group>
<article-title>Risk of fractures after stroke: Results from the Ontario Stroke Registry</article-title>
<source/>Neurology
          <year>2017</year>
<volume>88</volume>
<fpage>57</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000003457</pub-id>
<pub-id pub-id-type="pmid">27881629</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-21-04946">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Den Bos</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Speelman</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Van Nimwegen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Der Schouw</surname>
<given-names>Y.T.</given-names>
</name>
<name>
<surname>Backx</surname>
<given-names>F.J.G.</given-names>
</name>
<name>
<surname>Bloem</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Munneke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Verhaar</surname>
<given-names>H.J.J.</given-names>
</name>
</person-group>
<article-title>Bone mineral density and vitamin D status in Parkinson’s disease patients</article-title>
<source/>J. Neurol.
          <year>2013</year>
<volume>260</volume>
<fpage>754</fpage>
<lpage>760</lpage>
<pub-id pub-id-type="doi">10.1007/s00415-012-6697-x</pub-id>
<pub-id pub-id-type="pmid">23052606</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-21-04946">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torsney</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Noyce</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Doherty</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Bestwick</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>Bone health in Parkinson’s disease: A systematic review and meta-analysis</article-title>
<source/>J. Neurol. Neurosurg. Psychiatry
          <year>2014</year>
<volume>85</volume>
<fpage>1159</fpage>
<lpage>1166</lpage>
<pub-id pub-id-type="doi">10.1136/jnnp-2013-307307</pub-id>
<pub-id pub-id-type="pmid">24620034</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-21-04946">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Handa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kiyohara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hosonuma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sakai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Karakawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chatani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Inagaki</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone loss caused by dopaminergic degeneration and levodopa treatment in Parkinson’s disease model mice</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-50336-4</pub-id>
<pub-id pub-id-type="pmid">30626917</pub-id>
</element-citation>
</ref>
<ref id="B90-ijms-21-04946">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mundlos</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cleidocranial dysplasia: Clinical and molecular genetics</article-title>
<source/>J. Med. Genet.
          <year>1999</year>
<volume>36</volume>
<fpage>177</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.36.3.177</pub-id>
<pub-id pub-id-type="pmid">10204840</pub-id>
</element-citation>
</ref>
<ref id="B91-ijms-21-04946">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Izumi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yahagi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fujii</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kosaki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hosokai</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kosaki</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Cleidocranial dysplasia plus vascular anomalies with 6p21.2 microdeletion spanning RUNX2 and VEGF (4)</article-title>
<source/>Am. J. Med. Genet.
          <year>2006</year>
<volume>140 A</volume>
<fpage>398</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.31061</pub-id>
<pub-id pub-id-type="pmid">16419134</pub-id>
</element-citation>
</ref>
<ref id="B92-ijms-21-04946">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takenouchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Torii</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kosaki</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Progressive cognitive decline in an adult patient with cleidocranial dysplasia</article-title>
<source/>Eur. J. Med. Genet.
          <year>2014</year>
<volume>57</volume>
<fpage>319</fpage>
<lpage>321</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2014.04.015</pub-id>
<pub-id pub-id-type="pmid">24797831</pub-id>
</element-citation>
</ref>
<ref id="B93-ijms-21-04946">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trivier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>De Cesare</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Jacquot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pannetier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zackai</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mandel</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Sassone-Corsi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hanauer</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Mutations in the kinase Rsk-2 associated with Coffin-Lowry syndrome</article-title>
<source/>Nature
          <year>1996</year>
<volume>384</volume>
<fpage>567</fpage>
<lpage>570</lpage>
<pub-id pub-id-type="doi">10.1038/384567a0</pub-id>
<pub-id pub-id-type="pmid">8955270</pub-id>
</element-citation>
</ref>
<ref id="B94-ijms-21-04946">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques Pereira</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pannetier</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Heron</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hanauer</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Coffin-Lowry syndrome</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2010</year>
<volume>18</volume>
<fpage>627</fpage>
<lpage>633</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2009.189</pub-id>
<pub-id pub-id-type="pmid">19888300</pub-id>
</element-citation>
</ref>
<ref id="B95-ijms-21-04946">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poirier</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jacquot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vaillend</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Soutthiphong</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Libbey</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Laroche</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hanauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Welzl</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lipp</surname>
<given-names>H.P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior</article-title>
<source/>Behav. Genet.
          <year>2007</year>
<volume>37</volume>
<fpage>31</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1007/s10519-006-9116-1</pub-id>
<pub-id pub-id-type="pmid">17033934</pub-id>
</element-citation>
</ref>
<ref id="B96-ijms-21-04946">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kandel</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Dudai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mayford</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>The molecular and systems biology of memory</article-title>
<source/>Cell
          <year>2014</year>
<volume>157</volume>
<fpage>163</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2014.03.001</pub-id>
<pub-id pub-id-type="pmid">24679534</pub-id>
</element-citation>
</ref>
<ref id="B97-ijms-21-04946">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bialek</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Jacquot</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Masuoka</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Schinke</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brancorsini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sassone-Corsi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Townes</surname>
<given-names>T.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology: Implication for Coffin-Lowry syndrome</article-title>
<source/>Cell
          <year>2004</year>
<volume>117</volume>
<fpage>387</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(04)00344-7</pub-id>
<pub-id pub-id-type="pmid">15109498</pub-id>
</element-citation>
</ref>
<ref id="B98-ijms-21-04946">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Boules</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Phimphilai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Franceschi</surname>
<given-names>R.T.</given-names>
</name>
</person-group>
<article-title>Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression</article-title>
<source/>J. Biol. Chem.
          <year>2005</year>
<volume>280</volume>
<fpage>30689</fpage>
<lpage>30696</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M500750200</pub-id>
<pub-id pub-id-type="pmid">16000305</pub-id>
</element-citation>
</ref>
<ref id="B99-ijms-21-04946">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balemans</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)</article-title>
<source/>Hum. Mol. Genet.
          <year>2001</year>
<volume>10</volume>
<fpage>537</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/10.5.537</pub-id>
<pub-id pub-id-type="pmid">11181578</pub-id>
</element-citation>
</ref>
<ref id="B100-ijms-21-04946">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balemans</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ebeling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Van Hul</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wuyts</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lacza</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dioszegi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dikkers</surname>
<given-names>F.G.</given-names>
</name>
<name>
<surname>Hildering</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Willems</surname>
<given-names>P.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease</article-title>
<source/>J. Med. Genet.
          <year>2002</year>
<volume>39</volume>
<fpage>91</fpage>
<lpage>97</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.39.2.91</pub-id>
<pub-id pub-id-type="pmid">11836356</pub-id>
</element-citation>
</ref>
<ref id="B101-ijms-21-04946">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarez</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>De Vera</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Heslip</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Evaluation of the anatomic burden of patients with hereditary multiple exostoses</article-title>
<source/>Clin. Orthop. Relat. Res.
          <year>2007</year>
<fpage>73</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1097/BLO.0b013e3181334b51</pub-id>
<pub-id pub-id-type="pmid">17589361</pub-id>
</element-citation>
</ref>
<ref id="B102-ijms-21-04946">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamagata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Momoi</surname>
<given-names>M.Y.</given-names>
</name>
</person-group>
<article-title>Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1</article-title>
<source/>J. Hum. Genet.
          <year>2002</year>
<volume>47</volume>
<fpage>262</fpage>
<lpage>265</lpage>
<pub-id pub-id-type="doi">10.1007/s100380200036</pub-id>
<pub-id pub-id-type="pmid">12032595</pub-id>
</element-citation>
</ref>
<ref id="B103-ijms-21-04946">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narvid</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gorno-Tempini</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Slavotinek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>DeArmond</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Cha</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Rankin</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Of brain and bone: The unusual case of Dr. A</article-title>
<source/>Neurocase
          <year>2009</year>
<volume>15</volume>
<fpage>190</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1080/13554790802632967</pub-id>
<pub-id pub-id-type="pmid">20183548</pub-id>
</element-citation>
</ref>
<ref id="B104-ijms-21-04946">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marinus</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moseley</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Birklein</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Maihöfner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kingery</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Hilten</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Van Syndrome–current state of the art</article-title>
<source/>Lancet Neurol.
          <year>2011</year>
<volume>10</volume>
<fpage>637</fpage>
<lpage>648</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(11)70106-5</pub-id>
<pub-id pub-id-type="pmid">21683929</pub-id>
</element-citation>
</ref>
<ref id="B105-ijms-21-04946">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lohnberg</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Altmaier</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>A review of psychosocial factors in complex regional pain syndrome</article-title>
<source/>J. Clin. Psychol. Med. Settings
          <year>2013</year>
<volume>20</volume>
<fpage>247</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1007/s10880-012-9322-3</pub-id>
<pub-id pub-id-type="pmid">22961122</pub-id>
</element-citation>
</ref>
<ref id="B106-ijms-21-04946">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bazika-Gerasch</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kumowski</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fiege</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kaisler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vollert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dietrich</surname>
<given-names>J.W.</given-names>
</name>
</person-group>
<article-title>Compared to limb pain of other origin, ultrasonographic osteodensitometry reveals loss of bone density in complex regional pain syndrome</article-title>
<source/>Pain
          <year>2019</year>
<volume>160</volume>
<fpage>1261</fpage>
<lpage>1269</lpage>
<pub-id pub-id-type="doi">10.1097/j.pain.0000000000001520</pub-id>
<pub-id pub-id-type="pmid">30747906</pub-id>
</element-citation>
</ref>
<ref id="B107-ijms-21-04946">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krämer</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Hofbauer</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Szalay</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Breimhorst</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eberle</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zieschang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Rauner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schlereth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schreckenberger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Birklein</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Osteoprotegerin: A new biomarker for impaired bone metabolism in complex regional pain syndrome?</article-title>
<source/>Pain
          <year>2014</year>
<volume>155</volume>
<fpage>889</fpage>
<lpage>895</lpage>
<pub-id pub-id-type="doi">10.1016/j.pain.2014.01.014</pub-id>
<pub-id pub-id-type="pmid">24447513</pub-id>
</element-citation>
</ref>
<ref id="B108-ijms-21-04946">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menon</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Schwab</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>A.I.</given-names>
</name>
</person-group>
<article-title>Position statement: Definition of traumatic brain injury</article-title>
<source/>Arch. Phys. Med. Rehabil.
          <year>2010</year>
<volume>91</volume>
<fpage>1637</fpage>
<lpage>1640</lpage>
<pub-id pub-id-type="doi">10.1016/j.apmr.2010.05.017</pub-id>
<pub-id pub-id-type="pmid">21044706</pub-id>
</element-citation>
</ref>
<ref id="B109-ijms-21-04946">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marmarou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Steyerberg</surname>
<given-names>E.W.</given-names>
</name>
</person-group>
<article-title>Mortality from traumatic brain injury</article-title>
<source/>Acta Neurochir. Suppl.
          <year>2005</year>
<fpage>281</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1007/3-211-32318-X_58</pub-id>
<pub-id pub-id-type="pmid">16463866</pub-id>
</element-citation>
</ref>
<ref id="B110-ijms-21-04946">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blennow</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hardy</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zetterberg</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The Neuropathology and Neurobiology of Traumatic Brain Injury</article-title>
<source/>Neuron
          <year>2012</year>
<volume>76</volume>
<fpage>886</fpage>
<lpage>899</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2012.11.021</pub-id>
<pub-id pub-id-type="pmid">23217738</pub-id>
</element-citation>
</ref>
<ref id="B111-ijms-21-04946">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barshikar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>K.R.</given-names>
</name>
</person-group>
<article-title>Sleep Disturbance After TBI</article-title>
<source/>Curr. Neurol. Neurosci. Rep.
          <year>2017</year>
<volume>17</volume>
<pub-id pub-id-type="doi">10.1007/s11910-017-0792-4</pub-id>
</element-citation>
</ref>
<ref id="B112-ijms-21-04946">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Werner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Engelhard</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Pathophysiology of traumatic brain injury</article-title>
<source/>Br. J. Anaesth.
          <year>2007</year>
<volume>99</volume>
<fpage>4</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1093/bja/aem131</pub-id>
<pub-id pub-id-type="pmid">17573392</pub-id>
</element-citation>
</ref>
<ref id="B113-ijms-21-04946">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strbian</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Durukan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pitkonen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marinkovic</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tatlisumak</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pedrono</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Abo-Ramadan</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Tatlisumak</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia</article-title>
<source/>Neuroscience
          <year>2008</year>
<volume>153</volume>
<fpage>175</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.02.012</pub-id>
<pub-id pub-id-type="pmid">18367342</pub-id>
</element-citation>
</ref>
<ref id="B114-ijms-21-04946">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonald</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Sharkey</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kaukas</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Shultz</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Corrigan</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Beyond the Brain: Peripheral Interactions after Traumatic Brain Injury</article-title>
<source/>J. Neurotrauma
          <year>2020</year>
<volume>37</volume>
<fpage>770</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1089/neu.2019.6885</pub-id>
<pub-id pub-id-type="pmid">32041478</pub-id>
</element-citation>
</ref>
<ref id="B115-ijms-21-04946">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trentz</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Handschin</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Bestmann</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hoerstrup</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Trentz</surname>
<given-names>O.L.</given-names>
</name>
<name>
<surname>Platz</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Influence of brain injury on early posttraumatic bone metabolism</article-title>
<source/>Crit. Care Med.
          <year>2005</year>
<volume>33</volume>
<fpage>399</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1097/01.CCM.0000152221.87477.21</pub-id>
<pub-id pub-id-type="pmid">15699845</pub-id>
</element-citation>
</ref>
<ref id="B116-ijms-21-04946">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banham-Hall</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kothwal</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pipkin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bentley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dickens</surname>
<given-names>G.L.</given-names>
</name>
</person-group>
<article-title>Prevalence of low bone mineral density in inpatients with traumatic brain injury receiving neurobehavioural rehabilitation: A postoperative, observational study</article-title>
<source/>Physiother
          <year>2013</year>
<volume>99</volume>
<fpage>328</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1016/j.physio.2012.12.009</pub-id>
</element-citation>
</ref>
<ref id="B117-ijms-21-04946">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mohan</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The negative impact of traumatic brain injury (TBI) on bone in a mouse model</article-title>
<source/>Brain Inj.
          <year>2014</year>
<volume>28</volume>
<fpage>244</fpage>
<lpage>251</lpage>
<pub-id pub-id-type="doi">10.3109/02699052.2013.859735</pub-id>
<pub-id pub-id-type="pmid">24295038</pub-id>
</element-citation>
</ref>
<ref id="B118-ijms-21-04946">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brady</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Shultz</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Romano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>van der Poel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Wark</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Grills</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>Experimental Traumatic Brain Injury Induces Bone Loss in Rats</article-title>
<source/>J. Neurotrauma
          <year>2016</year>
<volume>33</volume>
<fpage>2154</fpage>
<lpage>2160</lpage>
<pub-id pub-id-type="doi">10.1089/neu.2014.3836</pub-id>
<pub-id pub-id-type="pmid">25686841</pub-id>
</element-citation>
</ref>
<ref id="B119-ijms-21-04946">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajwa</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Kesavan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mohan</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Long-term consequences of Traumatic brain injury in bone metabolism</article-title>
<source/>Front. Neurol.
          <year>2018</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.3389/fneur.2018.00115</pub-id>
</element-citation>
</ref>
<ref id="B120-ijms-21-04946">
<label>120.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singleton</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Vaibhav</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Khayrullin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mendhe</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kolhe</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Awad</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone Marrow Derived Extracellular Vesicles Activate Osteoclast Differentiation in Traumatic Brain Injury Induced Bone Loss</article-title>
<source/>Cells
          <year>2019</year>
<volume>8</volume>
<elocation-id>63</elocation-id>
<pub-id pub-id-type="doi">10.3390/cells8010063</pub-id>
</element-citation>
</ref>
<ref id="B121-ijms-21-04946">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simonsen</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Sonne-Holm</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krasheninnikoff</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Engberg</surname>
<given-names>A.W.</given-names>
</name>
</person-group>
<article-title>Symptomatic heterotopic ossification after very severe traumatic brain injury in 114 patients: Incidence and risk factors</article-title>
<source/>Injury
          <year>2007</year>
<volume>38</volume>
<fpage>1146</fpage>
<lpage>1150</lpage>
<pub-id pub-id-type="doi">10.1016/j.injury.2007.03.019</pub-id>
<pub-id pub-id-type="pmid">17572418</pub-id>
</element-citation>
</ref>
<ref id="B122-ijms-21-04946">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almangour</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Schnitzler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Debaud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Denormandie</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Genêt</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Recurrence of heterotopic ossification after removal in patients with traumatic brain injury: A systematic review</article-title>
<source/>Ann. Phys. Rehabil. Med.
          <year>2016</year>
<volume>59</volume>
<fpage>263</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="doi">10.1016/j.rehab.2016.03.009</pub-id>
<pub-id pub-id-type="pmid">27173174</pub-id>
</element-citation>
</ref>
<ref id="B123-ijms-21-04946">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W.X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Z.T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Relationship between heterotopic ossification and traumatic brain injury: Why severe traumatic brain injury increases the risk of heterotopic ossification</article-title>
<source/>J. Orthop. Transl.
          <year>2018</year>
<volume>12</volume>
<fpage>16</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1016/j.jot.2017.10.002</pub-id>
</element-citation>
</ref>
<ref id="B124-ijms-21-04946">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brady</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Shultz</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Neurological heterotopic ossification: Current understanding and future directions</article-title>
<source/>Bone
          <year>2018</year>
<volume>109</volume>
<fpage>35</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2017.05.015</pub-id>
<pub-id pub-id-type="pmid">28526267</pub-id>
</element-citation>
</ref>
<ref id="B125-ijms-21-04946">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Gugala</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Olmsted-Davis</surname>
<given-names>E.A.</given-names>
</name>
</person-group>
<article-title>Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification</article-title>
<source/>Bone
          <year>2018</year>
<volume>109</volume>
<fpage>22</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2017.07.016</pub-id>
<pub-id pub-id-type="pmid">28716552</pub-id>
</element-citation>
</ref>
<ref id="B126-ijms-21-04946">
<label>126.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anthonissen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Steffen</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Alessandri</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Baranowski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rommens</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Victor</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hofmann</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Traumatic brain injury enhances the formation of heterotopic ossification around the hip: An animal model study</article-title>
<source/>Arch. Orthop. Trauma Surg.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1007/s00402-019-03326-0</pub-id>
</element-citation>
</ref>
<ref id="B127-ijms-21-04946">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brady</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.Z.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Casilla-Espinosa</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Yamakawa</surname>
<given-names>G.R.</given-names>
</name>
<name>
<surname>Wortman</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grills</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Mychasiuk</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>T.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel rat model of heterotopic ossification after polytrauma with traumatic brain injury</article-title>
<source/>Bone
          <year>2020</year>
<volume>133</volume>
<pub-id pub-id-type="doi">10.1016/j.bone.2020.115263</pub-id>
</element-citation>
</ref>
<ref id="B128-ijms-21-04946">
<label>128.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newman</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Stone</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Accelerated fracture union in association with severe head injury</article-title>
<source/>Injury
          <year>1987</year>
<volume>18</volume>
<fpage>241</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1016/0020-1383(87)90006-4</pub-id>
<pub-id pub-id-type="pmid">3508863</pub-id>
</element-citation>
</ref>
<ref id="B129-ijms-21-04946">
<label>129.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perkins</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Skirving</surname>
<given-names>A.P.</given-names>
</name>
</person-group>
<article-title>Callus formation and the rate of healing of femoral fractures in patients with head injuries</article-title>
<source/>J. Bone Jt. Surg. Ser. B
          <year>1987</year>
<volume>69</volume>
<fpage>521</fpage>
<lpage>524</lpage>
<pub-id pub-id-type="doi">10.1302/0301-620X.69B4.3611150</pub-id>
</element-citation>
</ref>
<ref id="B130-ijms-21-04946">
<label>130.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spencer</surname>
<given-names>R.F.</given-names>
</name>
</person-group>
<article-title>The effect of head injury on fracture healing. A quantitative assessment</article-title>
<source/>J. Bone Jt. Surg. Ser. B
          <year>1987</year>
<volume>69</volume>
<fpage>525</fpage>
<lpage>528</lpage>
<pub-id pub-id-type="doi">10.1302/0301-620X.69B4.3611151</pub-id>
</element-citation>
</ref>
<ref id="B131-ijms-21-04946">
<label>131.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giannoudis</surname>
<given-names>P.V.</given-names>
</name>
<name>
<surname>Mushtaq</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Harwood</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kambhampati</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Dimoutsos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stavrou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Pape</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Accelerated bone healing and excessive callus formation in patients with femoral fracture and head injury</article-title>
<source/>Injury
          <year>2006</year>
<volume>37</volume>
<pub-id pub-id-type="doi">10.1016/j.injury.2006.08.020</pub-id>
<pub-id pub-id-type="pmid">16963358</pub-id>
</element-citation>
</ref>
<ref id="B132-ijms-21-04946">
<label>132.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cadosch</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gautschi</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Thyer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Skirving</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Filgueira</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zellweger</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Humoral factors enhance fracture-healing and callus formation in patients with traumatic brain injury</article-title>
<source/>J. Bone Jt. Surg. Ser. A
          <year>2009</year>
<volume>91</volume>
<fpage>282</fpage>
<lpage>288</lpage>
<pub-id pub-id-type="doi">10.2106/JBJS.G.01613</pub-id>
<pub-id pub-id-type="pmid">19181971</pub-id>
</element-citation>
</ref>
<ref id="B133-ijms-21-04946">
<label>133.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Does traumatic brain injury result in accelerated mandibular fracture healing?</article-title>
<source/>J. Oral Maxillofac. Surg.
          <year>2012</year>
<volume>70</volume>
<fpage>2135</fpage>
<lpage>2142</lpage>
<pub-id pub-id-type="doi">10.1016/j.joms.2012.04.016</pub-id>
<pub-id pub-id-type="pmid">22907111</pub-id>
</element-citation>
</ref>
<ref id="B134-ijms-21-04946">
<label>134.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>T.Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T.C.</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>K.C.</given-names>
</name>
</person-group>
<article-title>The effects of an injury to the brain on bone healing and callus formation in young adults with fractures of the femoral shaft</article-title>
<source/>J. Bone Jt. Surg. Ser. B
          <year>2012</year>
<volume>94 B</volume>
<fpage>227</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="doi">10.1302/0301-620X.94B2.28193</pub-id>
</element-citation>
</ref>
<ref id="B135-ijms-21-04946">
<label>135.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claes</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Recknagel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ignatius</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Fracture healing under healthy and inflammatory conditions</article-title>
<source/>Nat. Rev. Rheumatol.
          <year>2012</year>
<volume>8</volume>
<fpage>133</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1038/nrrheum.2012.1</pub-id>
<pub-id pub-id-type="pmid">22293759</pub-id>
</element-citation>
</ref>
<ref id="B136-ijms-21-04946">
<label>136.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schell</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Duda</surname>
<given-names>G.N.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tsitsilonis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Schmidt-Bleek</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>The haematoma and its role in bone healing</article-title>
<source/>J. Exp. Orthop.
          <year>2017</year>
<volume>4</volume>
<pub-id pub-id-type="doi">10.1186/s40634-017-0079-3</pub-id>
</element-citation>
</ref>
<ref id="B137-ijms-21-04946">
<label>137.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Koopmans</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kobbe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Poeze</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Andruszkow</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brink</surname>
<given-names>P.R.G.</given-names>
</name>
<name>
<surname>Pape</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Improved fracture healing in patients with concomitant traumatic brain injury: Proven or not?</article-title>
<source/>Mediators Inflamm.
          <year>2015</year>
<volume>2015</volume>
<pub-id pub-id-type="doi">10.1155/2015/204842</pub-id>
</element-citation>
</ref>
<ref id="B138-ijms-21-04946">
<label>138.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toffoli</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Gautschi</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Frey</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Filgueira</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zellweger</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>From brain to bone: Evidence for the release of osteogenic humoral factors after traumatic brain injury</article-title>
<source/>Brain Inj.
          <year>2008</year>
<volume>22</volume>
<fpage>511</fpage>
<lpage>518</lpage>
<pub-id pub-id-type="doi">10.1080/02699050802158235</pub-id>
<pub-id pub-id-type="pmid">18568704</pub-id>
</element-citation>
</ref>
<ref id="B139-ijms-21-04946">
<label>139.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bidner</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Rubins</surname>
<given-names>I.M.</given-names>
</name>
<name>
<surname>Desjardins</surname>
<given-names>J.V.</given-names>
</name>
<name>
<surname>Zukor</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Goltzman</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Evidence for a humoral mechanism for enhanced osteogenesis after head injury</article-title>
<source/>J. Bone Jt. Surg. Ser. A
          <year>1990</year>
<volume>72</volume>
<fpage>1144</fpage>
<lpage>1149</lpage>
<pub-id pub-id-type="doi">10.2106/00004623-199072080-00004</pub-id>
</element-citation>
</ref>
<ref id="B140-ijms-21-04946">
<label>140.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gautschi</surname>
<given-names>O.P.</given-names>
</name>
<name>
<surname>Toffoli</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Joesbury</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Skirving</surname>
<given-names>A.P.</given-names>
</name>
<name>
<surname>Filgueira</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zellweger</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Osteoinductive effect of cerebrospinal fluid from brain-injured patients</article-title>
<source/>J. Neurotrauma
          <year>2007</year>
<volume>24</volume>
<fpage>154</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1089/neu.2006.0166</pub-id>
<pub-id pub-id-type="pmid">17263679</pub-id>
</element-citation>
</ref>
<ref id="B141-ijms-21-04946">
<label>141.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsitsilonis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seemann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Misch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wichlas</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>N.P.</given-names>
</name>
<name>
<surname>Schmidt-Bleek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kleber</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schaser</surname>
<given-names>K.D.</given-names>
</name>
</person-group>
<article-title>The effect of traumatic brain injury on bone healing: An experimental study in a novel in vivo animal model</article-title>
<source/>Injury
          <year>2015</year>
<volume>46</volume>
<fpage>661</fpage>
<lpage>665</lpage>
<pub-id pub-id-type="doi">10.1016/j.injury.2015.01.044</pub-id>
<pub-id pub-id-type="pmid">25682315</pub-id>
</element-citation>
</ref>
<ref id="B142-ijms-21-04946">
<label>142.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Locher</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Lünnemann</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Garbe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schaser</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Schmidt-Bleek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Duda</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tsitsilonis</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Traumatic brain injury and bone healing: Radiographic and biomechanical analyses of bone formation and stability in a combined murine trauma model</article-title>
<source/>J. Musculoskelet. Neuronal Interact.
          <year>2015</year>
<volume>15</volume>
<fpage>309</fpage>
<lpage>315</lpage>
<pub-id pub-id-type="pmid">26636276</pub-id>
</element-citation>
</ref>
<ref id="B143-ijms-21-04946">
<label>143.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morley</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Marsh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Drakoulakis</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pape</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Giannoudis</surname>
<given-names>P.V.</given-names>
</name>
</person-group>
<article-title>Does traumatic brain injury result in accelerated fracture healing?</article-title>
<source/>Injury
          <year>2005</year>
<volume>36</volume>
<fpage>363</fpage>
<lpage>368</lpage>
<pub-id pub-id-type="doi">10.1016/j.injury.2004.08.028</pub-id>
<pub-id pub-id-type="pmid">15710151</pub-id>
</element-citation>
</ref>
<ref id="B144-ijms-21-04946">
<label>144.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morioka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Marmor</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sacramento</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miclau</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Beattie</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Marcucio</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Miclau</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differential fracture response to traumatic brain injury suggests dominance of neuroinflammatory response in polytrauma</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1038/s41598-019-48126-z</pub-id>
</element-citation>
</ref>
<ref id="B145-ijms-21-04946">
<label>145.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L.Y.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>Osteoporosis after spinal cord injury</article-title>
<source/>Osteoporos. Int.
          <year>2006</year>
<volume>17</volume>
<fpage>180</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1007/s00198-005-2028-8</pub-id>
<pub-id pub-id-type="pmid">16217589</pub-id>
</element-citation>
</ref>
<ref id="B146-ijms-21-04946">
<label>146.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dauty</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perrouin Verbe</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Maugars</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dubois</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mathe</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Supralesional and sublesional bone mineral density in spinal cord-injured patients</article-title>
<source/>Bone
          <year>2000</year>
<volume>27</volume>
<fpage>305</fpage>
<lpage>309</lpage>
<pub-id pub-id-type="doi">10.1016/S8756-3282(00)00326-4</pub-id>
<pub-id pub-id-type="pmid">10913927</pub-id>
</element-citation>
</ref>
<ref id="B147-ijms-21-04946">
<label>147.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>BIERING-SØRENSEN</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>BOHR</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>SCHAADT</surname>
<given-names>O.P.</given-names>
</name>
</person-group>
<article-title>Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury</article-title>
<source/>Eur. J. Clin. Investig.
          <year>1990</year>
<volume>20</volume>
<fpage>330</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2362.1990.tb01865.x</pub-id>
<pub-id pub-id-type="pmid">2114994</pub-id>
</element-citation>
</ref>
<ref id="B148-ijms-21-04946">
<label>148.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frey-Rindova</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>De Bruin</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Stüssi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dambacher</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>V.</given-names>
</name>
</person-group>
<article-title>Bone mineral density in upper and lower extremities during 12 months after spinal cord injury measured by peripheral quantitative computed tomography</article-title>
<source/>Spinal Cord
          <year>2000</year>
<volume>38</volume>
<fpage>26</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1038/sj.sc.3100905</pub-id>
<pub-id pub-id-type="pmid">10762194</pub-id>
</element-citation>
</ref>
<ref id="B149-ijms-21-04946">
<label>149.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Bruin</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dambacher</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Stüssi</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Longitudinal changes in bone in men with spinal cord injury</article-title>
<source/>Clin. Rehabil.
          <year>2000</year>
<volume>14</volume>
<fpage>145</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1191/026921500670532165</pub-id>
<pub-id pub-id-type="pmid">10763791</pub-id>
</element-citation>
</ref>
<ref id="B150-ijms-21-04946">
<label>150.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sullivan</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Mehta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Heterotopic ossification after central nervous system trauma</article-title>
<source/>Bone Joint Res.
          <year>2013</year>
<volume>2</volume>
<fpage>51</fpage>
<lpage>57</lpage>
<pub-id pub-id-type="doi">10.1302/2046-3758.23.2000152</pub-id>
<pub-id pub-id-type="pmid">23610702</pub-id>
</element-citation>
</ref>
<ref id="B151-ijms-21-04946">
<label>151.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albrecht</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Al Kibria</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gruber-Baldini</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Magaziner</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Risk of Mortality in Individuals with Hip Fracture and Traumatic Brain Injury</article-title>
<source/>J. Am. Geriatr. Soc.
          <year>2019</year>
<volume>67</volume>
<fpage>124</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1111/jgs.15661</pub-id>
<pub-id pub-id-type="pmid">30471090</pub-id>
</element-citation>
</ref>
<ref id="B152-ijms-21-04946">
<label>152.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hensler</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sauerland</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bouillon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Raum</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rixen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Helling</surname>
<given-names>H.J.</given-names>
</name>
<name>
<surname>Andermahr</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Neugebauer</surname>
<given-names>E.A.M.</given-names>
</name>
</person-group>
<article-title>Association between injury pattern of patients with multiple injuries and circulating levels of soluble tumor necrosis factor receptors, interleukin-6 and interleukin-10, and polymorphonuclear neutrophil elastase</article-title>
<source/>J. Trauma
          <year>2002</year>
<volume>52</volume>
<fpage>962</fpage>
<lpage>970</lpage>
<pub-id pub-id-type="doi">10.1097/00005373-200205000-00023</pub-id>
<pub-id pub-id-type="pmid">11988666</pub-id>
</element-citation>
</ref>
<ref id="B153-ijms-21-04946">
<label>153.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Loane</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Neuroinflammation after traumatic brain injury: Opportunities for therapeutic intervention</article-title>
<source/>Brain. Behav. Immun.
          <year>2012</year>
<volume>26</volume>
<fpage>1191</fpage>
<lpage>1201</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2012.06.008</pub-id>
<pub-id pub-id-type="pmid">22728326</pub-id>
</element-citation>
</ref>
<ref id="B154-ijms-21-04946">
<label>154.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Diamond</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Boles</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Tisherman</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Kochanek</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>A.K.</given-names>
</name>
</person-group>
<article-title>Acute CSF interleukin-6 trajectories after TBI: Associations with neuroinflammation, polytrauma, and outcome</article-title>
<source/>Brain. Behav. Immun.
          <year>2015</year>
<volume>45</volume>
<fpage>253</fpage>
<lpage>262</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2014.12.021</pub-id>
<pub-id pub-id-type="pmid">25555531</pub-id>
</element-citation>
</ref>
<ref id="B155-ijms-21-04946">
<label>155.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shultz</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>D.K.</given-names>
</name>
<name>
<surname>Brady</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Beynon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S.F.</given-names>
</name>
<name>
<surname>Kaye</surname>
<given-names>A.H.</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>T.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Tibial fracture exacerbates traumatic brain injury outcomes and neuroinflammation in a novel mouse model of multitrauma</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2015</year>
<volume>35</volume>
<fpage>1339</fpage>
<lpage>1347</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2015.56</pub-id>
<pub-id pub-id-type="pmid">25853909</pub-id>
</element-citation>
</ref>
<ref id="B156-ijms-21-04946">
<label>156.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Bone Fracture Enhances Trauma Brain Injury</article-title>
<source/>Scand. J. Immunol.
          <year>2016</year>
<volume>83</volume>
<fpage>26</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1111/sji.12393</pub-id>
<pub-id pub-id-type="pmid">26448486</pub-id>
</element-citation>
</ref>
<ref id="B157-ijms-21-04946">
<label>157.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elabd</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cousin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Upadhyayula</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R.Y.</given-names>
</name>
<name>
<surname>Chooljian</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kung</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>K.P.</given-names>
</name>
<name>
<surname>Conboy</surname>
<given-names>I.M.</given-names>
</name>
</person-group>
<article-title>Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration</article-title>
<source/>Nat. Commun.
          <year>2014</year>
<volume>5</volume>
<pub-id pub-id-type="doi">10.1038/ncomms5082</pub-id>
</element-citation>
</ref>
<ref id="B158-ijms-21-04946">
<label>158.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>D.-X.</given-names>
</name>
<name>
<surname>Manchester</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Sanchez-Barcelo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mediavilla</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Significance of High Levels of Endogenous Melatonin in Mammalian Cerebrospinal Fluid and in the Central Nervous System</article-title>
<source/>Curr. Neuropharmacol.
          <year>2010</year>
<volume>8</volume>
<fpage>162</fpage>
<lpage>167</lpage>
<pub-id pub-id-type="doi">10.2174/157015910792246182</pub-id>
<pub-id pub-id-type="pmid">21358967</pub-id>
</element-citation>
</ref>
<ref id="B159-ijms-21-04946">
<label>159.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Melatonin: Another avenue for treating osteoporosis?</article-title>
<source/>J. Pineal Res.
          <year>2019</year>
<volume>66</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1111/jpi.12548</pub-id>
</element-citation>
</ref>
<ref id="B160-ijms-21-04946">
<label>160.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schweiger</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Deuschle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Körner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lammers</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Schmider</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gotthardt</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Holsboer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Heuser</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Low lumbar bone mineral density in patients with major depression</article-title>
<source/>Am. J. Psychiatry
          <year>1994</year>
<volume>151</volume>
<fpage>1691</fpage>
<lpage>1693</lpage>
<pub-id pub-id-type="doi">10.1176/ajp.151.11.1691</pub-id>
<pub-id pub-id-type="pmid">7943462</pub-id>
</element-citation>
</ref>
<ref id="B161-ijms-21-04946">
<label>161.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramnemark</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Borssén</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gustafson</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Stroke, a major and increasing risk factor for femoral neck fracture</article-title>
<source/>Stroke
          <year>2000</year>
<volume>31</volume>
<fpage>1572</fpage>
<lpage>1577</lpage>
<pub-id pub-id-type="doi">10.1161/01.STR.31.7.1572</pub-id>
<pub-id pub-id-type="pmid">10884456</pub-id>
</element-citation>
</ref>
<ref id="B162-ijms-21-04946">
<label>162.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pouwels</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lalmohamed</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Leufkens</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>De Boer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Van Staa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>De Vries</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Risk of hip/femur fracture after stroke: A population-based case-control study</article-title>
<source/>Stroke
          <year>2009</year>
<volume>40</volume>
<fpage>3281</fpage>
<lpage>3285</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.109.554055</pub-id>
<pub-id pub-id-type="pmid">19661475</pub-id>
</element-citation>
</ref>
<ref id="B163-ijms-21-04946">
<label>163.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kalionis</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer’s disease</article-title>
<source/>Neurochem. Int.
          <year>2014</year>
<volume>75</volume>
<fpage>19</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2014.05.004</pub-id>
<pub-id pub-id-type="pmid">24859746</pub-id>
</element-citation>
</ref>
<ref id="B164-ijms-21-04946">
<label>164.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Genêt</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jourdan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schnitzler</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lautridou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guillemot</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Judet</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Poiraudeau</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Denormandie</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Troublesome Heterotopic ossification after central nervous system damage: A survey of 570 surgeries</article-title>
<source/>PLoS ONE
          <year>2011</year>
<volume>6</volume>
<fpage>2</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0016632</pub-id>
<pub-id pub-id-type="pmid">21304993</pub-id>
</element-citation>
</ref>
<ref id="B165-ijms-21-04946">
<label>165.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perumal</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>SP</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shankar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gaddam</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Jayaramaraju</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rajasekaran</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Does accelerated bone healing associated with traumatic brain injury (TBI) occur in open fractures</article-title>
<source/>Int. J. Orthop. Sci.
          <year>2018</year>
<volume>4</volume>
<fpage>677</fpage>
<lpage>681</lpage>
<pub-id pub-id-type="doi">10.22271/ortho.2018.v4.i2j.99</pub-id>
</element-citation>
</ref>
<ref id="B166-ijms-21-04946">
<label>166.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cipriano</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Pill</surname>
<given-names>S.G.</given-names>
</name>
<name>
<surname>Keenan</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Heterotopic ossification following traumatic brain injury and spinal cord injury</article-title>
<source/>J. Am. Acad. Orthop. Surg.
          <year>2009</year>
<volume>17</volume>
<fpage>689</fpage>
<lpage>697</lpage>
<pub-id pub-id-type="doi">10.5435/00124635-200911000-00003</pub-id>
<pub-id pub-id-type="pmid">19880679</pub-id>
</element-citation>
</ref>
<ref id="B167-ijms-21-04946">
<label>167.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Bezooijen</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>Papapoulos</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Hamdy</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>ten Dijke</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Löwik</surname>
<given-names>C.W.</given-names>
</name>
</person-group>
<article-title>Control of bone formation by osteocytes? lessons from the rare skeletal disorders sclerosteosis and van Buchem disease</article-title>
<source/>BoneKEy-Osteovision
          <year>2005</year>
<volume>2</volume>
<fpage>33</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1138/20050189</pub-id>
</element-citation>
</ref>
<ref id="B168-ijms-21-04946">
<label>168.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsai</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Sung</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Fracture as an independent risk factor of dementia: A nationwide population-based cohort study</article-title>
<source/>Medicine
          <year>2014</year>
<volume>93</volume>
<fpage>1</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1097/MD.0000000000000188</pub-id>
</element-citation>
</ref>
<ref id="B169-ijms-21-04946">
<label>169.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jodoin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rouleau</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Charlebois-Plante</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Benoit</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Leduc</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Laflamme</surname>
<given-names>G.Y.</given-names>
</name>
<name>
<surname>Gosselin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Larson-Dupuis</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>De Beaumont</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Incidence rate of mild traumatic brain injury among patients who have suffered from an isolated limb fracture: Upper limb fracture patients are more at risk</article-title>
<source/>Injury
          <year>2016</year>
<volume>47</volume>
<fpage>1835</fpage>
<lpage>1840</lpage>
<pub-id pub-id-type="doi">10.1016/j.injury.2016.05.036</pub-id>
<pub-id pub-id-type="pmid">27291349</pub-id>
</element-citation>
</ref>
<ref id="B170-ijms-21-04946">
<label>170.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Regulation of skeletal homeostasis</article-title>
<source/>Endocr. Rev.
          <year>2018</year>
<volume>39</volume>
<fpage>701</fpage>
<lpage>718</lpage>
<pub-id pub-id-type="doi">10.1210/er.2018-00050</pub-id>
<pub-id pub-id-type="pmid">29897433</pub-id>
</element-citation>
</ref>
<ref id="B171-ijms-21-04946">
<label>171.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lizneva</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>New</surname>
<given-names>M.I.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>FSH, Bone Mass, Body Fat, and Biological Aging</article-title>
<source/>Endocrinology
          <year>2018</year>
<volume>159</volume>
<fpage>3503</fpage>
<lpage>3514</lpage>
<pub-id pub-id-type="doi">10.1210/en.2018-00601</pub-id>
<pub-id pub-id-type="pmid">30085049</pub-id>
</element-citation>
</ref>
<ref id="B172-ijms-21-04946">
<label>172.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lizneva</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rahimova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Atabiekov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Javaid</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alamoush</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Taneja</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Azziz</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FSH beyond fertility</article-title>
<source/>Front. Endocrinol.
          <year>2019</year>
<volume>10</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.3389/fendo.2019.00136</pub-id>
</element-citation>
</ref>
<ref id="B173-ijms-21-04946">
<label>173.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coss</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Commentary on the Recent FSH Collection: Known Knowns and Known Unknowns</article-title>
<source/>Endocrinology
          <year>2020</year>
<volume>161</volume>
<fpage>1</fpage>
<lpage>6</lpage>
<pub-id pub-id-type="doi">10.1210/endocr/bqz035</pub-id>
<pub-id pub-id-type="pmid">31865385</pub-id>
</element-citation>
</ref>
<ref id="B174-ijms-21-04946">
<label>174.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seibel</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Dunstan</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Allan</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Handelsman</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>Sex Steroids, Not FSH, Influence Bone Mass</article-title>
<source/>Cell
          <year>2006</year>
<volume>127</volume>
<fpage>1079</fpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.12.002</pub-id>
<pub-id pub-id-type="pmid">17174881</pub-id>
</element-citation>
</ref>
<ref id="B175-ijms-21-04946">
<label>175.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prior</surname>
<given-names>J.C.</given-names>
</name>
</person-group>
<article-title>FSH and bone—Important physiology or not?</article-title>
<source/>Trends Mol. Med.
          <year>2007</year>
<volume>13</volume>
<fpage>1</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmed.2006.11.004</pub-id>
<pub-id pub-id-type="pmid">17141571</pub-id>
</element-citation>
</ref>
<ref id="B176-ijms-21-04946">
<label>176.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García-Martín</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Reyes-García</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>García-Castro</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Rozas-Moreno</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Escobar-Jiménez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Muñoz-Torres</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Role of serum FSH measurement on bone resorption in postmenopausal women</article-title>
<source/>Endocrine
          <year>2012</year>
<volume>41</volume>
<fpage>302</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1007/s12020-011-9541-7</pub-id>
<pub-id pub-id-type="pmid">21964645</pub-id>
</element-citation>
</ref>
<ref id="B177-ijms-21-04946">
<label>177.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sharrow</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Papachristou</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Yaroslavskiy</surname>
<given-names>B.B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>FSH Directly Regulates Bone Mass</article-title>
<source/>Cell
          <year>2006</year>
<volume>125</volume>
<fpage>247</fpage>
<lpage>260</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.01.051</pub-id>
<pub-id pub-id-type="pmid">16630814</pub-id>
</element-citation>
</ref>
<ref id="B178-ijms-21-04946">
<label>178.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iqbal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Zallone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Further evidence that FSH causes bone loss independently of low estrogen</article-title>
<source/>Endocrine
          <year>2012</year>
<volume>41</volume>
<fpage>171</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1007/s12020-012-9626-y</pub-id>
<pub-id pub-id-type="pmid">22350658</pub-id>
</element-citation>
</ref>
<ref id="B179-ijms-21-04946">
<label>179.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Mali</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Regulation of FSH receptor promoter activation in the osteoclast</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2007</year>
<volume>361</volume>
<fpage>910</fpage>
<lpage>915</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2007.07.081</pub-id>
<pub-id pub-id-type="pmid">17681281</pub-id>
</element-citation>
</ref>
<ref id="B180-ijms-21-04946">
<label>180.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Haider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Lizneva</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epitope-specific monoclonal antibodies to FSHβ increase bone mass</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>2192</fpage>
<lpage>2197</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1718144115</pub-id>
<pub-id pub-id-type="pmid">29440419</pub-id>
</element-citation>
</ref>
<ref id="B181-ijms-21-04946">
<label>181.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abe</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Marians</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.B.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eldeiry</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rajendren</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>H.C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TSH is a negative regulator of skeletal remodeling</article-title>
<source/>Cell
          <year>2003</year>
<volume>115</volume>
<fpage>151</fpage>
<lpage>162</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00771-2</pub-id>
<pub-id pub-id-type="pmid">14567913</pub-id>
</element-citation>
</ref>
<ref id="B182-ijms-21-04946">
<label>182.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Morshed</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Latif</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>T.F.</given-names>
</name>
</person-group>
<article-title>The influence of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on osteoclastogenesis</article-title>
<source/>Thyroid
          <year>2011</year>
<volume>21</volume>
<fpage>897</fpage>
<lpage>906</lpage>
<pub-id pub-id-type="doi">10.1089/thy.2010.0457</pub-id>
<pub-id pub-id-type="pmid">21745106</pub-id>
</element-citation>
</ref>
<ref id="B183-ijms-21-04946">
<label>183.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hase</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Eldeiry</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Brebene</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Amano</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>TNFα mediates the skeletal effects of thyroid-stimulating hormone</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2006</year>
<volume>103</volume>
<fpage>12849</fpage>
<lpage>12854</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0600427103</pub-id>
<pub-id pub-id-type="pmid">16908863</pub-id>
</element-citation>
</ref>
<ref id="B184-ijms-21-04946">
<label>184.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampath</surname>
<given-names>T.K.</given-names>
</name>
<name>
<surname>Simic</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sendak</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Draca</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bowe</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Schiavi</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>McPherson</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Vukicevic</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats</article-title>
<source/>J. Bone Miner. Res.
          <year>2007</year>
<volume>22</volume>
<fpage>849</fpage>
<lpage>859</lpage>
<pub-id pub-id-type="doi">10.1359/jbmr.070302</pub-id>
<pub-id pub-id-type="pmid">17352644</pub-id>
</element-citation>
</ref>
<ref id="B185-ijms-21-04946">
<label>185.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baliram</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Latif</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Berkowitz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Frid</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>T.F.</given-names>
</name>
</person-group>
<article-title>Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2011</year>
<volume>108</volume>
<fpage>16277</fpage>
<lpage>16282</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1110286108</pub-id>
<pub-id pub-id-type="pmid">21911383</pub-id>
</element-citation>
</ref>
<ref id="B186-ijms-21-04946">
<label>186.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernard</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Binart</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Prolactin—A pleiotropic factor in health and disease</article-title>
<source/>Nat. Rev. Endocrinol.
          <year>2019</year>
<volume>15</volume>
<pub-id pub-id-type="doi">10.1038/s41574-019-0194-6</pub-id>
</element-citation>
</ref>
<ref id="B187-ijms-21-04946">
<label>187.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clément-Lacroix</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ormandy</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lepescheux</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ammann</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Damotte</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Goffin</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bouchard</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Amling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gaillard-Kelly</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Binart</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Osteoblasts are a new target for prolactin: Analysis of bone formation in prolactin receptor knockout mice</article-title>
<source/>Endocrinology
          <year>1999</year>
<volume>140</volume>
<fpage>96</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1210/endo.140.1.6436</pub-id>
<pub-id pub-id-type="pmid">9886812</pub-id>
</element-citation>
</ref>
<ref id="B188-ijms-21-04946">
<label>188.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiloiro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Giampietro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Marinis</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Prolactinoma and Bone</article-title>
<source/>Curr. Opin. Endocr. Metab. Res.
          <year>2018</year>
<volume>3</volume>
<fpage>21</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1016/j.coemr.2018.02.006</pub-id>
</element-citation>
</ref>
<ref id="B189-ijms-21-04946">
<label>189.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coss</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Luben</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Effects of prolactin on osteoblast alkaline phosphatase and bone formation in the developing rat</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2000</year>
<volume>279</volume>
<fpage>1216</fpage>
<lpage>1225</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.2000.279.6.E1216</pub-id>
</element-citation>
</ref>
<ref id="B190-ijms-21-04946">
<label>190.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seriwatanachai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Thongchote</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Charoenphandhu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pandaranandaka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tudpor</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Teerapornpuntakit</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Suthiphongchai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Krishnamra</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor κB ligand/osteoprotegerin ratio</article-title>
<source/>Bone
          <year>2008</year>
<volume>42</volume>
<fpage>535</fpage>
<lpage>546</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2007.11.008</pub-id>
<pub-id pub-id-type="pmid">18166509</pub-id>
</element-citation>
</ref>
<ref id="B191-ijms-21-04946">
<label>191.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seriwatanachai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Charoenphandhu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Suthiphongchai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Krishnamra</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Prolactin decreases the expression ratio of receptor activator of nuclear factor κB ligand/osteoprotegerin in human fetal osteoblast cells</article-title>
<source/>Cell Biol. Int.
          <year>2008</year>
<volume>32</volume>
<fpage>1126</fpage>
<lpage>1135</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellbi.2008.04.026</pub-id>
<pub-id pub-id-type="pmid">18556224</pub-id>
</element-citation>
</ref>
<ref id="B192-ijms-21-04946">
<label>192.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seriwatanachai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Krishnamra</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Van Leeuwen</surname>
<given-names>J.P.T.M.</given-names>
</name>
</person-group>
<article-title>Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization</article-title>
<source/>J. Cell. Biochem.
          <year>2009</year>
<volume>107</volume>
<fpage>677</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.22161</pub-id>
<pub-id pub-id-type="pmid">19365811</pub-id>
</element-citation>
</ref>
<ref id="B193-ijms-21-04946">
<label>193.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krishnamra</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Seemoung</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Effects of acute and long-term administration of prolactin on bone 45Ca uptake, calcium deposit, and calcium resorption in weaned, young, and mature rats</article-title>
<source/>Can. J. Physiol. Pharmacol.
          <year>1996</year>
<volume>74</volume>
<fpage>1157</fpage>
<lpage>1165</lpage>
<pub-id pub-id-type="doi">10.1139/y96-123</pub-id>
<pub-id pub-id-type="pmid">9022836</pub-id>
</element-citation>
</ref>
<ref id="B194-ijms-21-04946">
<label>194.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>T.F.</given-names>
</name>
<name>
<surname>New</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zallone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Pituitary-bone connection in skeletal regulation</article-title>
<source/>Horm. Mol. Biol. Clin. Investig.
          <year>2016</year>
<volume>28</volume>
<fpage>85</fpage>
<lpage>94</lpage>
<pub-id pub-id-type="doi">10.1515/hmbci-2016-0015</pub-id>
<pub-id pub-id-type="pmid">27508964</pub-id>
</element-citation>
</ref>
<ref id="B195-ijms-21-04946">
<label>195.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isales</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>ACTH is a novel regulator of bone mass</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2010</year>
<volume>1192</volume>
<fpage>110</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05231.x</pub-id>
<pub-id pub-id-type="pmid">20392225</pub-id>
</element-citation>
</ref>
<ref id="B196-ijms-21-04946">
<label>196.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weinstein</surname>
<given-names>R.S.</given-names>
</name>
</person-group>
<article-title>Glucocorticoid-induced osteonecrosis</article-title>
<source/>Endocrine
          <year>2012</year>
<volume>41</volume>
<fpage>183</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1007/s12020-011-9580-0</pub-id>
<pub-id pub-id-type="pmid">22169965</pub-id>
</element-citation>
</ref>
<ref id="B197-ijms-21-04946">
<label>197.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pállinger</surname>
<given-names>É.</given-names>
</name>
<name>
<surname>Csaba</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>A hormone map of human immune cells showing the presence of adrenocorticotropic hormone, triiodothyronine and endorphin in immunophenotyped white blood cells</article-title>
<source/>Immunology
          <year>2008</year>
<volume>123</volume>
<fpage>584</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2567.2007.02731.x</pub-id>
<pub-id pub-id-type="pmid">18005034</pub-id>
</element-citation>
</ref>
<ref id="B198-ijms-21-04946">
<label>198.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohlsson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bengtsson</surname>
<given-names>B.-Å.</given-names>
</name>
<name>
<surname>Isaksson</surname>
<given-names>O.G.P.</given-names>
</name>
<name>
<surname>Andreassen</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Slootweg</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Growth Hormone and Bone</article-title>
<source/>Endocr. Rev.
          <year>1998</year>
<volume>19</volume>
<fpage>55</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="pmid">9494780</pub-id>
</element-citation>
</ref>
<ref id="B199-ijms-21-04946">
<label>199.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giustina</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mazziotti</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Canalis</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Growth hormone, insulin-like growth factors, and the skeleton</article-title>
<source/>Endocr. Rev.
          <year>2008</year>
<volume>29</volume>
<fpage>535</fpage>
<lpage>559</lpage>
<pub-id pub-id-type="doi">10.1210/er.2007-0036</pub-id>
<pub-id pub-id-type="pmid">18436706</pub-id>
</element-citation>
</ref>
<ref id="B200-ijms-21-04946">
<label>200.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cuscito</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Corcelli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Moonga</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Di Benedetto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Grano</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2013</year>
<volume>110</volume>
<fpage>18644</fpage>
<lpage>18649</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1318257110</pub-id>
<pub-id pub-id-type="pmid">24167258</pub-id>
</element-citation>
</ref>
<ref id="B201-ijms-21-04946">
<label>201.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mavani</surname>
<given-names>G.P.</given-names>
</name>
<name>
<surname>DeVita</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Michelis</surname>
<given-names>M.F.</given-names>
</name>
</person-group>
<article-title>A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin</article-title>
<source/>Front. Med.
          <year>2015</year>
<volume>2</volume>
<fpage>19</fpage>
<pub-id pub-id-type="doi">10.3389/fmed.2015.00019</pub-id>
<pub-id pub-id-type="pmid">25853137</pub-id>
</element-citation>
</ref>
<ref id="B202-ijms-21-04946">
<label>202.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arrowsmith</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wray</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Oxytocin: Its mechanism of action and receptor signalling in the myometrium</article-title>
<source/>J. Neuroendocrinol.
          <year>2014</year>
<volume>26</volume>
<fpage>356</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1111/jne.12154</pub-id>
<pub-id pub-id-type="pmid">24888645</pub-id>
</element-citation>
</ref>
<ref id="B203-ijms-21-04946">
<label>203.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tamma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cuscito</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dhawan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Calvano</surname>
<given-names>C.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functions of vasopressin and oxytocin in bone mass regulation</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2016</year>
<volume>113</volume>
<fpage>164</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1523762113</pub-id>
<pub-id pub-id-type="pmid">26699482</pub-id>
</element-citation>
</ref>
<ref id="B204-ijms-21-04946">
<label>204.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zaidi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zallone</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Oxytocin and bone</article-title>
<source/>Am. J. Physiol. Regul. Integr. Comp. Physiol.
          <year>2014</year>
<volume>307</volume>
<fpage>R970</fpage>
<lpage>R977</lpage>
<pub-id pub-id-type="doi">10.1152/ajpregu.00040.2014</pub-id>
<pub-id pub-id-type="pmid">25209411</pub-id>
</element-citation>
</ref>
<ref id="B205-ijms-21-04946">
<label>205.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>DiBenedetto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Greco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Montemurro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Patano</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Strippoli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vergari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mancini</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin is an anabolic bone hormone</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2009</year>
<volume>106</volume>
<fpage>7149</fpage>
<lpage>7154</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0901890106</pub-id>
<pub-id pub-id-type="pmid">19369205</pub-id>
</element-citation>
</ref>
<ref id="B206-ijms-21-04946">
<label>206.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Copland</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Ives</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Soloff</surname>
<given-names>M.S.</given-names>
</name>
</person-group>
<article-title>Functional oxytocin receptors discovered in human osteoblasts</article-title>
<source/>Endocrinology
          <year>1999</year>
<volume>140</volume>
<fpage>4371</fpage>
<lpage>4374</lpage>
<pub-id pub-id-type="doi">10.1210/endo.140.9.7130</pub-id>
<pub-id pub-id-type="pmid">10465312</pub-id>
</element-citation>
</ref>
<ref id="B207-ijms-21-04946">
<label>207.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colucci</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Grano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zallone</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Human osteoclasts express oxytocin receptor</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2002</year>
<volume>297</volume>
<fpage>442</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-291X(02)02009-0</pub-id>
<pub-id pub-id-type="pmid">12270111</pub-id>
</element-citation>
</ref>
<ref id="B208-ijms-21-04946">
<label>208.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Di Benedetto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tamma</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Grano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Colucci</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cuscito</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton</article-title>
<source/>J. Biol. Chem.
          <year>2012</year>
<volume>287</volume>
<fpage>29159</fpage>
<lpage>29167</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.365049</pub-id>
<pub-id pub-id-type="pmid">22761429</pub-id>
</element-citation>
</ref>
<ref id="B209-ijms-21-04946">
<label>209.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leston</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Harthé</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Brun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mottolese</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mertens</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sindou</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Claustrat</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Melatonin is released in the third ventricle in humans. A study in movement disorders</article-title>
<source/>Neurosci. Lett.
          <year>2010</year>
<volume>469</volume>
<fpage>294</fpage>
<lpage>297</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2009.12.008</pub-id>
<pub-id pub-id-type="pmid">20004701</pub-id>
</element-citation>
</ref>
<ref id="B210-ijms-21-04946">
<label>210.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slominski</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Schlabritz-Loutsevitch</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ostrom</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Slominski</surname>
<given-names>A.T.</given-names>
</name>
</person-group>
<article-title>Melatonin membrane receptors in peripheral tissues: Distribution and functions</article-title>
<source/>Mol. Cell. Endocrinol.
          <year>2012</year>
<volume>351</volume>
<fpage>152</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1016/j.mce.2012.01.004</pub-id>
<pub-id pub-id-type="pmid">22245784</pub-id>
</element-citation>
</ref>
<ref id="B211-ijms-21-04946">
<label>211.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roth</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.L.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Il Melatonin promotes osteoblast differentiation and bone formation</article-title>
<source/>J. Biol. Chem.
          <year>1999</year>
<volume>274</volume>
<fpage>22041</fpage>
<lpage>22047</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.274.31.22041</pub-id>
<pub-id pub-id-type="pmid">10419530</pub-id>
</element-citation>
</ref>
<ref id="B212-ijms-21-04946">
<label>212.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakade</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Koyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ariji</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yajima</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaku</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro</article-title>
<source/>J. Pineal Res.
          <year>1999</year>
<volume>27</volume>
<fpage>106</fpage>
<lpage>110</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-079X.1999.tb00603.x</pub-id>
<pub-id pub-id-type="pmid">10496146</pub-id>
</element-citation>
</ref>
<ref id="B213-ijms-21-04946">
<label>213.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression</article-title>
<source/>J. Pineal Res.
          <year>2010</year>
<volume>49</volume>
<fpage>364</fpage>
<lpage>372</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-079X.2010.00803.x</pub-id>
<pub-id pub-id-type="pmid">20738756</pub-id>
</element-citation>
</ref>
<ref id="B214-ijms-21-04946">
<label>214.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amstrup</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Sikjaer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Heickendorff</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mosekilde</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rejnmark</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: A randomized controlled trial</article-title>
<source/>J. Pineal Res.
          <year>2015</year>
<volume>59</volume>
<fpage>221</fpage>
<lpage>229</lpage>
<pub-id pub-id-type="doi">10.1111/jpi.12252</pub-id>
<pub-id pub-id-type="pmid">26036434</pub-id>
</element-citation>
</ref>
<ref id="B215-ijms-21-04946">
<label>215.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez-Barcelo</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Mediavilla</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>D.X.</given-names>
</name>
<name>
<surname>Reiter</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Clinical Uses of Melatonin: Evaluation of Human Trials</article-title>
<source/>Curr. Med. Chem.
          <year>2010</year>
<volume>17</volume>
<fpage>2070</fpage>
<lpage>2095</lpage>
<pub-id pub-id-type="doi">10.2174/092986710791233689</pub-id>
<pub-id pub-id-type="pmid">20423309</pub-id>
</element-citation>
</ref>
<ref id="B216-ijms-21-04946">
<label>216.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>B.C.P.</given-names>
</name>
<name>
<surname>Nagtegaal</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Hagen</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Van Der Westerlaken</surname>
<given-names>M.M.L.</given-names>
</name>
<name>
<surname>Boringa</surname>
<given-names>J.B.S.</given-names>
</name>
<name>
<surname>Kerkhof</surname>
<given-names>G.A.</given-names>
</name>
<name>
<surname>Ter Wee</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: A randomized, placebo-controlled, cross-over study (EMSCAP study)</article-title>
<source/>Br. J. Clin. Pharmacol.
          <year>2009</year>
<volume>67</volume>
<fpage>68</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2125.2008.03320.x</pub-id>
<pub-id pub-id-type="pmid">19076157</pub-id>
</element-citation>
</ref>
<ref id="B217-ijms-21-04946">
<label>217.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Driessler</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Baldock</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Hypothalamic regulation of bone</article-title>
<source/>J. Mol. Endocrinol.
          <year>2010</year>
<volume>45</volume>
<fpage>175</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1677/JME-10-0015</pub-id>
<pub-id pub-id-type="pmid">20660619</pub-id>
</element-citation>
</ref>
<ref id="B218-ijms-21-04946">
<label>218.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gehlert</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Role of hypothalamic neuropeptide Y in feeding and obesity</article-title>
<source/>Neuropeptides
          <year>1999</year>
<volume>33</volume>
<fpage>329</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1054/npep.1999.0057</pub-id>
<pub-id pub-id-type="pmid">10657510</pub-id>
</element-citation>
</ref>
<ref id="B219-ijms-21-04946">
<label>219.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teixeira</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>D.M.</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Herzog</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lamghari</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors</article-title>
<source/>J. Cell. Biochem.
          <year>2009</year>
<volume>107</volume>
<fpage>908</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.22194</pub-id>
<pub-id pub-id-type="pmid">19459152</pub-id>
</element-citation>
</ref>
<ref id="B220-ijms-21-04946">
<label>220.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldock</surname>
<given-names>P.A.</given-names>
</name>
<name>
<surname>Allison</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Slack</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>E.J.D.</given-names>
</name>
<name>
<surname>Enriquez</surname>
<given-names>R.F.</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>During</surname>
<given-names>M.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis</article-title>
<source/>J. Biol. Chem.
          <year>2007</year>
<volume>282</volume>
<fpage>19092</fpage>
<lpage>19102</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M700644200</pub-id>
<pub-id pub-id-type="pmid">17491016</pub-id>
</element-citation>
</ref>
<ref id="B221-ijms-21-04946">
<label>221.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elefteriou</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Impact of the autonomic nervous system on the skeleton</article-title>
<source/>Physiol. Rev.
          <year>2018</year>
<volume>98</volume>
<fpage>1083</fpage>
<lpage>1112</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00014.2017</pub-id>
<pub-id pub-id-type="pmid">29717928</pub-id>
</element-citation>
</ref>
<ref id="B222-ijms-21-04946">
<label>222.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horsnell</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Baldock</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis</article-title>
<source/>Curr. Osteoporos. Rep.
          <year>2016</year>
<volume>14</volume>
<fpage>26</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1007/s11914-016-0300-9</pub-id>
<pub-id pub-id-type="pmid">26872458</pub-id>
</element-citation>
</ref>
<ref id="B223-ijms-21-04946">
<label>223.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cline</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>E.R.</given-names>
</name>
</person-group>
<article-title>Hypothalamus-adipose tissue crosstalk: Neuropeptide y and the regulation of energy metabolism</article-title>
<source/>Nutr. Metab.
          <year>2014</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1186/1743-7075-11-27</pub-id>
</element-citation>
</ref>
<ref id="B224-ijms-21-04946">
<label>224.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baldock</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Karl</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Driessler</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zengin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hörmer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuropeptide Y Attenuates Stress-Induced Bone Loss Through Suppression of Noradrenaline Circuits</article-title>
<source/>J. Bone Miner. Res.
          <year>2014</year>
<volume>29</volume>
<fpage>2238</fpage>
<lpage>2249</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.2205</pub-id>
<pub-id pub-id-type="pmid">24535841</pub-id>
</element-citation>
</ref>
<ref id="B225-ijms-21-04946">
<label>225.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ilnytska</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Argyropoulos</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The role of the Agouti-related protein in energy balance regulation</article-title>
<source/>Cell. Mol. Life Sci.
          <year>2008</year>
<volume>65</volume>
<fpage>2721</fpage>
<lpage>2731</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-008-8104-4</pub-id>
<pub-id pub-id-type="pmid">18470724</pub-id>
</element-citation>
</ref>
<ref id="B226-ijms-21-04946">
<label>226.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Deletion of ATF4 in AgRP neurons promotes fat loss mainly via increasing energy expenditure</article-title>
<source/>Diabetes
          <year>2017</year>
<volume>66</volume>
<fpage>640</fpage>
<lpage>650</lpage>
<pub-id pub-id-type="doi">10.2337/db16-0954</pub-id>
<pub-id pub-id-type="pmid">27993927</pub-id>
</element-citation>
</ref>
<ref id="B227-ijms-21-04946">
<label>227.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.H.</given-names>
</name>
<name>
<surname>Dietrich</surname>
<given-names>M.O.</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>G.Q.</given-names>
</name>
<name>
<surname>Diano</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Insogna</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Horvath</surname>
<given-names>T.L.</given-names>
</name>
</person-group>
<article-title>AgRP Neurons Regulate Bone Mass</article-title>
<source/>Cell Rep.
          <year>2015</year>
<volume>13</volume>
<fpage>8</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.08.070</pub-id>
<pub-id pub-id-type="pmid">26411686</pub-id>
</element-citation>
</ref>
<ref id="B228-ijms-21-04946">
<label>228.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Swart</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Jahng</surname>
<given-names>J.W.</given-names>
</name>
<name>
<surname>Overton</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Houpt</surname>
<given-names>T.A.</given-names>
</name>
</person-group>
<article-title>Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice</article-title>
<source/>Am. J. Physiol. Regul. Integr. Comp. Physiol.
          <year>2002</year>
<volume>283</volume>
<fpage>1020</fpage>
<lpage>1026</lpage>
<pub-id pub-id-type="doi">10.1152/ajpregu.00501.2001</pub-id>
</element-citation>
</ref>
<ref id="B229-ijms-21-04946">
<label>229.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuperman</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dine</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Staikin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Golani</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ramot</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nahum</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kühne</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shemesh</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wurst</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CRFR1 in AgRP Neurons Modulates Sympathetic Nervous System Activity to Adapt to Cold Stress and Fasting</article-title>
<source/>Cell Metab.
          <year>2016</year>
<volume>23</volume>
<fpage>1185</fpage>
<lpage>1199</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2016.04.017</pub-id>
<pub-id pub-id-type="pmid">27211900</pub-id>
</element-citation>
</ref>
<ref id="B230-ijms-21-04946">
<label>230.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Madden</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Brooks</surname>
<given-names>V.L.</given-names>
</name>
</person-group>
<article-title>Arcuate neuropeptide y inhibits sympathetic nerve activity via multiple neuropathways</article-title>
<source/>J. Clin. Investig.
          <year>2017</year>
<volume>127</volume>
<fpage>2868</fpage>
<lpage>2880</lpage>
<pub-id pub-id-type="doi">10.1172/JCI92008</pub-id>
<pub-id pub-id-type="pmid">28628036</pub-id>
</element-citation>
</ref>
<ref id="B231-ijms-21-04946">
<label>231.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morton</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Baskin</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Barsh</surname>
<given-names>G.S.</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>M.W.</given-names>
</name>
</person-group>
<article-title>Central nervous system control of food intake and body weight</article-title>
<source/>Nature
          <year>2006</year>
<volume>443</volume>
<fpage>289</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="doi">10.1038/nature05026</pub-id>
<pub-id pub-id-type="pmid">16988703</pub-id>
</element-citation>
</ref>
<ref id="B232-ijms-21-04946">
<label>232.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maletínská</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Maixnerová</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Matyšková</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Haugvicová</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pirník</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kiss</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Železná</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Synergistic effect of CART (cocaine- and amphetamine-regulated transcript) peptide and cholecystokinin on food intake regulation in lean mice</article-title>
<source/>BMC Neurosci.
          <year>2008</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1186/1471-2202-9-101</pub-id>
</element-citation>
</ref>
<ref id="B233-ijms-21-04946">
<label>233.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elefteriou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ahn</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Starbuck</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Bannon</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Leptin regulation of bone resorption by the sympathetic nervous system and CART</article-title>
<source/>Nature
          <year>2005</year>
<volume>434</volume>
<fpage>514</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1038/nature03398</pub-id>
<pub-id pub-id-type="pmid">15724149</pub-id>
</element-citation>
</ref>
<ref id="B234-ijms-21-04946">
<label>234.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Elefteriou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Cocaine and amphetamine-regulated transcript may regulate bone remodeling as a circulating molecule</article-title>
<source/>Endocrinology
          <year>2008</year>
<volume>149</volume>
<fpage>3933</fpage>
<lpage>3941</lpage>
<pub-id pub-id-type="doi">10.1210/en.2008-0109</pub-id>
<pub-id pub-id-type="pmid">18450969</pub-id>
</element-citation>
</ref>
<ref id="B235-ijms-21-04946">
<label>235.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamane</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iddamalgoda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Unno</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hoshino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Melanin production through novel processing of proopiomelanocortin in the extracellular compartment of the auricular skin of C57BL/6 mice after UV-irradiation</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1038/srep14579</pub-id>
</element-citation>
</ref>
<ref id="B236-ijms-21-04946">
<label>236.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Böhm</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Grässel</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Role of proopiomelanocortin-derived peptides and their receptors in the osteoarticular system: From basic to translational research</article-title>
<source/>Endocr. Rev.
          <year>2012</year>
<volume>33</volume>
<fpage>623</fpage>
<lpage>651</lpage>
<pub-id pub-id-type="doi">10.1210/er.2011-1016</pub-id>
<pub-id pub-id-type="pmid">22736674</pub-id>
</element-citation>
</ref>
<ref id="B237-ijms-21-04946">
<label>237.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cornish</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Callon</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Mountjoy</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Bava</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Naot</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>I.R.</given-names>
</name>
</person-group>
<article-title>A-Melanocyte-Stimulating Hormone Is a Novel Regulator of Bone</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2003</year>
<volume>284</volume>
<pub-id pub-id-type="doi">10.1152/ajpendo.00412.2002</pub-id>
</element-citation>
</ref>
<ref id="B238-ijms-21-04946">
<label>238.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farooqi</surname>
<given-names>I.S.</given-names>
</name>
<name>
<surname>Yeo</surname>
<given-names>G.S.H.</given-names>
</name>
<name>
<surname>Keogh</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Aminian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jebb</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cheetham</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>O’Rahilly</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Dominant and recessive inheritance of morbid obesity associate with melanocortin 4 receptor deficiency</article-title>
<source/>J. Clin. Investig.
          <year>2000</year>
<volume>106</volume>
<fpage>271</fpage>
<lpage>279</lpage>
<pub-id pub-id-type="doi">10.1172/JCI9397</pub-id>
<pub-id pub-id-type="pmid">10903343</pub-id>
</element-citation>
</ref>
<ref id="B239-ijms-21-04946">
<label>239.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garg</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McGuigan</surname>
<given-names>F.E.</given-names>
</name>
<name>
<surname>Ridderstråle</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gerdhem</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Luthman</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Åkesson</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Variation in the MC4R gene is associated with bone phenotypes in elderly Swedish women</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1371/journal.pone.0088565</pub-id>
</element-citation>
</ref>
<ref id="B240-ijms-21-04946">
<label>240.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grässel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Muschter</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Do neuroendocrine peptides and their receptors qualify as novel therapeutic targets in osteoarthritis?</article-title>
<source/>Int. J. Mol. Sci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>367</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19020367</pub-id>
</element-citation>
</ref>
<ref id="B241-ijms-21-04946">
<label>241.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ezura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kajita</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hosoi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shiraki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Emi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women</article-title>
<source/>J. Hum. Genet.
          <year>2005</year>
<volume>50</volume>
<fpage>235</fpage>
<lpage>240</lpage>
<pub-id pub-id-type="doi">10.1007/s10038-005-0244-x</pub-id>
<pub-id pub-id-type="pmid">15864412</pub-id>
</element-citation>
</ref>
<ref id="B242-ijms-21-04946">
<label>242.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farman</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Windahl</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Westberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Isaksson</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Egecioglu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schele</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ryberg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jansson</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Tuukkanen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Koskela</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Female mice lacking estrogen receptor-α in hypothalamic proopiomelanocortin (POMC) neurons display enhanced estrogenic response on cortical bone mass</article-title>
<source/>Endocrinology
          <year>2016</year>
<volume>157</volume>
<fpage>3242</fpage>
<lpage>3252</lpage>
<pub-id pub-id-type="doi">10.1210/en.2016-1181</pub-id>
<pub-id pub-id-type="pmid">27254004</pub-id>
</element-citation>
</ref>
<ref id="B243-ijms-21-04946">
<label>243.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujii</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hosoya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fukusumi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kawamata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Habata</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hinuma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Onda</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fujino</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Identification of neuromedin U as the cognate ligand of the orphan G protein-coupled receptor FM-3</article-title>
<source/>J. Biol. Chem.
          <year>2000</year>
<volume>275</volume>
<fpage>21068</fpage>
<lpage>21074</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M001546200</pub-id>
<pub-id pub-id-type="pmid">10783389</pub-id>
</element-citation>
</ref>
<ref id="B244-ijms-21-04946">
<label>244.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brighton</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Szekeres</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Willars</surname>
<given-names>G.B.</given-names>
</name>
</person-group>
<article-title>Neuromedin U and its receptors: Structure, function, and physiological roles</article-title>
<source/>Pharmacol. Rev.
          <year>2004</year>
<volume>56</volume>
<fpage>231</fpage>
<lpage>248</lpage>
<pub-id pub-id-type="doi">10.1124/pr.56.2.3</pub-id>
<pub-id pub-id-type="pmid">15169928</pub-id>
</element-citation>
</ref>
<ref id="B245-ijms-21-04946">
<label>245.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hanada</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Iwasaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Inose</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ida</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mieda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeuchi</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Central control of bone remodeling by neuromedin U</article-title>
<source/>Nat. Med.
          <year>2007</year>
<volume>13</volume>
<fpage>1234</fpage>
<lpage>1240</lpage>
<pub-id pub-id-type="doi">10.1038/nm1640</pub-id>
<pub-id pub-id-type="pmid">17873881</pub-id>
</element-citation>
</ref>
<ref id="B246-ijms-21-04946">
<label>246.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Date</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimbara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sakihara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kanai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kangawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakazato</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Central actions of neuromedin U via corticotropin-releasing hormone</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2003</year>
<volume>311</volume>
<fpage>954</fpage>
<lpage>958</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2003.10.098</pub-id>
<pub-id pub-id-type="pmid">14623274</pub-id>
</element-citation>
</ref>
<ref id="B247-ijms-21-04946">
<label>247.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wren</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Small</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Abbott</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Jethwa</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Zollner</surname>
<given-names>A.N.</given-names>
</name>
<name>
<surname>Ghatei</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Bloom</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Hypothalamic actions of neuromedin U</article-title>
<source/>Endocrinology
          <year>2002</year>
<volume>143</volume>
<fpage>4227</fpage>
<lpage>4234</lpage>
<pub-id pub-id-type="doi">10.1210/en.2002-220308</pub-id>
<pub-id pub-id-type="pmid">12399416</pub-id>
</element-citation>
</ref>
<ref id="B248-ijms-21-04946">
<label>248.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaisho</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Asakawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Matsumiya</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nishizawa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kanematsu-Yamaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dote</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>J.I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice</article-title>
<source/>Int. J. Obes.
          <year>2017</year>
<volume>41</volume>
<fpage>1790</fpage>
<lpage>1797</lpage>
<pub-id pub-id-type="doi">10.1038/ijo.2017.176</pub-id>
<pub-id pub-id-type="pmid">28757640</pub-id>
</element-citation>
</ref>
<ref id="B249-ijms-21-04946">
<label>249.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampson</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Felsing</surname>
<given-names>D.E.</given-names>
</name>
<name>
<surname>Raval</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Patrikeev</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rytting</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>J.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Small-Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models</article-title>
<source/>Pharmacol. Res. Perspect.
          <year>2018</year>
<volume>6</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1002/prp2.425</pub-id>
</element-citation>
</ref>
<ref id="B250-ijms-21-04946">
<label>250.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>K.B.</given-names>
</name>
<name>
<surname>Mollano</surname>
<given-names>A.V.</given-names>
</name>
<name>
<surname>Morcuende</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>R.R.</given-names>
</name>
<name>
<surname>Saltzman</surname>
<given-names>C.L.</given-names>
</name>
</person-group>
<article-title>Bone and brain: A review of neural, hormonal, and musculoskeletal connections</article-title>
<source/>Iowa Orthop. J.
          <year>2004</year>
<volume>24</volume>
<fpage>123</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="pmid">15296219</pub-id>
</element-citation>
</ref>
<ref id="B251-ijms-21-04946">
<label>251.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hohmann</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Elde</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rysavy</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Einzig</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gebhard</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers</article-title>
<source/>Science
          <year>1986</year>
<volume>232</volume>
<fpage>868</fpage>
<lpage>871</lpage>
<pub-id pub-id-type="doi">10.1126/science.3518059</pub-id>
<pub-id pub-id-type="pmid">3518059</pub-id>
</element-citation>
</ref>
<ref id="B252-ijms-21-04946">
<label>252.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bjurholm</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kreicbergs</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Terenius</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schultzberg</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues</article-title>
<source/>J. Auton. Nerv. Syst.
          <year>1988</year>
<volume>25</volume>
<fpage>119</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/0165-1838(88)90016-1</pub-id>
<pub-id pub-id-type="pmid">2906951</pub-id>
</element-citation>
</ref>
<ref id="B253-ijms-21-04946">
<label>253.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Elde</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Distribution of CGRP-, VIP-, DβH-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat</article-title>
<source/>Cell Tissue Res.
          <year>1991</year>
<volume>264</volume>
<fpage>469</fpage>
<lpage>480</lpage>
<pub-id pub-id-type="doi">10.1007/BF00319037</pub-id>
<pub-id pub-id-type="pmid">1714353</pub-id>
</element-citation>
</ref>
<ref id="B254-ijms-21-04946">
<label>254.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Togari</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koshihara</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nagatsu</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Expression of mRNAs for neuropeptide receptors and β-adrenergic receptors in human osteoblasts and human osteogenic sarcoma cells</article-title>
<source/>Neurosci. Lett.
          <year>1997</year>
<volume>233</volume>
<fpage>125</fpage>
<lpage>128</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(97)00649-6</pub-id>
<pub-id pub-id-type="pmid">9350848</pub-id>
</element-citation>
</ref>
<ref id="B255-ijms-21-04946">
<label>255.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ransjö</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mukohyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lundberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lerner</surname>
<given-names>U.H.</given-names>
</name>
</person-group>
<article-title>Microisolated mouse osteoclasts express VIP-1 and PACAP receptors</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2000</year>
<volume>274</volume>
<fpage>400</fpage>
<lpage>404</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.2000.3151</pub-id>
<pub-id pub-id-type="pmid">10913350</pub-id>
</element-citation>
</ref>
<ref id="B256-ijms-21-04946">
<label>256.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukohyama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ransjö</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ohyama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lerner</surname>
<given-names>U.H.</given-names>
</name>
</person-group>
<article-title>The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK</article-title>
<source/>Biochem. Biophys. Res. Commun.
          <year>2000</year>
<volume>271</volume>
<fpage>158</fpage>
<lpage>163</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.2000.2599</pub-id>
<pub-id pub-id-type="pmid">10777696</pub-id>
</element-citation>
</ref>
<ref id="B257-ijms-21-04946">
<label>257.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Juarranz</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Abad</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Arranz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gutierrez-Cañas</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Rosignoli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gomariz</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Leceta</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis</article-title>
<source/>Arthritis Res. Ther.
          <year>2005</year>
<volume>7</volume>
<fpage>R1034</fpage>
<pub-id pub-id-type="doi">10.1186/ar1779</pub-id>
<pub-id pub-id-type="pmid">16207319</pub-id>
</element-citation>
</ref>
<ref id="B258-ijms-21-04946">
<label>258.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Vernejoul</surname>
<given-names>M.-C.</given-names>
</name>
<name>
<surname>Collet</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chabbi-Achengli</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Serotonin: Good or bad for bone</article-title>
<source/>Bonekey Rep.
          <year>2012</year>
<volume>1</volume>
<pub-id pub-id-type="doi">10.1038/bonekey.2012.120</pub-id>
</element-citation>
</ref>
<ref id="B259-ijms-21-04946">
<label>259.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Ryu</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Suda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Gingrich</surname>
<given-names>J.A.</given-names>
</name>
<name>
<surname>Schütz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Glorieux</surname>
<given-names>F.H.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Zajac</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Insogna</surname>
<given-names>K.L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum</article-title>
<source/>Cell
          <year>2008</year>
<volume>135</volume>
<fpage>825</fpage>
<lpage>837</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2008.09.059</pub-id>
<pub-id pub-id-type="pmid">19041748</pub-id>
</element-citation>
</ref>
<ref id="B260-ijms-21-04946">
<label>260.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>K.R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.C.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>H.M.</given-names>
</name>
</person-group>
<article-title>Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss</article-title>
<source/>Theranostics
          <year>2018</year>
<volume>8</volume>
<fpage>3087</fpage>
<lpage>3098</lpage>
<pub-id pub-id-type="doi">10.7150/thno.24426</pub-id>
<pub-id pub-id-type="pmid">29896304</pub-id>
</element-citation>
</ref>
<ref id="B261-ijms-21-04946">
<label>261.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Niziolek</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Zylstra</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Alenina</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Matthes</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jacobsen</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>R.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lrp5 functions in bone to regulate bone mass</article-title>
<source/>Nat. Med.
          <year>2011</year>
<volume>17</volume>
<fpage>684</fpage>
<lpage>691</lpage>
<pub-id pub-id-type="doi">10.1038/nm.2388</pub-id>
<pub-id pub-id-type="pmid">21602802</pub-id>
</element-citation>
</ref>
<ref id="B262-ijms-21-04946">
<label>262.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ducy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The two faces of serotonin in bone biology</article-title>
<source/>J. Cell Biol.
          <year>2010</year>
<volume>191</volume>
<fpage>7</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201006123</pub-id>
<pub-id pub-id-type="pmid">20921133</pub-id>
</element-citation>
</ref>
<ref id="B263-ijms-21-04946">
<label>263.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sheu</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Lanteigne</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stürmer</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pate</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Azrael</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>SSRI use and risk of fractures among perimenopausal women without mental disorders</article-title>
<source/>Inj. Prev.
          <year>2015</year>
<volume>21</volume>
<fpage>397</fpage>
<lpage>403</lpage>
<pub-id pub-id-type="doi">10.1136/injuryprev-2014-041483</pub-id>
<pub-id pub-id-type="pmid">26113668</pub-id>
</element-citation>
</ref>
<ref id="B264-ijms-21-04946">
<label>264.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feuer</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Demmer</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Thai</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vogiatzi</surname>
<given-names>M.G.</given-names>
</name>
</person-group>
<article-title>Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study</article-title>
<source/>Bone
          <year>2015</year>
<volume>78</volume>
<fpage>28</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2015.04.042</pub-id>
<pub-id pub-id-type="pmid">25940460</pub-id>
</element-citation>
</ref>
<ref id="B265-ijms-21-04946">
<label>265.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rauma</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Honkanen</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Tuppurainen</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Kröger</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Koivumaa-Honkanen</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of antidepressants on postmenopausal bone loss—A 5-year longitudinal study from the OSTPRE cohort</article-title>
<source/>Bone
          <year>2016</year>
<volume>89</volume>
<fpage>25</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2016.05.003</pub-id>
<pub-id pub-id-type="pmid">27179631</pub-id>
</element-citation>
</ref>
<ref id="B266-ijms-21-04946">
<label>266.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.X.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X.Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Dopamine D1 receptor-mediated activation of the ERK signaling pathway is involved in the osteogenic differentiation of bone mesenchymal stem cells</article-title>
<source/>Stem Cell Res. Ther.
          <year>2020</year>
<volume>11</volume>
<fpage>12</fpage>
<pub-id pub-id-type="doi">10.1186/s13287-019-1529-x</pub-id>
<pub-id pub-id-type="pmid">31900224</pub-id>
</element-citation>
</ref>
<ref id="B267-ijms-21-04946">
<label>267.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheong</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Dopamine receptor expression on primary osteoblasts and bone marrow mesenchymal stem cells of rats</article-title>
<source/>Int. J. Clin. Exp. Med.
          <year>2018</year>
<volume>11</volume>
<fpage>1765</fpage>
<lpage>1771</lpage>
</element-citation>
</ref>
<ref id="B268-ijms-21-04946">
<label>268.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S.W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Dopaminergic effects on in vitro osteogenesis</article-title>
<source/>Bone Res.
          <year>2015</year>
<volume>3</volume>
<pub-id pub-id-type="doi">10.1038/boneres.2015.20</pub-id>
</element-citation>
</ref>
<ref id="B269-ijms-21-04946">
<label>269.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamaoka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Dopamine D2-like receptor signaling suppresses human osteoclastogenesis</article-title>
<source/>Bone
          <year>2013</year>
<volume>56</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2013.04.019</pub-id>
<pub-id pub-id-type="pmid">23631878</pub-id>
</element-citation>
</ref>
<ref id="B270-ijms-21-04946">
<label>270.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motyl</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Beauchemin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Barlow</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>P.T.</given-names>
</name>
<name>
<surname>Nagano</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Treyball</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Contractor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Baron</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Houseknecht</surname>
<given-names>K.L.</given-names>
</name>
</person-group>
<article-title>A novel role for dopamine signaling in the pathogenesis of bone loss from the atypical antipsychotic drug risperidone in female mice</article-title>
<source/>Bone
          <year>2017</year>
<volume>103</volume>
<fpage>168</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2017.07.008</pub-id>
<pub-id pub-id-type="pmid">28689816</pub-id>
</element-citation>
</ref>
<ref id="B271-ijms-21-04946">
<label>271.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.H.</given-names>
</name>
</person-group>
<article-title>Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences</article-title>
<source/>Clin. Psychopharmacol. Neurosci.
          <year>2016</year>
<volume>14</volume>
<fpage>238</fpage>
<lpage>249</lpage>
<pub-id pub-id-type="doi">10.9758/cpn.2016.14.3.238</pub-id>
<pub-id pub-id-type="pmid">27489377</pub-id>
</element-citation>
</ref>
<ref id="B272-ijms-21-04946">
<label>272.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Genever</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Skerry</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Publicover</surname>
<given-names>S.J.</given-names>
</name>
</person-group>
<article-title>The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors</article-title>
<source/>Calcif. Tissue Int.
          <year>2002</year>
<volume>70</volume>
<fpage>194</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1007/s00223-001-2004-z</pub-id>
<pub-id pub-id-type="pmid">11907717</pub-id>
</element-citation>
</ref>
<ref id="B273-ijms-21-04946">
<label>273.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chenu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Serre</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Raynal</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Burt-Pichat</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Delmas</surname>
<given-names>P.D.</given-names>
</name>
</person-group>
<article-title>Glutamate receptors are expressed by bone cells and are involved in bone resorption</article-title>
<source/>Bone
          <year>1998</year>
<volume>22</volume>
<fpage>295</fpage>
<lpage>299</lpage>
<pub-id pub-id-type="doi">10.1016/S8756-3282(97)00295-0</pub-id>
<pub-id pub-id-type="pmid">9556127</pub-id>
</element-citation>
</ref>
<ref id="B274-ijms-21-04946">
<label>274.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Merle</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Itzstein</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Delmas</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Chenu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis</article-title>
<source/>J. Cell. Biochem.
          <year>2003</year>
<volume>90</volume>
<fpage>424</fpage>
<lpage>436</lpage>
<pub-id pub-id-type="doi">10.1002/jcb.10625</pub-id>
<pub-id pub-id-type="pmid">14505357</pub-id>
</element-citation>
</ref>
<ref id="B275-ijms-21-04946">
<label>275.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morimoto</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Uehara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yatsushiro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Juge</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Senoh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Echigo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mizoguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ninomiya</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Secretion of L-glutamate from osteoclasts through transcytosis</article-title>
<source/>EMBO J.
          <year>2006</year>
<volume>25</volume>
<fpage>4175</fpage>
<lpage>4186</lpage>
<pub-id pub-id-type="doi">10.1038/sj.emboj.7601317</pub-id>
<pub-id pub-id-type="pmid">16957773</pub-id>
</element-citation>
</ref>
<ref id="B276-ijms-21-04946">
<label>276.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname>
<given-names>A.F.</given-names>
</name>
</person-group>
<article-title>Osteoblastic glutamate receptor function regulates bone formation and resorption</article-title>
<source/>J. Musculoskelet. Neuronal Interact.
          <year>2002</year>
<volume>2</volume>
<fpage>285</fpage>
<lpage>290</lpage>
<pub-id pub-id-type="pmid">15758456</pub-id>
</element-citation>
</ref>
<ref id="B277-ijms-21-04946">
<label>277.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Serre</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Farlay</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Delmas</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Chenu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Evidence for a dense and intimate innervation of the bone tissue, including glutamate-containing fibers</article-title>
<source/>Bone
          <year>1999</year>
<volume>25</volume>
<fpage>623</fpage>
<lpage>629</lpage>
<pub-id pub-id-type="doi">10.1016/S8756-3282(99)00215-X</pub-id>
<pub-id pub-id-type="pmid">10593406</pub-id>
</element-citation>
</ref>
<ref id="B278-ijms-21-04946">
<label>278.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhangu</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Genever</surname>
<given-names>P.G.</given-names>
</name>
<name>
<surname>Spencer</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Grewal</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Skerry</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>Evidence for targeted vesicular glutamate exocytosis in osteoblasts</article-title>
<source/>Bone
          <year>2001</year>
<volume>29</volume>
<fpage>16</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1016/S8756-3282(01)00482-3</pub-id>
<pub-id pub-id-type="pmid">11472886</pub-id>
</element-citation>
</ref>
<ref id="B279-ijms-21-04946">
<label>279.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olkku</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahonen</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Wnt and steroid pathways control glutamate signalling by regulating glutamine synthetase activity in osteoblastic cells</article-title>
<source/>Bone
          <year>2008</year>
<volume>43</volume>
<fpage>483</fpage>
<lpage>493</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2008.04.016</pub-id>
<pub-id pub-id-type="pmid">18555765</pub-id>
</element-citation>
</ref>
<ref id="B280-ijms-21-04946">
<label>280.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Idris</surname>
<given-names>A.I.</given-names>
</name>
<name>
<surname>Ralston</surname>
<given-names>S.H.</given-names>
</name>
</person-group>
<article-title>Role of cannabinoids in the regulation of bone remodeling</article-title>
<source/>Front. Endocrinol.
          <year>2012</year>
<volume>3</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.3389/fendo.2012.00136</pub-id>
</element-citation>
</ref>
<ref id="B281-ijms-21-04946">
<label>281.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reppert</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>D.R.</given-names>
</name>
</person-group>
<article-title>Coordination of circadian timing in mammals</article-title>
<source/>Nature
          <year>2002</year>
<volume>418</volume>
<fpage>935</fpage>
<lpage>941</lpage>
<pub-id pub-id-type="doi">10.1038/nature00965</pub-id>
<pub-id pub-id-type="pmid">12198538</pub-id>
</element-citation>
</ref>
<ref id="B282-ijms-21-04946">
<label>282.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalsbeek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Palm</surname>
<given-names>I.F.</given-names>
</name>
<name>
<surname>La Fleur</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Scheer</surname>
<given-names>F.A.J.L.</given-names>
</name>
<name>
<surname>Perreau-Lenz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ruiter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kreier</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cailotto</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Buijs</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>SCN outputs and the hypothalamic balance of life</article-title>
<source/>J. Biol. Rhythms
          <year>2006</year>
<volume>21</volume>
<fpage>458</fpage>
<lpage>469</lpage>
<pub-id pub-id-type="doi">10.1177/0748730406293854</pub-id>
<pub-id pub-id-type="pmid">17107936</pub-id>
</element-citation>
</ref>
<ref id="B283-ijms-21-04946">
<label>283.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartness</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Demas</surname>
<given-names>G.E.</given-names>
</name>
</person-group>
<article-title>SCN efferents to peripheral tissues: Implications for biological rhythms</article-title>
<source/>J. Biol. Rhythms
          <year>2001</year>
<volume>16</volume>
<fpage>196</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1177/074873040101600302</pub-id>
<pub-id pub-id-type="pmid">11407779</pub-id>
</element-citation>
</ref>
<ref id="B284-ijms-21-04946">
<label>284.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buijs</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Escobar</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Swaab</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>The circadian system and the balance of the autonomic nervous system</article-title>
<source/>Handb. Clin. Neurol.
          <year>2013</year>
<volume>117</volume>
<fpage>173</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1016/B978-0-444-53491-0.00015-8</pub-id>
<pub-id pub-id-type="pmid">24095125</pub-id>
</element-citation>
</ref>
<ref id="B285-ijms-21-04946">
<label>285.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buijs</surname>
<given-names>F.N.</given-names>
</name>
<name>
<surname>León-Mercado</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Guzmán-Ruiz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guerrero-Vargas</surname>
<given-names>N.N.</given-names>
</name>
<name>
<surname>Romo-Nava</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Buijs</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>The circadian system: A regulatory feedback network of periphery and brain</article-title>
<source/>Physiology
          <year>2016</year>
<volume>31</volume>
<fpage>170</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1152/physiol.00037.2015</pub-id>
<pub-id pub-id-type="pmid">27053731</pub-id>
</element-citation>
</ref>
<ref id="B286-ijms-21-04946">
<label>286.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takarada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ochi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Nakazato</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kodama</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shimba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mieda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fukasawa</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone Resorption Is Regulated by Circadian Clock in Osteoblasts</article-title>
<source/>J. Bone Miner. Res.
          <year>2017</year>
<volume>32</volume>
<fpage>872</fpage>
<lpage>881</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.3053</pub-id>
<pub-id pub-id-type="pmid">27925286</pub-id>
</element-citation>
</ref>
<ref id="B287-ijms-21-04946">
<label>287.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>W.V.</given-names>
</name>
<name>
<surname>Fenster</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>D.J.</given-names>
</name>
</person-group>
<article-title>In Vitro Evaluation of Circadian Patterns of Bone Collagen Formation</article-title>
<source/>Proc. Soc. Exp. Biol. Med.
          <year>1985</year>
<volume>180</volume>
<fpage>375</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.3181/00379727-180-42192</pub-id>
<pub-id pub-id-type="pmid">4048175</pub-id>
</element-citation>
</ref>
<ref id="B288-ijms-21-04946">
<label>288.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McElderry</surname>
<given-names>J.D.P.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Khmaladze</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Franceschi</surname>
<given-names>R.T.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>M.D.</given-names>
</name>
</person-group>
<article-title>Tracking circadian rhythms of bone mineral deposition in murine calvarial organ cultures</article-title>
<source/>J. Bone Miner. Res.
          <year>2013</year>
<volume>28</volume>
<fpage>1846</fpage>
<lpage>1854</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.1924</pub-id>
<pub-id pub-id-type="pmid">23505073</pub-id>
</element-citation>
</ref>
<ref id="B289-ijms-21-04946">
<label>289.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ochi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fukuda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sunamura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takarada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hinoi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Okawa</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Circadian Clock Regulates Bone Resorption in Mice</article-title>
<source/>J. Bone Miner. Res.
          <year>2016</year>
<volume>31</volume>
<fpage>1344</fpage>
<lpage>1355</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.2803</pub-id>
<pub-id pub-id-type="pmid">26841172</pub-id>
</element-citation>
</ref>
<ref id="B290-ijms-21-04946">
<label>290.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kinoshita</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shimba</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ozono</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Michigami</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Sympathetic activation induces skeletal Fgf23 expression in a circadian rhythm-dependent manner</article-title>
<source/>J. Biol. Chem.
          <year>2014</year>
<volume>289</volume>
<fpage>1457</fpage>
<lpage>1466</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M113.500850</pub-id>
<pub-id pub-id-type="pmid">24302726</pub-id>
</element-citation>
</ref>
<ref id="B291-ijms-21-04946">
<label>291.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boucher</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Vanneaux</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Domet</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Parouchev</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Larghero</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Circadian clock genes modulate human bone marrow mesenchymal stem cell differentiation, migration and cell cycle</article-title>
<source/>PLoS ONE
          <year>2016</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0146674</pub-id>
</element-citation>
</ref>
<ref id="B292-ijms-21-04946">
<label>292.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herkenham</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lynn</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Little</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Melvin</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>De Costa</surname>
<given-names>B.R.</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>K.C.</given-names>
</name>
</person-group>
<article-title>Cannabinoid receptor localization in brain</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>1990</year>
<volume>87</volume>
<fpage>1932</fpage>
<lpage>1936</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.87.5.1932</pub-id>
<pub-id pub-id-type="pmid">2308954</pub-id>
</element-citation>
</ref>
<ref id="B293-ijms-21-04946">
<label>293.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishac</surname>
<given-names>E.J.N.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lake</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Abood</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Kunos</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves</article-title>
<source/>Br. J. Pharmacol.
          <year>1996</year>
<volume>118</volume>
<fpage>2023</fpage>
<lpage>2028</lpage>
<pub-id pub-id-type="doi">10.1111/j.1476-5381.1996.tb15639.x</pub-id>
<pub-id pub-id-type="pmid">8864538</pub-id>
</element-citation>
</ref>
<ref id="B294-ijms-21-04946">
<label>294.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munro</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Abu-Shaar</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Molecular characterization of a peripheral receptor for cannabinoids</article-title>
<source/>Nature
          <year>1993</year>
<volume>365</volume>
<fpage>61</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.1038/365061a0</pub-id>
<pub-id pub-id-type="pmid">7689702</pub-id>
</element-citation>
</ref>
<ref id="B295-ijms-21-04946">
<label>295.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Howlett</surname>
<given-names>A.C.</given-names>
</name>
</person-group>
<article-title>The cannabinoid receptors</article-title>
<source/>Prostaglandins Other Lipid Mediat.
          <year>2002</year>
<volume>68–69</volume>
<fpage>619</fpage>
<lpage>631</lpage>
<pub-id pub-id-type="doi">10.1016/S0090-6980(02)00060-6</pub-id>
</element-citation>
</ref>
<ref id="B296-ijms-21-04946">
<label>296.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pertwee</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Cannabinoid receptors and their ligands</article-title>
<source/>Prostaglandins Leukot. Essent. Fat. Acids
          <year>2002</year>
<volume>66</volume>
<fpage>101</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1054/plef.2001.0341</pub-id>
</element-citation>
</ref>
<ref id="B297-ijms-21-04946">
<label>297.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackie</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Signaling via CNS cannabinoid receptors</article-title>
<source/>Mol. Cell. Endocrinol.
          <year>2008</year>
<volume>286</volume>
<pub-id pub-id-type="doi">10.1016/j.mce.2008.01.022</pub-id>
<pub-id pub-id-type="pmid">18336996</pub-id>
</element-citation>
</ref>
<ref id="B298-ijms-21-04946">
<label>298.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bab</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zimmer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Melamed</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Cannabinoids and the skeleton: From marijuana to reversal of bone loss</article-title>
<source/>Ann. Med.
          <year>2009</year>
<volume>41</volume>
<fpage>560</fpage>
<lpage>567</lpage>
<pub-id pub-id-type="doi">10.1080/07853890903121025</pub-id>
<pub-id pub-id-type="pmid">19634029</pub-id>
</element-citation>
</ref>
<ref id="B299-ijms-21-04946">
<label>299.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karsak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Malkin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tolia</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Kubisch</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nürnberg</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zimmer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Livshits</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>The cannabinoid receptor type 2 (CNR2) gene is associated with hand bone strength phenotypes in an ethnically homogeneous family sample</article-title>
<source/>Hum. Genet.
          <year>2009</year>
<volume>126</volume>
<fpage>629</fpage>
<lpage>636</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-009-0708-8</pub-id>
<pub-id pub-id-type="pmid">19565271</pub-id>
</element-citation>
</ref>
<ref id="B300-ijms-21-04946">
<label>300.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trembovler</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Di Marzo</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Petrosino</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Leo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Alexandrovich</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Regev</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Casap</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Shteyer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ledent</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</article-title>
<source/>FASEB J.
          <year>2008</year>
<volume>22</volume>
<fpage>285</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1096/fj.06-7957com</pub-id>
<pub-id pub-id-type="pmid">17704191</pub-id>
</element-citation>
</ref>
<ref id="B301-ijms-21-04946">
<label>301.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Srivastava</surname>
<given-names>R.K.</given-names>
</name>
<name>
<surname>de Azua</surname>
<given-names>I.R.</given-names>
</name>
<name>
<surname>Bindila</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Baraghithy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lutz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bab</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor</article-title>
<source/>Bone
          <year>2018</year>
<volume>108</volume>
<fpage>34</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2017.12.018</pub-id>
<pub-id pub-id-type="pmid">29274505</pub-id>
</element-citation>
</ref>
<ref id="B302-ijms-21-04946">
<label>302.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apostu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lucaciu</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mester</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Benea</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Oltean-Dan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Onisor</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Baciut</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bran</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cannabinoids and bone regeneration</article-title>
<source/>Drug Metab. Rev.
          <year>2019</year>
<volume>51</volume>
<fpage>65</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1080/03602532.2019.1574303</pub-id>
<pub-id pub-id-type="pmid">30702341</pub-id>
</element-citation>
</ref>
<ref id="B303-ijms-21-04946">
<label>303.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kogan</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Melamed</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Raphael</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Breuer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stok</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Sondergaard</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Escudero</surname>
<given-names>A.V.V.</given-names>
</name>
<name>
<surname>Baraghithy</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Attar-Namdar</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts</article-title>
<source/>J. Bone Miner. Res.
          <year>2015</year>
<volume>30</volume>
<fpage>1905</fpage>
<lpage>1913</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.2513</pub-id>
<pub-id pub-id-type="pmid">25801536</pub-id>
</element-citation>
</ref>
<ref id="B304-ijms-21-04946">
<label>304.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elefteriou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Control of bone remodeling by the peripheral sympathetic nervous system</article-title>
<source/>Calcif. Tissue Int.
          <year>2014</year>
<volume>94</volume>
<fpage>140</fpage>
<lpage>151</lpage>
<pub-id pub-id-type="doi">10.1007/s00223-013-9752-4</pub-id>
<pub-id pub-id-type="pmid">23765388</pub-id>
</element-citation>
</ref>
<ref id="B305-ijms-21-04946">
<label>305.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bajayo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Denes</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bachar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kram</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Attar-Namdar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zallone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kovács</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Yirmiya</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bab</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>15455</fpage>
<lpage>15460</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1206061109</pub-id>
<pub-id pub-id-type="pmid">22949675</pub-id>
</element-citation>
</ref>
<ref id="B306-ijms-21-04946">
<label>306.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eimar</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tamimi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Murshed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tamimi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Cholinergic regulation of bone</article-title>
<source/>J. Musculoskelet. Neuronal Interact.
          <year>2013</year>
<volume>13</volume>
<fpage>124</fpage>
<lpage>132</lpage>
<pub-id pub-id-type="pmid">23728099</pub-id>
</element-citation>
</ref>
<ref id="B307-ijms-21-04946">
<label>307.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Oury</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Wess</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.S.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.E.</given-names>
</name>
<name>
<surname>Murshed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Signaling through the M3 Muscarinic Receptor Favors Bone Mass Accrual by Decreasing Sympathetic Activity</article-title>
<source/>Cell Metab.
          <year>2010</year>
<volume>11</volume>
<fpage>231</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2010.01.005</pub-id>
<pub-id pub-id-type="pmid">20197056</pub-id>
</element-citation>
</ref>
<ref id="B308-ijms-21-04946">
<label>308.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kondo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Togari</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Continuous treatment with a low-dose β-agonist reduces bone mass by increasing bone resorption without suppressing bone formation</article-title>
<source/>Calcif. Tissue Int.
          <year>2011</year>
<volume>88</volume>
<fpage>23</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1007/s00223-010-9421-9</pub-id>
<pub-id pub-id-type="pmid">20882384</pub-id>
</element-citation>
</ref>
<ref id="B309-ijms-21-04946">
<label>309.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ducy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Amling</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Priemel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Schilling</surname>
<given-names>A.F.</given-names>
</name>
<name>
<surname>Beil</surname>
<given-names>F.T.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vinson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rueger</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass</article-title>
<source/>Cell
          <year>2000</year>
<volume>100</volume>
<fpage>197</fpage>
<lpage>207</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)81558-5</pub-id>
<pub-id pub-id-type="pmid">10660043</pub-id>
</element-citation>
</ref>
<ref id="B310-ijms-21-04946">
<label>310.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Elefteriou</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Levasseur</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Armstrong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ducy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Leptin regulates bone formation via the sympathetic nervous system</article-title>
<source/>Cell
          <year>2002</year>
<volume>111</volume>
<fpage>305</fpage>
<lpage>317</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(02)01049-8</pub-id>
<pub-id pub-id-type="pmid">12419242</pub-id>
</element-citation>
</ref>
<ref id="B311-ijms-21-04946">
<label>311.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamrick</surname>
<given-names>M.W.</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>S.L.</given-names>
</name>
</person-group>
<article-title>Leptin and the sympathetic connection of fat to bone</article-title>
<source/>Osteoporos. Int.
          <year>2008</year>
<volume>19</volume>
<fpage>905</fpage>
<lpage>912</lpage>
<pub-id pub-id-type="doi">10.1007/s00198-007-0487-9</pub-id>
<pub-id pub-id-type="pmid">17924050</pub-id>
</element-citation>
</ref>
<ref id="B312-ijms-21-04946">
<label>312.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Malaval</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lafage-Proust</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Vico</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Opposite effects of leptin on bone metabolism: A dose-dependent balance related to energy intake and insulin-like growth factor-I pathway</article-title>
<source/>Endocrinology
          <year>2007</year>
<volume>148</volume>
<fpage>3419</fpage>
<lpage>3425</lpage>
<pub-id pub-id-type="doi">10.1210/en.2006-1541</pub-id>
<pub-id pub-id-type="pmid">17431002</pub-id>
</element-citation>
</ref>
<ref id="B313-ijms-21-04946">
<label>313.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mach</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Sabino</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Luger</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Schwei</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Pomonis</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Keyser</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Clohisy</surname>
<given-names>D.R.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>O’leary</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Origins of skeletal pain: Sensory and sympathetic innervation of the mouse femur</article-title>
<source/>Neuroscience
          <year>2002</year>
<volume>113</volume>
<fpage>155</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-4522(02)00165-3</pub-id>
<pub-id pub-id-type="pmid">12123694</pub-id>
</element-citation>
</ref>
<ref id="B314-ijms-21-04946">
<label>314.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chartier</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>S.A.T.</given-names>
</name>
<name>
<surname>Majuta</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Mantyh</surname>
<given-names>P.W.</given-names>
</name>
</person-group>
<article-title>The Changing Sensory and Sympathetic Innervation of the Young, Adult and Aging Mouse Femur</article-title>
<source/>Neuroscience
          <year>2018</year>
<volume>387</volume>
<fpage>178</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2018.01.047</pub-id>
<pub-id pub-id-type="pmid">29432884</pub-id>
</element-citation>
</ref>
<ref id="B315-ijms-21-04946">
<label>315.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Offley</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>T.Z.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>J.D.</given-names>
</name>
<name>
<surname>Vogel</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lindsey</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Kingery</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity</article-title>
<source/>J. Bone Miner. Res.
          <year>2005</year>
<volume>20</volume>
<fpage>257</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1359/JBMR.041108</pub-id>
<pub-id pub-id-type="pmid">15647820</pub-id>
</element-citation>
</ref>
<ref id="B316-ijms-21-04946">
<label>316.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Togari</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Effects of capsaicin-induced sensory denervation on bone metabolism in adult rats</article-title>
<source/>Bone
          <year>2010</year>
<volume>46</volume>
<fpage>1591</fpage>
<lpage>1596</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2010.02.022</pub-id>
<pub-id pub-id-type="pmid">20193788</pub-id>
</element-citation>
</ref>
<ref id="B317-ijms-21-04946">
<label>317.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Russell</surname>
<given-names>F.A.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Smillie</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Kodji</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Brain</surname>
<given-names>S.D.</given-names>
</name>
</person-group>
<article-title>Calcitonin gene-related peptide: Physiology and pathophysiology</article-title>
<source/>Physiol. Rev.
          <year>2014</year>
<volume>94</volume>
<fpage>1099</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00034.2013</pub-id>
<pub-id pub-id-type="pmid">25287861</pub-id>
</element-citation>
</ref>
<ref id="B318-ijms-21-04946">
<label>318.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Halloran</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Kingery</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-κB activation, osteoclastogenesis and bone resorption</article-title>
<source/>Bone
          <year>2010</year>
<volume>46</volume>
<fpage>1369</fpage>
<lpage>1379</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2009.11.029</pub-id>
<pub-id pub-id-type="pmid">19962460</pub-id>
</element-citation>
</ref>
<ref id="B319-ijms-21-04946">
<label>319.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liiu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Calcitonin gene-related peptide promotes the expression of osteoblastic genes and activates the WNT signal transduction pathway in bone marrow stromal stem cells</article-title>
<source/>Mol. Med. Rep.
          <year>2016</year>
<volume>13</volume>
<fpage>4689</fpage>
<lpage>4696</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2016.5117</pub-id>
<pub-id pub-id-type="pmid">27082317</pub-id>
</element-citation>
</ref>
<ref id="B320-ijms-21-04946">
<label>320.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishizuka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hirukawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Togari</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol</article-title>
<source/>Neurosci. Lett.
          <year>2005</year>
<volume>379</volume>
<fpage>47</fpage>
<lpage>51</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2004.12.046</pub-id>
<pub-id pub-id-type="pmid">15814197</pub-id>
</element-citation>
</ref>
<ref id="B321-ijms-21-04946">
<label>321.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onuoha</surname>
<given-names>G.N.</given-names>
</name>
<name>
<surname>Alpar</surname>
<given-names>E.K.</given-names>
</name>
</person-group>
<article-title>Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur</article-title>
<source/>Neuropeptides
          <year>2000</year>
<volume>34</volume>
<fpage>116</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1054/npep.2000.0803</pub-id>
<pub-id pub-id-type="pmid">10985928</pub-id>
</element-citation>
</ref>
<ref id="B322-ijms-21-04946">
<label>322.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Y.Q.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Expressions and significance of calcitonin gene-related peptide and nerve growth factor in rabbit model of traumatic brain injury complicated with tibial fracture: Preliminary results</article-title>
<source/>Eur. Rev. Med. Pharmacol. Sci.
          <year>2019</year>
<volume>23</volume>
<fpage>5040</fpage>
<lpage>5050</lpage>
<pub-id pub-id-type="pmid">31298358</pub-id>
</element-citation>
</ref>
<ref id="B323-ijms-21-04946">
<label>323.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrison</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Geppetti</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Substance P</article-title>
<source/>Int. J. Biochem. Cell Biol.
          <year>2001</year>
<volume>33</volume>
<fpage>555</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="doi">10.1016/S1357-2725(01)00031-0</pub-id>
<pub-id pub-id-type="pmid">11378438</pub-id>
</element-citation>
</ref>
<ref id="B324-ijms-21-04946">
<label>324.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cook</surname>
<given-names>N.L.</given-names>
</name>
<name>
<surname>Vink</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Donkin</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>van den Heuvel</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Validation of reference genes for normalization of real-time quantitative RT-PCR data in traumatic brain injury</article-title>
<source/>J. Neurosci. Res.
          <year>2009</year>
<volume>87</volume>
<fpage>34</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.21846</pub-id>
<pub-id pub-id-type="pmid">18711751</pub-id>
</element-citation>
</ref>
<ref id="B325-ijms-21-04946">
<label>325.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Donkin</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Nimmo</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Cernak</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Blumbergs</surname>
<given-names>P.C.</given-names>
</name>
<name>
<surname>Vink</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury</article-title>
<source/>J. Cereb. Blood Flow Metab.
          <year>2009</year>
<volume>29</volume>
<fpage>1388</fpage>
<lpage>1398</lpage>
<pub-id pub-id-type="doi">10.1038/jcbfm.2009.63</pub-id>
<pub-id pub-id-type="pmid">19436311</pub-id>
</element-citation>
</ref>
<ref id="B326-ijms-21-04946">
<label>326.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Halloran</surname>
<given-names>B.P.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Kingery</surname>
<given-names>W.S.</given-names>
</name>
</person-group>
<article-title>Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro</article-title>
<source/>Bone
          <year>2009</year>
<volume>45</volume>
<fpage>309</fpage>
<lpage>320</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2009.04.203</pub-id>
<pub-id pub-id-type="pmid">19379851</pub-id>
</element-citation>
</ref>
<ref id="B327-ijms-21-04946">
<label>327.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>F.X.Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Shan</surname>
<given-names>S.K.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>L.Q.</given-names>
</name>
</person-group>
<article-title>The Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity</article-title>
<source/>Front. Endocrinol.
          <year>2020</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.3389/fendo.2020.00077</pub-id>
</element-citation>
</ref>
<ref id="B328-ijms-21-04946">
<label>328.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niedermair</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schirner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Seebröker</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Straub</surname>
<given-names>R.H.</given-names>
</name>
<name>
<surname>Grässel</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.1038/s41598-018-27432-y</pub-id>
</element-citation>
</ref>
<ref id="B329-ijms-21-04946">
<label>329.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.S.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>L.Y.</given-names>
</name>
</person-group>
<article-title>Changes of substance P during fracture healing in ovariectomized mice</article-title>
<source/>Regul. Pept.
          <year>2010</year>
<volume>159</volume>
<fpage>28</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="doi">10.1016/j.regpep.2009.11.004</pub-id>
<pub-id pub-id-type="pmid">19903498</pub-id>
</element-citation>
</ref>
<ref id="B330-ijms-21-04946">
<label>330.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hofman</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rabenschlag</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Andruszkow</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Andruszkow</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Möckel</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lammers</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kolejewska</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kobbe</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Greven</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Teuben</surname>
<given-names>M.P.J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of neurokinin-1-receptor blockage on fracture healing in rats</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1038/s41598-019-46278-6</pub-id>
</element-citation>
</ref>
<ref id="B331-ijms-21-04946">
<label>331.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>X.F.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>E.D.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>L.S.</given-names>
</name>
</person-group>
<article-title>Inhibition of substance P signaling aggravates the bone loss in ovariectomy-induced osteoporosis</article-title>
<source/>Prog. Biophys. Mol. Biol.
          <year>2016</year>
<volume>122</volume>
<fpage>112</fpage>
<lpage>121</lpage>
<pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2016.05.011</pub-id>
<pub-id pub-id-type="pmid">27237582</pub-id>
</element-citation>
</ref>
<ref id="B332-ijms-21-04946">
<label>332.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tran</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Kolodkin</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Bharadwaj</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Semaphorin Regulation of Cellular Morphology</article-title>
<source/>Annu. Rev. Cell Dev. Biol.
          <year>2007</year>
<volume>23</volume>
<fpage>263</fpage>
<lpage>292</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.cellbio.22.010605.093554</pub-id>
<pub-id pub-id-type="pmid">17539753</pub-id>
</element-citation>
</ref>
<ref id="B333-ijms-21-04946">
<label>333.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wee</surname>
<given-names>N.K.Y.</given-names>
</name>
<name>
<surname>Kulkarni</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Horsnell</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Baldock</surname>
<given-names>P.A.</given-names>
</name>
</person-group>
<article-title>The brain in bone and fuel metabolism</article-title>
<source/>Bone
          <year>2016</year>
<volume>82</volume>
<fpage>56</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2015.10.020</pub-id>
<pub-id pub-id-type="pmid">26545334</pub-id>
</element-citation>
</ref>
<ref id="B334-ijms-21-04946">
<label>334.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Neural regulation of bone remodeling: Identifying novel neural molecules and pathways between brain and bone</article-title>
<source/>J. Cell. Physiol.
          <year>2019</year>
<volume>234</volume>
<fpage>5466</fpage>
<lpage>5477</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.26502</pub-id>
<pub-id pub-id-type="pmid">29377116</pub-id>
</element-citation>
</ref>
<ref id="B335-ijms-21-04946">
<label>335.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Taniguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kodama</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kumanogoh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Takayanagi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Osteoprotection by semaphorin 3A</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>69</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1038/nature11000</pub-id>
<pub-id pub-id-type="pmid">22522930</pub-id>
</element-citation>
</ref>
<ref id="B336-ijms-21-04946">
<label>336.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukuda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ochi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sunamura</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shibata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoshida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sema3A regulates bone-mass accrual through sensory innervations</article-title>
<source/>Nature
          <year>2013</year>
<volume>497</volume>
<fpage>490</fpage>
<lpage>493</lpage>
<pub-id pub-id-type="doi">10.1038/nature12115</pub-id>
<pub-id pub-id-type="pmid">23644455</pub-id>
</element-citation>
</ref>
<ref id="B337-ijms-21-04946">
<label>337.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ducy</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Desbois</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Boyce</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Pinero</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Story</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Dunstan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bonadio</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gundberg</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased bone formation in osteocalcin-deficient mice</article-title>
<source/>Nature
          <year>1996</year>
<volume>382</volume>
<fpage>448</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1038/382448a0</pub-id>
<pub-id pub-id-type="pmid">8684484</pub-id>
</element-citation>
</ref>
<ref id="B338-ijms-21-04946">
<label>338.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz-Franco</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Franco-Diaz de Leon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Villafan-Bernal</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>Osteocalcin-GPRC6A: An update of its clinical and biological multi-organic interactions (Review)</article-title>
<source/>Mol. Med. Rep.
          <year>2019</year>
<volume>19</volume>
<fpage>15</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2018.9627</pub-id>
<pub-id pub-id-type="pmid">30431093</pub-id>
</element-citation>
</ref>
<ref id="B339-ijms-21-04946">
<label>339.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oury</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Khrimian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Denny</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Gardin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chamouni</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Goeden</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Srinivas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X.B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>XMaternal and offspring pools of osteocalcin influence brain development and functions</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<fpage>228</fpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.08.042</pub-id>
<pub-id pub-id-type="pmid">24074871</pub-id>
</element-citation>
</ref>
<ref id="B340-ijms-21-04946">
<label>340.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bradburn</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mcphee</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Bagley</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sipila</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stenroth</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Narici</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Pääsuke</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gapeyeva</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Osborne</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sassano</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between osteocalcin and cognitive performance in healthy older adults</article-title>
<source/>Age Ageing
          <year>2016</year>
<volume>45</volume>
<fpage>844</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1093/ageing/afw137</pub-id>
<pub-id pub-id-type="pmid">27515675</pub-id>
</element-citation>
</ref>
<ref id="B341-ijms-21-04946">
<label>341.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y.F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.M.</given-names>
</name>
</person-group>
<article-title>Roles for osteocalcin in brain signalling: Implications in cognition- and motor-related disorders</article-title>
<source/>Mol. Brain
          <year>2019</year>
<volume>12</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1186/s13041-019-0444-5</pub-id>
<pub-id pub-id-type="pmid">30606245</pub-id>
</element-citation>
</ref>
<ref id="B342-ijms-21-04946">
<label>342.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moser</surname>
<given-names>S.C.</given-names>
</name>
<name>
<surname>van der Eerden</surname>
<given-names>B.C.J.</given-names>
</name>
</person-group>
<article-title>Osteocalcin — A versatile bone-derived hormone</article-title>
<source/>Front. Endocrinol.
          <year>2019</year>
<volume>10</volume>
<fpage>4</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.3389/fendo.2018.00794</pub-id>
<pub-id pub-id-type="pmid">30687236</pub-id>
</element-citation>
</ref>
<ref id="B343-ijms-21-04946">
<label>343.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diegel</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Hann</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ayturk</surname>
<given-names>U.M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>J.C.W.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Droscha</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Madaj</surname>
<given-names>Z.B.</given-names>
</name>
<name>
<surname>Foxa</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Izaguirre</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Transgenics Core</surname>
<given-names>V.V.A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An osteocalcin-deficient mouse strain without endocrine abnormalities</article-title>
<source/>PLoS Genet.
          <year>2020</year>
<volume>16</volume>
<elocation-id>e1008361</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1008361</pub-id>
<pub-id pub-id-type="pmid">32463812</pub-id>
</element-citation>
</ref>
<ref id="B344-ijms-21-04946">
<label>344.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moriishi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ozasa</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ishimoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hasegawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miyazaki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fukuyama</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Komori</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Osteocalcin is necessary for the alignment of apatite crystallites, but not glucose metabolism, testosterone synthesis, or muscle mass</article-title>
<source/>PLoS Genet.
          <year>2020</year>
<volume>16</volume>
<elocation-id>e1008586</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1008586</pub-id>
<pub-id pub-id-type="pmid">32463816</pub-id>
</element-citation>
</ref>
<ref id="B345-ijms-21-04946">
<label>345.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mera</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ferron</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mosialou</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Regulation of energy metabolism by bone-derived hormones</article-title>
<source/>Cold Spring Harb. Perspect. Med.
          <year>2018</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.1101/cshperspect.a031666</pub-id>
<pub-id pub-id-type="pmid">28778968</pub-id>
</element-citation>
</ref>
<ref id="B346-ijms-21-04946">
<label>346.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mosialou</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Shikhel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Maurizi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Friedman</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Barasch</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MC4R-dependent suppression of appetite by bone-derived lipocalin 2</article-title>
<source/>Nature
          <year>2017</year>
<volume>543</volume>
<fpage>385</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1038/nature21697</pub-id>
<pub-id pub-id-type="pmid">28273060</pub-id>
</element-citation>
</ref>
<ref id="B347-ijms-21-04946">
<label>347.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koide</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Regulatory mechanisms of sclerostin expression during bone remodeling</article-title>
<source/>J. Bone Miner. Metab.
          <year>2019</year>
<volume>37</volume>
<fpage>9</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1007/s00774-018-0971-7</pub-id>
<pub-id pub-id-type="pmid">30357564</pub-id>
</element-citation>
</ref>
<ref id="B348-ijms-21-04946">
<label>348.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kneissel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>WNT signaling in bone homeostasis and disease: From human mutations to treatments</article-title>
<source/>Nat. Med.
          <year>2013</year>
<volume>19</volume>
<fpage>179</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="doi">10.1038/nm.3074</pub-id>
<pub-id pub-id-type="pmid">23389618</pub-id>
</element-citation>
</ref>
<ref id="B349-ijms-21-04946">
<label>349.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname>
<given-names>A.D.</given-names>
</name>
<name>
<surname>Shoback</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Michael Lewiecki</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Sclerostin inhibition: A novel therapeutic approach in the treatment of osteoporosis</article-title>
<source/>Int. J. Womens. Health
          <year>2015</year>
<volume>7</volume>
<fpage>565</fpage>
<lpage>580</lpage>
<pub-id pub-id-type="pmid">26082665</pub-id>
</element-citation>
</ref>
<ref id="B350-ijms-21-04946">
<label>350.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McClung</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Grauer</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Boonen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bolognese</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Diez-Perez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Langdahl</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Reginster</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Zanchetta</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>S.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Romosozumab in postmenopausal women with low bone mineral density</article-title>
<source/>N. Engl. J. Med.
          <year>2014</year>
<volume>370</volume>
<fpage>412</fpage>
<lpage>420</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1305224</pub-id>
<pub-id pub-id-type="pmid">24382002</pub-id>
</element-citation>
</ref>
<ref id="B351-ijms-21-04946">
<label>351.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosman</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Crittenden</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>N.E.</given-names>
</name>
<name>
<surname>Lippuner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Milmont</surname>
<given-names>C.E.</given-names>
</name>
<name>
<surname>Libanati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Grauer</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab</article-title>
<source/>J. Bone Miner. Res.
          <year>2018</year>
<volume>33</volume>
<fpage>1219</fpage>
<lpage>1226</lpage>
<pub-id pub-id-type="doi">10.1002/jbmr.3427</pub-id>
<pub-id pub-id-type="pmid">29573473</pub-id>
</element-citation>
</ref>
<ref id="B352-ijms-21-04946">
<label>352.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Graeff</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>G.M.</given-names>
</name>
<name>
<surname>Peña</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Borggrefe</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Padhi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kaufman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Libanati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Glüer</surname>
<given-names>C.C.</given-names>
</name>
</person-group>
<article-title>Administration of romosozumab improves vertebral trabecular and cortical bone as assessed with quantitative computed tomography and finite element analysis</article-title>
<source/>Bone
          <year>2015</year>
<volume>81</volume>
<fpage>364</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2015.07.036</pub-id>
<pub-id pub-id-type="pmid">26232375</pub-id>
</element-citation>
</ref>
<ref id="B353-ijms-21-04946">
<label>353.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saag</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Petersen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Brandi</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Karaplis</surname>
<given-names>A.C.</given-names>
</name>
<name>
<surname>Lorentzon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Maddox</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Meisner</surname>
<given-names>P.D.</given-names>
</name>
<name>
<surname>Grauer</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Romosozumab or alendronate for fracture prevention in women with osteoporosis</article-title>
<source/>N. Engl. J. Med.
          <year>2017</year>
<volume>377</volume>
<fpage>1417</fpage>
<lpage>1427</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa1708322</pub-id>
<pub-id pub-id-type="pmid">28892457</pub-id>
</element-citation>
</ref>
<ref id="B354-ijms-21-04946">
<label>354.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inestrosa</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Varela-Nallar</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Wnt signaling in the nervous system and in Alzheimer’s disease</article-title>
<source/>J. Mol. Cell Biol.
          <year>2014</year>
<volume>6</volume>
<fpage>64</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1093/jmcb/mjt051</pub-id>
<pub-id pub-id-type="pmid">24549157</pub-id>
</element-citation>
</ref>
<ref id="B355-ijms-21-04946">
<label>355.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weivoda</surname>
<given-names>M.M.</given-names>
</name>
<name>
<surname>Youssef</surname>
<given-names>S.J.</given-names>
</name>
<name>
<surname>Oursler</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Sclerostin expression and functions beyond the osteocyte</article-title>
<source/>Bone
          <year>2017</year>
<volume>96</volume>
<fpage>45</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2016.11.024</pub-id>
<pub-id pub-id-type="pmid">27888056</pub-id>
</element-citation>
</ref>
<ref id="B356-ijms-21-04946">
<label>356.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinzone</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Thudi</surname>
<given-names>N.K.</given-names>
</name>
<name>
<surname>Vonau</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qiang</surname>
<given-names>Y.W.</given-names>
</name>
<name>
<surname>Rosol</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Shaughnessy</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>The role of Dickkopf-1 in bone development, homeostasis, and disease</article-title>
<source/>Blood
          <year>2009</year>
<volume>113</volume>
<fpage>517</fpage>
<lpage>525</lpage>
<pub-id pub-id-type="doi">10.1182/blood-2008-03-145169</pub-id>
<pub-id pub-id-type="pmid">18687985</pub-id>
</element-citation>
</ref>
<ref id="B357-ijms-21-04946">
<label>357.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sarosi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Cattley</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Pretorius</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Asuncion</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Grisanti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morony</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Adamu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia</article-title>
<source/>Bone
          <year>2006</year>
<volume>39</volume>
<fpage>754</fpage>
<lpage>766</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2006.03.017</pub-id>
<pub-id pub-id-type="pmid">16730481</pub-id>
</element-citation>
</ref>
<ref id="B358-ijms-21-04946">
<label>358.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieven</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Knobloch</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rüther</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>The regulation of Dkk1 expression during embryonic development</article-title>
<source/>Dev. Biol.
          <year>2010</year>
<volume>340</volume>
<fpage>256</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2010.01.037</pub-id>
<pub-id pub-id-type="pmid">20144607</pub-id>
</element-citation>
</ref>
<ref id="B359-ijms-21-04946">
<label>359.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Dickkopf-1: Current knowledge and related diseases</article-title>
<source/>Life Sci.
          <year>2018</year>
<volume>209</volume>
<fpage>249</fpage>
<lpage>254</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2018.08.019</pub-id>
<pub-id pub-id-type="pmid">30102902</pub-id>
</element-citation>
</ref>
<ref id="B360-ijms-21-04946">
<label>360.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okamoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iwamura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Terashima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Soya</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Asashima</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuwabara</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Reduction in paracrine Wnt3 factors during aging causes impaired adult neurogenesis</article-title>
<source/>FASEB J.
          <year>2011</year>
<volume>25</volume>
<fpage>3570</fpage>
<lpage>3582</lpage>
<pub-id pub-id-type="doi">10.1096/fj.11-184697</pub-id>
<pub-id pub-id-type="pmid">21746862</pub-id>
</element-citation>
</ref>
<ref id="B361-ijms-21-04946">
<label>361.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ren</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The role of DKK1 in Alzheimer’s disease: A potential intervention point of brain damage prevention?</article-title>
<source/>Pharmacol. Res.
          <year>2019</year>
<volume>144</volume>
<fpage>331</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2019.04.033</pub-id>
<pub-id pub-id-type="pmid">31042564</pub-id>
</element-citation>
</ref>
<ref id="B362-ijms-21-04946">
<label>362.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purro</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Dickins</surname>
<given-names>E.M.</given-names>
</name>
<name>
<surname>Salinas</surname>
<given-names>P.C.</given-names>
</name>
</person-group>
<article-title>The secreted Wnt antagonist dickkopf-1 is required for amyloid β-mediated synaptic loss</article-title>
<source/>J. Neurosci.
          <year>2012</year>
<volume>32</volume>
<fpage>3492</fpage>
<lpage>3498</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4562-11.2012</pub-id>
<pub-id pub-id-type="pmid">22399772</pub-id>
</element-citation>
</ref>
<ref id="B363-ijms-21-04946">
<label>363.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchetti</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin signaling pathway governs a full program for dopaminergic neuron survival, neurorescue and regeneration in the MPTP mouse model of Parkinson’s disease</article-title>
<source/>Int. J. Mol. Sci.
          <year>2018</year>
<volume>19</volume>
<elocation-id>3743</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms19123743</pub-id>
<pub-id pub-id-type="pmid">30477246</pub-id>
</element-citation>
</ref>
<ref id="B364-ijms-21-04946">
<label>364.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Corrado</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sanpaolo</surname>
<given-names>E.R.</given-names>
</name>
<name>
<surname>Di Bello</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cantatore</surname>
<given-names>F.P.</given-names>
</name>
</person-group>
<article-title>Osteoblast as a target of anti-osteoporotic treatment</article-title>
<source/>Postgrad. Med.
          <year>2017</year>
<volume>129</volume>
<fpage>858</fpage>
<lpage>865</lpage>
<pub-id pub-id-type="doi">10.1080/00325481.2017.1362312</pub-id>
<pub-id pub-id-type="pmid">28770650</pub-id>
</element-citation>
</ref>
<ref id="B365-ijms-21-04946">
<label>365.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Florio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gunasekaran</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stolina</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tipton</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Salimi-Moosavi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Asuncion</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair</article-title>
<source/>Nat. Commun.
          <year>2016</year>
<volume>7</volume>
<pub-id pub-id-type="doi">10.1038/ncomms11505</pub-id>
<pub-id pub-id-type="pmid">27230681</pub-id>
</element-citation>
</ref>
<ref id="B366-ijms-21-04946">
<label>366.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simard</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Soulet</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gowing</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Julien</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Rivest</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer’s disease</article-title>
<source/>Neuron
          <year>2006</year>
<volume>49</volume>
<fpage>489</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2006.01.022</pub-id>
<pub-id pub-id-type="pmid">16476660</pub-id>
</element-citation>
</ref>
<ref id="B367-ijms-21-04946">
<label>367.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Arlian</surname>
<given-names>B.M.</given-names>
</name>
<name>
<surname>Macauley</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Paulson</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Lerner</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Migration-based selections of antibodies that convert bone marrow into trafficking microglia-like cells that reduce brain amyloid β</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>E372</fpage>
<lpage>E381</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1719259115</pub-id>
<pub-id pub-id-type="pmid">29295920</pub-id>
</element-citation>
</ref>
<ref id="B368-ijms-21-04946">
<label>368.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawanishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Itezono</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nagayama</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Konoya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chisaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Toda</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nakata</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yano</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kitamura</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer’s Disease</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2018</year>
<volume>64</volume>
<fpage>563</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-170994</pub-id>
<pub-id pub-id-type="pmid">29914020</pub-id>
</element-citation>
</ref>
<ref id="B369-ijms-21-04946">
<label>369.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuroda</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sueyoshi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aitani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kouda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Satake</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shima</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Toda</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Peripheral Blood-Derived Microglia-Like Cells Decrease Amyloid-β Burden and Ameliorate Cognitive Impairment in a Mouse Model of Alzheimer’s Disease</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2020</year>
<volume>73</volume>
<fpage>413</fpage>
<lpage>429</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-190974</pub-id>
<pub-id pub-id-type="pmid">31796681</pub-id>
</element-citation>
</ref>
<ref id="B370-ijms-21-04946">
<label>370.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costa-Marques</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Pardon</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Leovsky</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Swarbrick</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fabian</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stolzing</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Transplantation of bone marrow derived macrophages reduces markers of neuropathology in an APP/PS1 mouse model</article-title>
<source/>Transl. Neurodegener.
          <year>2019</year>
<volume>8</volume>
<fpage>1</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1186/s40035-019-0173-9</pub-id>
<pub-id pub-id-type="pmid">30627430</pub-id>
</element-citation>
</ref>
<ref id="B371-ijms-21-04946">
<label>371.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lampron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gosselin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rivest</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Targeting the hematopoietic system for the treatment of Alzheimer’s disease</article-title>
<source/>Brain. Behav. Immun.
          <year>2011</year>
<volume>25</volume>
<fpage>71</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbi.2010.12.018</pub-id>
</element-citation>
</ref>
<ref id="B372-ijms-21-04946">
<label>372.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cuscito</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mongelli</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pignataro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Buccoliero</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sartini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Comite</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The myokine irisin increases cortical bone mass</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>12157</fpage>
<lpage>12162</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1516622112</pub-id>
<pub-id pub-id-type="pmid">26374841</pub-id>
</element-citation>
</ref>
<ref id="B373-ijms-21-04946">
<label>373.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colaianni</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mongelli</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cuscito</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Pignataro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lippo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Spiro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Notarnicola</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Severi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Passeri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>1</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-02557-8</pub-id>
<pub-id pub-id-type="pmid">28127051</pub-id>
</element-citation>
</ref>
<ref id="B374-ijms-21-04946">
<label>374.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arhire</surname>
<given-names>L.I.</given-names>
</name>
<name>
<surname>Mihalache</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Covasa</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome</article-title>
<source/>Front. Endocrinol.
          <year>2019</year>
<volume>10</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.3389/fendo.2019.00524</pub-id>
<pub-id pub-id-type="pmid">31428053</pub-id>
</element-citation>
</ref>
<ref id="B375-ijms-21-04946">
<label>375.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munoz</surname>
<given-names>I.Y.M.</given-names>
</name>
<name>
<surname>Del Socorro Camarillo Romero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>De Jesus Garduno Garcia</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Irisin a novel metabolic biomarker: Present knowledge and future directions</article-title>
<source/>Int. J. Endocrinol.
          <year>2018</year>
<volume>2018</volume>
<pub-id pub-id-type="doi">10.1155/2018/7816806</pub-id>
</element-citation>
</ref>
<ref id="B376-ijms-21-04946">
<label>376.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Asadi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gorjipour</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Behrouzifar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vakili</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Irisin Peptide Protects Brain Against Ischemic Injury Through Reducing Apoptosis and Enhancing BDNF in a Rodent Model of Stroke</article-title>
<source/>Neurochem. Res.
          <year>2018</year>
<volume>43</volume>
<fpage>1549</fpage>
<lpage>1560</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-018-2569-9</pub-id>
<pub-id pub-id-type="pmid">29882126</pub-id>
</element-citation>
</ref>
<ref id="B377-ijms-21-04946">
<label>377.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ting</surname>
<given-names>S.-M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Obertas</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ricote</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aronowski</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Brain Cleanup as a Potential Target for Poststroke Recovery</article-title>
<source/>Stroke
          <year>2020</year>
<fpage>958</fpage>
<lpage>966</lpage>
<pub-id pub-id-type="doi">10.1161/STROKEAHA.119.027315</pub-id>
<pub-id pub-id-type="pmid">31914884</pub-id>
</element-citation>
</ref>
<ref id="B378-ijms-21-04946">
<label>378.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lourenco</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Frozza</surname>
<given-names>R.L.</given-names>
</name>
<name>
<surname>de Freitas</surname>
<given-names>G.B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kincheski</surname>
<given-names>G.C.</given-names>
</name>
<name>
<surname>Ribeiro</surname>
<given-names>F.C.</given-names>
</name>
<name>
<surname>Gonçalves</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Beckman</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Staniszewski</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models</article-title>
<source/>Nat. Med.
          <year>2019</year>
<volume>25</volume>
<fpage>165</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1038/s41591-018-0275-4</pub-id>
<pub-id pub-id-type="pmid">30617325</pub-id>
</element-citation>
</ref>
<ref id="B379-ijms-21-04946">
<label>379.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reinholt</surname>
<given-names>F.P.</given-names>
</name>
<name>
<surname>Hultenby</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oldbergf</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heinegardt</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Osteopontin-a possible anchor of osteoclasts to bone (bone matrix proteins/cell adhesion/vitronectin receptor)</article-title>
<source/>Proc. Nadl. Acad. Sci. USA
          <year>1990</year>
<volume>87</volume>
<fpage>4473</fpage>
<lpage>4475</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.87.12.4473</pub-id>
</element-citation>
</ref>
<ref id="B380-ijms-21-04946">
<label>380.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Amhmed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jakhu</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Role of osteopontin in bone remodeling and orthodontic tooth movement: A review</article-title>
<source/>Prog. Orthod.
          <year>2018</year>
<volume>19</volume>
<pub-id pub-id-type="doi">10.1186/s40510-018-0216-2</pub-id>
</element-citation>
</ref>
<ref id="B381-ijms-21-04946">
<label>381.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cho</surname>
<given-names>E.H.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>K.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.A.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.W.</given-names>
</name>
</person-group>
<article-title>High serum osteopontin levels are associated with low bone mineral density in postmenopausal women</article-title>
<source/>J. Korean Med. Sci.
          <year>2013</year>
<volume>28</volume>
<fpage>1496</fpage>
<lpage>1499</lpage>
<pub-id pub-id-type="doi">10.3346/jkms.2013.28.10.1496</pub-id>
<pub-id pub-id-type="pmid">24133355</pub-id>
</element-citation>
</ref>
<ref id="B382-ijms-21-04946">
<label>382.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scatena</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liaw</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Giachelli</surname>
<given-names>C.M.</given-names>
</name>
</person-group>
<article-title>Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease</article-title>
<source/>Arterioscler. Thromb. Vasc. Biol.
          <year>2007</year>
<volume>27</volume>
<fpage>2302</fpage>
<lpage>2309</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.107.144824</pub-id>
<pub-id pub-id-type="pmid">17717292</pub-id>
</element-citation>
</ref>
<ref id="B383-ijms-21-04946">
<label>383.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Osteopontin: A key link between immunity, inflammation and the central nervous system</article-title>
<source/>Transl. Neurosci.
          <year>2012</year>
<volume>3</volume>
<fpage>288</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.2478/s13380-012-0028-7</pub-id>
<pub-id pub-id-type="pmid">23565338</pub-id>
</element-citation>
</ref>
<ref id="B384-ijms-21-04946">
<label>384.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gliem</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krammes</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Liaw</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>van Rooijen</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hartung</surname>
<given-names>H.P.</given-names>
</name>
<name>
<surname>Jander</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke</article-title>
<source/>Glia
          <year>2015</year>
<volume>63</volume>
<fpage>2198</fpage>
<lpage>2207</lpage>
<pub-id pub-id-type="doi">10.1002/glia.22885</pub-id>
<pub-id pub-id-type="pmid">26148976</pub-id>
</element-citation>
</ref>
<ref id="B385-ijms-21-04946">
<label>385.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carecchio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Comi</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The role of osteopontin in neurodegenerative diseases</article-title>
<source/>J. Alzheimer’s Dis.
          <year>2011</year>
<volume>25</volume>
<fpage>179</fpage>
<lpage>185</lpage>
<pub-id pub-id-type="doi">10.3233/JAD-2011-102151</pub-id>
<pub-id pub-id-type="pmid">21358042</pub-id>
</element-citation>
</ref>
<ref id="B386-ijms-21-04946">
<label>386.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanada</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Leibbrandt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hanada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kitaoka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Furuyashiki</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fujihara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Trichereau</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paolino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Qadri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Plehm</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Central control of fever and female body temperature by RANKL/RANK</article-title>
<source/>Nature
          <year>2009</year>
<volume>462</volume>
<fpage>505</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1038/nature08596</pub-id>
<pub-id pub-id-type="pmid">19940926</pub-id>
</element-citation>
</ref>
<ref id="B387-ijms-21-04946">
<label>387.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
</person-group>
<article-title>Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review)</article-title>
<source/>Mol. Med. Rep.
          <year>2015</year>
<volume>11</volume>
<fpage>3212</fpage>
<lpage>3218</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2015.3152</pub-id>
<pub-id pub-id-type="pmid">25572286</pub-id>
</element-citation>
</ref>
<ref id="B388-ijms-21-04946">
<label>388.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lacey</surname>
<given-names>D.L.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Simonet</surname>
<given-names>W.S.</given-names>
</name>
<name>
<surname>Kostenuik</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Dougall</surname>
<given-names>W.C.</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>J.K.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Dansey</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Bench to bedside: Elucidation of the OPG-RANK-RANKL pathway and the development of denosumab</article-title>
<source/>Nat. Rev. Drug Discov.
          <year>2012</year>
<volume>11</volume>
<fpage>401</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1038/nrd3705</pub-id>
<pub-id pub-id-type="pmid">22543469</pub-id>
</element-citation>
</ref>
<ref id="B389-ijms-21-04946">
<label>389.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lipton</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Fizazi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Stopeck</surname>
<given-names>A.T.</given-names>
</name>
<name>
<surname>Henry</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Yardley</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Richardson</surname>
<given-names>G.E.</given-names>
</name>
<name>
<surname>Siena</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maroto</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Clemens</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials</article-title>
<source/>Eur. J. Cancer
          <year>2012</year>
<volume>48</volume>
<fpage>3082</fpage>
<lpage>3092</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejca.2012.08.002</pub-id>
<pub-id pub-id-type="pmid">22975218</pub-id>
</element-citation>
</ref>
<ref id="B390-ijms-21-04946">
<label>390.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Qu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress</article-title>
<source/>Behav. Brain Res.
          <year>2020</year>
<volume>379</volume>
<pub-id pub-id-type="doi">10.1016/j.bbr.2019.112397</pub-id>
</element-citation>
</ref>
<ref id="B391-ijms-21-04946">
<label>391.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mattson</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Glutamate and neurotrophic factors in neuronal plasticity and disease</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>2008</year>
<volume>1144</volume>
<fpage>97</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">19076369</pub-id>
</element-citation>
</ref>
<ref id="B392-ijms-21-04946">
<label>392.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kajiya</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shiba</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ouhara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kitagawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brain-derived neurotrophic factor stimulates bone/cementum-related protein gene expression in cementoblasts</article-title>
<source/>J. Biol. Chem.
          <year>2008</year>
<volume>283</volume>
<fpage>16259</fpage>
<lpage>16267</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M800668200</pub-id>
<pub-id pub-id-type="pmid">18390540</pub-id>
</element-citation>
</ref>
<ref id="B393-ijms-21-04946">
<label>393.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camerino</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zayzafoon</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rymaszewski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heiny</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rios</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hauschka</surname>
<given-names>P.V.</given-names>
</name>
</person-group>
<article-title>Central depletion of brain-derived neurotrophic, factorin mice results in high bone mass and metabolic phenotype</article-title>
<source/>Endocrinology
          <year>2012</year>
<volume>153</volume>
<fpage>5394</fpage>
<lpage>5405</lpage>
<pub-id pub-id-type="doi">10.1210/en.2012-1378</pub-id>
<pub-id pub-id-type="pmid">23011922</pub-id>
</element-citation>
</ref>
<ref id="B394-ijms-21-04946">
<label>394.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laviola</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Natalicchio</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Perrini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Giorgino</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Abnormalities of IGF-I signaling in the pathogenesis of diseases of the bone, brain, and fetoplacental unit in humans</article-title>
<source/>Am. J. Physiol. Endocrinol. Metab.
          <year>2008</year>
<volume>295</volume>
<pub-id pub-id-type="doi">10.1152/ajpendo.90452.2008</pub-id>
<pub-id pub-id-type="pmid">18713961</pub-id>
</element-citation>
</ref>
<ref id="B395-ijms-21-04946">
<label>395.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wrigley</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Arafa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tropea</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Insulin-like growth factor 1: At the crossroads of brain development and aging</article-title>
<source/>Front. Cell. Neurosci.
          <year>2017</year>
<volume>11</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.3389/fncel.2017.00014</pub-id>
<pub-id pub-id-type="pmid">28154525</pub-id>
</element-citation>
</ref>
<ref id="B396-ijms-21-04946">
<label>396.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yakar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Boisclair</surname>
<given-names>Y.R.</given-names>
</name>
<name>
<surname>Leroith</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yakar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Beamer</surname>
<given-names>W.G.</given-names>
</name>
<name>
<surname>Ackert-bicknell</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ooi</surname>
<given-names>G.T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Circulating levels of IGF-1 directly regulate bone growth and density</article-title>
<source/>J. Clin. Investig.
          <year>2002</year>
<volume>110</volume>
<fpage>771</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1172/JCI0215463</pub-id>
<pub-id pub-id-type="pmid">12235108</pub-id>
</element-citation>
</ref>
<ref id="B397-ijms-21-04946">
<label>397.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosen</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>Insulin-like growth factor I and bone mineral density: Experience from animal models and human observational studies</article-title>
<source/>Best Pract. Res. Clin. Endocrinol. Metab.
          <year>2004</year>
<volume>18</volume>
<fpage>423</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1016/j.beem.2004.02.007</pub-id>
<pub-id pub-id-type="pmid">15261847</pub-id>
</element-citation>
</ref>
<ref id="B398-ijms-21-04946">
<label>398.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bragdon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moseychuk</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Saldanha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Julian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nohe</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Bone Morphogenetic Proteins: A critical review</article-title>
<source/>Cell. Signal.
          <year>2011</year>
<volume>23</volume>
<fpage>609</fpage>
<lpage>620</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2010.10.003</pub-id>
<pub-id pub-id-type="pmid">20959140</pub-id>
</element-citation>
</ref>
<ref id="B399-ijms-21-04946">
<label>399.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.L.</given-names>
</name>
<name>
<surname>Lein</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Gash</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hoffer</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>Y.H.</given-names>
</name>
</person-group>
<article-title>Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals</article-title>
<source/>Brain Res.
          <year>2003</year>
<volume>994</volume>
<fpage>81</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2003.09.020</pub-id>
<pub-id pub-id-type="pmid">14642451</pub-id>
</element-citation>
</ref>
<ref id="B400-ijms-21-04946">
<label>400.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sato</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Mikawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>BMP2 expression in the adult rat brain</article-title>
<source/>J. Comp. Neurol.
          <year>2010</year>
<volume>518</volume>
<fpage>4513</fpage>
<lpage>4530</lpage>
<pub-id pub-id-type="doi">10.1002/cne.22469</pub-id>
<pub-id pub-id-type="pmid">20886619</pub-id>
</element-citation>
</ref>
<ref id="B401-ijms-21-04946">
<label>401.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bond</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Bhalala</surname>
<given-names>O.G.</given-names>
</name>
<name>
<surname>Kessler</surname>
<given-names>J.A.</given-names>
</name>
</person-group>
<article-title>The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation</article-title>
<source/>Dev. Neurobiol.
          <year>2012</year>
<volume>72</volume>
<fpage>1068</fpage>
<lpage>1084</lpage>
<pub-id pub-id-type="doi">10.1002/dneu.22022</pub-id>
<pub-id pub-id-type="pmid">22489086</pub-id>
</element-citation>
</ref>
<ref id="B402-ijms-21-04946">
<label>402.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dettman</surname>
<given-names>R.W.</given-names>
</name>
<name>
<surname>Dizon</surname>
<given-names>M.L.V.</given-names>
</name>
</person-group>
<article-title>Bone morphogenetic protein signaling: A promising target for white matter protection in perinatal brain injury</article-title>
<source/>Neural Regen. Res.
          <year>2018</year>
<volume>13</volume>
<fpage>1183</fpage>
<lpage>1184</lpage>
<pub-id pub-id-type="doi">10.4103/1673-5374.235025</pub-id>
<pub-id pub-id-type="pmid">30028321</pub-id>
</element-citation>
</ref>
<ref id="B403-ijms-21-04946">
<label>403.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Frith</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>French</surname>
<given-names>M.H.</given-names>
</name>
<name>
<surname>Swartz</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Güngör</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Harrity</surname>
<given-names>T.W.</given-names>
</name>
<name>
<surname>Tamasi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rogers</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Feyen</surname>
<given-names>J.H.M.</given-names>
</name>
</person-group>
<article-title>The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity</article-title>
<source/>J. Bone Miner. Res.
          <year>2003</year>
<volume>18</volume>
<fpage>88</fpage>
<lpage>96</lpage>
<pub-id pub-id-type="doi">10.1359/jbmr.2003.18.1.88</pub-id>
<pub-id pub-id-type="pmid">12510809</pub-id>
</element-citation>
</ref>
<ref id="B404-ijms-21-04946">
<label>404.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Masuno</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shikimori</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Statins: Candidates for promoting bone formation via BMP-2</article-title>
<source/>Oral Med. Pathol.
          <year>2010</year>
<volume>14</volume>
<fpage>81</fpage>
<lpage>87</lpage>
<pub-id pub-id-type="doi">10.3353/omp.14.81</pub-id>
</element-citation>
</ref>
<ref id="B405-ijms-21-04946">
<label>405.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Mechanisms of bone anabolism regulated by statins</article-title>
<source/>Biosci. Rep.
          <year>2012</year>
<volume>32</volume>
<fpage>511</fpage>
<lpage>519</lpage>
<pub-id pub-id-type="doi">10.1042/BSR20110118</pub-id>
<pub-id pub-id-type="pmid">22799752</pub-id>
</element-citation>
</ref>
<ref id="B406-ijms-21-04946">
<label>406.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uzzan</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cucherat</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Perret</surname>
<given-names>G.Y.</given-names>
</name>
</person-group>
<article-title>Effects of statins on bone mineral density: A meta-analysis of clinical studies</article-title>
<source/>Bone
          <year>2007</year>
<volume>40</volume>
<fpage>1581</fpage>
<lpage>1587</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2007.02.019</pub-id>
<pub-id pub-id-type="pmid">17409043</pub-id>
</element-citation>
</ref>
<ref id="B407-ijms-21-04946">
<label>407.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morse</surname>
<given-names>L.R.</given-names>
</name>
<name>
<surname>Coker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Battaglino</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Statins and bone health: A mini review</article-title>
<source/>Actual. osteol.
          <year>2018</year>
<volume>14</volume>
<fpage>31</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">30237809</pub-id>
</element-citation>
</ref>
<ref id="B408-ijms-21-04946">
<label>408.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samsa</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Vasanji</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Midura</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Kondratov</surname>
<given-names>R.V.</given-names>
</name>
</person-group>
<article-title>Deficiency of circadian clock protein BMAL1 in mice results in a low bone mass phenotype</article-title>
<source/>Bone
          <year>2016</year>
<volume>84</volume>
<fpage>194</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2016.01.006</pub-id>
<pub-id pub-id-type="pmid">26789548</pub-id>
</element-citation>
</ref>
<ref id="B409-ijms-21-04946">
<label>409.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Man</surname>
<given-names>C.W.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>T.B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The effect of exogenous melatonin on reducing scoliotic curvature and improving bone quality in melatonin-deficient C57BL/6J mice</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-42467-5</pub-id>
<pub-id pub-id-type="pmid">30626917</pub-id>
</element-citation>
</ref>
<ref id="B410-ijms-21-04946">
<label>410.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rong</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function</article-title>
<source/>Bone
          <year>2014</year>
<volume>61</volume>
<fpage>164</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="doi">10.1016/j.bone.2014.01.010</pub-id>
<pub-id pub-id-type="pmid">24473375</pub-id>
</element-citation>
</ref>
<ref id="B411-ijms-21-04946">
<label>411.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khandekar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>RANKL reduces body weight and food intake via the modulation of hypothalamic NPY/CART expression</article-title>
<source/>Int. J. Med. Sci.
          <year>2018</year>
<volume>15</volume>
<fpage>969</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="doi">10.7150/ijms.24373</pub-id>
<pub-id pub-id-type="pmid">30013437</pub-id>
</element-citation>
</ref>
<ref id="B412-ijms-21-04946">
<label>412.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laksitorini</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Yathindranath</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hombach-Klonisch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>D.W.</given-names>
</name>
</person-group>
<article-title>Modulation of Wnt/β-catenin signaling promotes blood-brain barrier phenotype in cultured brain endothelial cells</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-56075-w</pub-id>
<pub-id pub-id-type="pmid">30626917</pub-id>
</element-citation>
</ref>
<ref id="B413-ijms-21-04946">
<label>413.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bree</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hadar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nemerovski</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pick</surname>
<given-names>C.G.</given-names>
</name>
<name>
<surname>Gabet</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Bone Anabolic Response in the Calvaria Following Mild Traumatic Brain Injury is Mediated by the Cannabinoid-1 Receptor</article-title>
<source/>Sci. Rep.
          <year>2019</year>
<volume>9</volume>
<fpage>1</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/s41598-019-51720-w</pub-id>
<pub-id pub-id-type="pmid">30626917</pub-id>
</element-citation>
</ref>
<ref id="B414-ijms-21-04946">
<label>414.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seemann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Graef</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Garbe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Duda</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schmidt-Bleek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Schaser</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Tsitsilonis</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Leptin-deficiency eradicates the positive effect of traumatic brain injury on bone healing: Histological analyses in a combined trauma mouse model</article-title>
<source/>J. Musculoskelet. Neuronal Interact.
          <year>2018</year>
<volume>18</volume>
<fpage>32</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="pmid">29504576</pub-id>
</element-citation>
</ref>
<ref id="B415-ijms-21-04946">
<label>415.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>G.X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>Y.Z.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>The role of the hippocampus and the function of calcitonin gene-related peptide in the mechanism of traumatic brain injury accelerating fracture-healing</article-title>
<source/>Eur. Rev. Med. Pharmacol. Sci.
          <year>2017</year>
<volume>21</volume>
<fpage>1522</fpage>
<lpage>1531</lpage>
<pub-id pub-id-type="pmid">28429354</pub-id>
</element-citation>
</ref>
<ref id="B416-ijms-21-04946">
<label>416.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>SDF-1 Promotes Endochondral Bone Repair during Fracture Healing at the Traumatic Brain Injury Condition</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<pub-id pub-id-type="doi">10.1371/journal.pone.0054077</pub-id>
<pub-id pub-id-type="pmid">23349789</pub-id>
</element-citation>
</ref>
<ref id="B417-ijms-21-04946">
<label>417.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>W.Z.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>S.B.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.M.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>X.W.</given-names>
</name>
</person-group>
<article-title>Leptin’s effect on accelerated fracture healing after traumatic brain injury</article-title>
<source/>Neurol. Res.
          <year>2013</year>
<volume>35</volume>
<fpage>537</fpage>
<lpage>544</lpage>
<pub-id pub-id-type="doi">10.1179/1743132813Y.0000000201</pub-id>
<pub-id pub-id-type="pmid">23594570</pub-id>
</element-citation>
</ref>
<ref id="B418-ijms-21-04946">
<label>418.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Que</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Arachidonic acid: A bridge between traumatic brain injury and fracture healing</article-title>
<source/>J. Neurotrauma
          <year>2012</year>
<volume>29</volume>
<fpage>2696</fpage>
<lpage>2705</lpage>
<pub-id pub-id-type="doi">10.1089/neu.2012.2442</pub-id>
<pub-id pub-id-type="pmid">22867040</pub-id>
</element-citation>
</ref>
<ref id="B419-ijms-21-04946">
<label>419.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Increased levels of calcitonin gene-related peptide in serum accelerate fracture healing following traumatic brain injury</article-title>
<source/>Mol. Med. Rep.
          <year>2012</year>
<volume>5</volume>
<fpage>432</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="doi">10.3892/mmr.2011.645</pub-id>
<pub-id pub-id-type="pmid">22038198</pub-id>
</element-citation>
</ref>
<ref id="B420-ijms-21-04946">
<label>420.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>The influence of brain injury or peripheral nerve injury on calcitonin gene-related peptide concentration variation and fractures healing process</article-title>
<source/>Artif. Cells Blood Substitutes Biotechnol.
          <year>2009</year>
<volume>37</volume>
<fpage>85</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1080/10731190902743149</pub-id>
</element-citation>
</ref>
<ref id="B421-ijms-21-04946">
<label>421.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>J.C.M.</given-names>
</name>
<name>
<surname>Dass</surname>
<given-names>C.R.</given-names>
</name>
<name>
<surname>Choong</surname>
<given-names>P.F.M.</given-names>
</name>
</person-group>
<article-title>Elevated leptin expression in a rat model of fracture and traumatic brain injury</article-title>
<source/>J. Pharm. Pharmacol.
          <year>2008</year>
<volume>60</volume>
<fpage>1667</fpage>
<lpage>1672</lpage>
<pub-id pub-id-type="doi">10.1211/jpp.60.12.0013</pub-id>
<pub-id pub-id-type="pmid">19000372</pub-id>
</element-citation>
</ref>
<ref id="B422-ijms-21-04946">
<label>422.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kain</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kakar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nicholls</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cullinane</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gerstenfeld</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Einhorn</surname>
<given-names>T.A.</given-names>
</name>
<name>
<surname>Tornetta</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Osteogenic effects of traumatic brain injury on experimental fracture-healing</article-title>
<source/>J. Bone Jt. Surg. Ser. A
          <year>2006</year>
<volume>88</volume>
<fpage>738</fpage>
<lpage>743</lpage>
<pub-id pub-id-type="doi">10.2106/JBJS.D.02648</pub-id>
</element-citation>
</ref>
<ref id="B423-ijms-21-04946">
<label>423.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khallaf</surname>
<given-names>F.G.</given-names>
</name>
<name>
<surname>Kehinde</surname>
<given-names>E.O.</given-names>
</name>
</person-group>
<article-title>The Effect of Serum from Acute Traumatic Brain or Spinal Cord Injury Patients on the Growth of Human Bone Marrow-Derived Mesenchymal Stem Cells</article-title>
<source/>J. Trauma Treat.
          <year>2016</year>
<volume>5</volume>
<pub-id pub-id-type="doi">10.4172/2167-1222.1000299</pub-id>
</element-citation>
</ref>
<ref id="B424-ijms-21-04946">
<label>424.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dengler-Crish</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Ball</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Novak</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>L.N.</given-names>
</name>
</person-group>
<article-title>Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer’s disease</article-title>
<source/>Neurobiol. Aging
          <year>2018</year>
<volume>67</volume>
<fpage>148</fpage>
<lpage>158</lpage>
<pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2018.03.021</pub-id>
<pub-id pub-id-type="pmid">29660685</pub-id>
</element-citation>
</ref>
<ref id="B425-ijms-21-04946">
<label>425.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khrimian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Obri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Karsenty</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Modulation of cognition and anxiety-like behavior by bone remodeling</article-title>
<source/>Mol. Metab.
          <year>2017</year>
<volume>6</volume>
<fpage>1610</fpage>
<lpage>1615</lpage>
<pub-id pub-id-type="doi">10.1016/j.molmet.2017.10.001</pub-id>
<pub-id pub-id-type="pmid">29157601</pub-id>
</element-citation>
</ref>
<ref id="B426-ijms-21-04946">
<label>426.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inatani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Irie</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Plump</surname>
<given-names>A.S.</given-names>
</name>
<name>
<surname>Tessier-Lavigne</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Mammalian Brain Morphogenesis and Midline Axon Guidance Require Heparan Sulfate</article-title>
<source/>Science
          <year>2003</year>
<volume>302</volume>
<fpage>1044</fpage>
<lpage>1046</lpage>
<pub-id pub-id-type="doi">10.1126/science.1090497</pub-id>
<pub-id pub-id-type="pmid">14605369</pub-id>
</element-citation>
</ref>
<ref id="B427-ijms-21-04946">
<label>427.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irie</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Badie-Mahdavi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2012</year>
<volume>109</volume>
<fpage>5052</fpage>
<lpage>5056</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1117881109</pub-id>
<pub-id pub-id-type="pmid">22411800</pub-id>
</element-citation>
</ref>
<ref id="B428-ijms-21-04946">
<label>428.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Jacovides</surname>
<given-names>C.L.</given-names>
</name>
<name>
<surname>Browne</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Cognetti</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>V.E.</given-names>
</name>
<name>
<surname>Leone</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kaplan</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>D.H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cerebral Edema and Neurological Recovery after Traumatic Brain Injury Are Worsened if Accompanied by a Concomitant Long Bone Fracture</article-title>
<source/>J. Neurotrauma
          <year>2019</year>
<volume>36</volume>
<fpage>609</fpage>
<lpage>618</lpage>
<pub-id pub-id-type="doi">10.1089/neu.2018.5812</pub-id>
<pub-id pub-id-type="pmid">30084745</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-21-04946-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Molecular bases of brain and bone crosstalk.</bold> Summary of the predominant mediator effect of (<bold>a</bold>) brain-derived on bone, (<bold>b</bold>) bone-derived on brain, (<bold>c</bold>) adipocyte-derived on bone via central modulation and (<bold>d</bold>) locally synthesized mediators affecting brain and bone concurrently. The mediator effect on brain function and bone mass previously reported was summarized as positive (+) and negative (−). Abbreviations: ACh = acetylcholine, ACTH = adrenocorticotrophic hormone, AgRP = agouti-related peptide, AVP = arginine-vasopressin, BDNF = brain-derived neurotrophic factor, BMPs = bone morphogenic proteins, CART = cocaine amphetamine regulated transcript, CGRP = calcitonin gene related peptide, DA = dopamine, FSH = follicular stimulating hormone, DKK1 = dickkopf-related protein 1, GH = growth hormone, GLU = glutamate, IGF-1 = insulin-like growth factor 1, LCN2 = lipocalin 2, NE = norepinephrine, NMU = neuromedin U, NPY = neuropeptide Y, OCN = osteocalcin, OPN = osteopontin, OT = oxytocin, PRL = prolactin, POMC = proopiomelanocortin, RANKL = receptor activator of nuclear factor-κB ligand, TSH = thyroid-stimulating hormone, VIP = vasoactive intestinal peptide.</p>
</caption>
<graphic xlink:href="ijms-21-04946-g001"></graphic>
</fig>
<table-wrap id="ijms-21-04946-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-21-04946-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Crosstalk of brain and bone: clinical observations.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Origin</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Condition</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Effect on Bone</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Clinical Studies/Reviews</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>brain</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>neuro-psychological causes</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">chronic stress and shift work</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>higher fracture risk</p></list-item><list-item><label>-</label><p>increased proinflammatory cytokines, which stimulate bone resorption</p></list-item><list-item><label>-</label><p>shift workers have a higher risk for osteoporosis and fracture potentially caused by hormonal changes</p></list-item><list-item><label>-</label><p>melatonin has bone protective effects and improves sleep parameters</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B13-ijms-21-04946">13</xref>,<xref ref-type="bibr" rid="B14-ijms-21-04946">14</xref>,<xref ref-type="bibr" rid="B25-ijms-21-04946">25</xref>,<xref ref-type="bibr" rid="B41-ijms-21-04946">41</xref>,<xref ref-type="bibr" rid="B42-ijms-21-04946">42</xref>,<xref ref-type="bibr" rid="B44-ijms-21-04946">44</xref>,<xref ref-type="bibr" rid="B45-ijms-21-04946">45</xref>,<xref ref-type="bibr" rid="B157-ijms-21-04946">157</xref>,<xref ref-type="bibr" rid="B158-ijms-21-04946">158</xref>] <break></break>reviewed by [<xref ref-type="bibr" rid="B159-ijms-21-04946">159</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">major depressive disorder (MDD)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>low BMD and a higher risk for fracture</p></list-item><list-item><label>-</label><p>hypothalamic-pituitary-adrenal (HPA) axis dysregulation with higher levels of glucocorticoids, catecholamines and lower levels of steroids</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B49-ijms-21-04946">49</xref>,<xref ref-type="bibr" rid="B50-ijms-21-04946">50</xref>,<xref ref-type="bibr" rid="B51-ijms-21-04946">51</xref>,<xref ref-type="bibr" rid="B52-ijms-21-04946">52</xref>,<xref ref-type="bibr" rid="B53-ijms-21-04946">53</xref>,<xref ref-type="bibr" rid="B54-ijms-21-04946">54</xref>,<xref ref-type="bibr" rid="B55-ijms-21-04946">55</xref>,<xref ref-type="bibr" rid="B56-ijms-21-04946">56</xref>,<xref ref-type="bibr" rid="B160-ijms-21-04946">160</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">stroke</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>reduced bone mineral density (BMD)</p></list-item><list-item><label>-</label><p>high serum concentration of bone turnover markers are found from early on</p></list-item><list-item><label>-</label><p>higher risk of heterotopic ossification (HO)</p></list-item><list-item><label>-</label><p>higher risk of fracture</p></list-item><list-item><label>-</label><p>bone fracture may affect ischemic stroke recovery</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B16-ijms-21-04946">16</xref>,<xref ref-type="bibr" rid="B62-ijms-21-04946">62</xref>,<xref ref-type="bibr" rid="B63-ijms-21-04946">63</xref>,<xref ref-type="bibr" rid="B64-ijms-21-04946">64</xref>,<xref ref-type="bibr" rid="B65-ijms-21-04946">65</xref>,<xref ref-type="bibr" rid="B66-ijms-21-04946">66</xref>,<xref ref-type="bibr" rid="B67-ijms-21-04946">67</xref>,<xref ref-type="bibr" rid="B68-ijms-21-04946">68</xref>,<xref ref-type="bibr" rid="B69-ijms-21-04946">69</xref>,<xref ref-type="bibr" rid="B161-ijms-21-04946">161</xref>,<xref ref-type="bibr" rid="B162-ijms-21-04946">162</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">dementia/Alzheimer’s disease (AD)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>lower BMD and increased fracture risk</p></list-item><list-item><label>-</label><p>less brain atrophy correlates with higher BMD</p></list-item><list-item><label>-</label><p>elevated osteopontin correlates with cognitive decline</p></list-item><list-item><label>-</label><p>AD progression linked to sclerostin, osteopontin/-calcin</p></list-item><list-item><label>-</label><p>abnormal Wnt/β-catenin signaling causes BBB dysfunction</p></list-item><list-item><label>-</label><p>Aβ plaques significantly enlarged in brain and bone, enhancing osteoclasts function</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B8-ijms-21-04946">8</xref>,<xref ref-type="bibr" rid="B73-ijms-21-04946">73</xref>,<xref ref-type="bibr" rid="B74-ijms-21-04946">74</xref>,<xref ref-type="bibr" rid="B75-ijms-21-04946">75</xref>,<xref ref-type="bibr" rid="B76-ijms-21-04946">76</xref>,<xref ref-type="bibr" rid="B77-ijms-21-04946">77</xref>,<xref ref-type="bibr" rid="B78-ijms-21-04946">78</xref>,<xref ref-type="bibr" rid="B86-ijms-21-04946">86</xref>] <break></break>reviewed by [<xref ref-type="bibr" rid="B163-ijms-21-04946">163</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Parkinson’s disease (PD) </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>increases fracture risk</p></list-item><list-item><label>-</label><p>lower BMD in early stages</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B23-ijms-21-04946">23</xref>,<xref ref-type="bibr" rid="B87-ijms-21-04946">87</xref>,<xref ref-type="bibr" rid="B88-ijms-21-04946">88</xref>] </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>trauma</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">traumatic brain injury (TBI) </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>reduction of BMD after TBI</p></list-item><list-item><label>-</label><p>TBI frequently associated with HO</p></list-item><list-item><label>-</label><p>TBI with concomitant fracture showed an accelerated fracture healing and enlarged callus formation</p></list-item><list-item><label>-</label><p>beneficial effect of TBI restricted to closed fractures</p></list-item><list-item><label>-</label><p>increased osteogenic effects following TBI (serum/CSF-mediated)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B19-ijms-21-04946">19</xref>,<xref ref-type="bibr" rid="B116-ijms-21-04946">116</xref>,<xref ref-type="bibr" rid="B121-ijms-21-04946">121</xref>,<xref ref-type="bibr" rid="B128-ijms-21-04946">128</xref>,<xref ref-type="bibr" rid="B129-ijms-21-04946">129</xref>,<xref ref-type="bibr" rid="B130-ijms-21-04946">130</xref>,<xref ref-type="bibr" rid="B131-ijms-21-04946">131</xref>,<xref ref-type="bibr" rid="B132-ijms-21-04946">132</xref>,<xref ref-type="bibr" rid="B133-ijms-21-04946">133</xref>,<xref ref-type="bibr" rid="B134-ijms-21-04946">134</xref>,<xref ref-type="bibr" rid="B139-ijms-21-04946">139</xref>,<xref ref-type="bibr" rid="B140-ijms-21-04946">140</xref>] <break></break>[<xref ref-type="bibr" rid="B164-ijms-21-04946">164</xref>,<xref ref-type="bibr" rid="B165-ijms-21-04946">165</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">spinal cord injury (SCI)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>isolated SCI associated with lower BMD and osteoporosis</p></list-item><list-item><label>-</label><p>SCI frequently associated with HO</p></list-item><list-item><label>-</label><p>SCI associated with accelerated fracture healing and enhanced callus formation in multitrauma</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B20-ijms-21-04946">20</xref>,<xref ref-type="bibr" rid="B145-ijms-21-04946">145</xref>,<xref ref-type="bibr" rid="B146-ijms-21-04946">146</xref>,<xref ref-type="bibr" rid="B147-ijms-21-04946">147</xref>,<xref ref-type="bibr" rid="B148-ijms-21-04946">148</xref>,<xref ref-type="bibr" rid="B149-ijms-21-04946">149</xref>] <break></break>[<xref ref-type="bibr" rid="B164-ijms-21-04946">164</xref>] <break></break>reviewed by [<xref ref-type="bibr" rid="B166-ijms-21-04946">166</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Effect on Brain</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>bone</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<italic>chronic</italic>
<break></break>
<italic>disorders</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">osteoporosis</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>associated with TBI, SCI, AD, PD, stroke and epilepsy</p></list-item><list-item><label>-</label><p>bidirectional impact of MDD, caused by fractures and pain leading to impaired quality of life</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">see each <break></break>condition/disorder for reference; <break></break>reviewed by [<xref ref-type="bibr" rid="B15-ijms-21-04946">15</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="3" style="border-bottom:solid thin" valign="top">
<italic>genetic</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">cleidocranial dysplasia (CCD)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>skeletal disorder characterized by skeletal anomalies</p></list-item><list-item><label>-</label><p><bold>brain</bold>: developmental delay or late-onset progressive cognitive decline, suggested to be osteocalcin induced</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">reviewed by [<xref ref-type="bibr" rid="B90-ijms-21-04946">90</xref>] <break></break>[<xref ref-type="bibr" rid="B91-ijms-21-04946">91</xref>,<xref ref-type="bibr" rid="B92-ijms-21-04946">92</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">hereditary multiple exostoses (HME)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>skeletal disorder characterized by multiple osteocartilaginous overgrowths (exostoses), skeletal deformities</p></list-item><list-item><label>-</label><p><bold>brain</bold>: nerve entrapment, chronic pain and association with autism or mental impairment e.g., dementia</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B101-ijms-21-04946">101</xref>,<xref ref-type="bibr" rid="B102-ijms-21-04946">102</xref>,<xref ref-type="bibr" rid="B103-ijms-21-04946">103</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">sclerosteosis and van Buchem disease</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>skeletal disorder (autosomal recessive) characterized by generalized hyperostosis with bone anomalies</p></list-item><list-item><label>-</label><p><bold>brain</bold>: mechanical impact causing raised intracranial pressure and entrapment of cranial nerves</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B99-ijms-21-04946">99</xref>,<xref ref-type="bibr" rid="B100-ijms-21-04946">100</xref>] <break></break>
<break></break>[<xref ref-type="bibr" rid="B167-ijms-21-04946">167</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<italic>trauma</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">fracture (Fx)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>increased Fx risk in neurodegenerative diseases and stroke, associated with reduced BMD</p></list-item><list-item><label>-</label><p>Fx history seen as independent risk factor of dementia</p></list-item><list-item><label>-</label><p>Fx patients at particular risk of concomitant mild TBI</p></list-item><list-item><label>-</label><p>peripheral injury caused higher functional deficits and mortality rates in patients suffering from TBI</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B23-ijms-21-04946">23</xref>] <break></break>
<break></break>[<xref ref-type="bibr" rid="B168-ijms-21-04946">168</xref>,<xref ref-type="bibr" rid="B169-ijms-21-04946">169</xref>] <break></break>
<break></break>reviewed by [<xref ref-type="bibr" rid="B22-ijms-21-04946">22</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Effect on Brain and Bone</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="top">
<bold>brain and bone</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<italic>genetic</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Coffin-Lowry syndrome (CLS) </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>loss-of function mutations of gene encoding for RSK2</p></list-item><list-item><label>-</label><p><bold>brain</bold>: severe psychomotor retardation</p></list-item><list-item><label>-</label><p><bold>bone</bold>: growth retardation with skeletal malformations</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B94-ijms-21-04946">94</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<italic>trauma</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">complex regional pain syndrome (CRPS)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>systemic chronic pain condition after trauma/surgery, causing autonomic, sensory and motor abnormalities</p></list-item><list-item><label>-</label><p><bold>brain</bold>: neurogenic inflammation, maladaptive neuro-plasticity and nociceptive sensitization with sensory gain/loss; potentially resulting in anxiety/depression</p></list-item><list-item><label>-</label><p><bold>bone</bold>: loss of BMD and increased periarticular bone metabolism with OPG as a potential biomarker</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">reviewed by [<xref ref-type="bibr" rid="B21-ijms-21-04946">21</xref>] <break></break>[<xref ref-type="bibr" rid="B104-ijms-21-04946">104</xref>,<xref ref-type="bibr" rid="B105-ijms-21-04946">105</xref>,<xref ref-type="bibr" rid="B106-ijms-21-04946">106</xref>,<xref ref-type="bibr" rid="B107-ijms-21-04946">107</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="ijms-21-04946-t002" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-21-04946-t002_Table 2</object-id>
<label>Table 2</label>
<caption>
<p>Crosstalk of brain and bone: experimental observations.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">
</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Origin</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Condition</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Effect on Bone</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Model</th>
<th align="left" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin" valign="middle">Pre-Clinical Studies/Reviews</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>brain</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>neuro-psychological causes</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">chronic stress and shift work</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>proinflammatory cytokines stimulate bone resorption</p></list-item><list-item><label>-</label><p>glucocorticoids are released, directly inhibiting bone formation</p></list-item><list-item><label>-</label><p>disturbed fracture healing</p></list-item><list-item><label>-</label><p>the bone tissues circadian clock genes (<italic>Bmal1</italic>) enhances BMD and osteoblasts activity while decreasing osteoclastogenesis</p></list-item><list-item><label>-</label><p>melatonin with combined calcium carbonate improves osteoporosis (bone quality)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">in vitro <break></break>mouse <break></break>mouse <break></break>mouse/rat <break></break>
<break></break>mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B43-ijms-21-04946">43</xref>] <break></break>[<xref ref-type="bibr" rid="B46-ijms-21-04946">46</xref>,<xref ref-type="bibr" rid="B47-ijms-21-04946">47</xref>] <break></break>[<xref ref-type="bibr" rid="B48-ijms-21-04946">48</xref>] <break></break>[<xref ref-type="bibr" rid="B37-ijms-21-04946">37</xref>,<xref ref-type="bibr" rid="B289-ijms-21-04946">289</xref>,<xref ref-type="bibr" rid="B408-ijms-21-04946">408</xref>] <break></break>
<break></break>[<xref ref-type="bibr" rid="B409-ijms-21-04946">409</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">depression</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>low osteoblast differentiation</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">rat</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B57-ijms-21-04946">57</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">stroke</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>fracture exacerbates ischemic cerebral injury</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B71-ijms-21-04946">71</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">dementia/Alzheimer’s disease (AD)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>Aβ increases osteoclastic activation</p></list-item><list-item><label>-</label><p>Wnt/b-catenin signaling ameliorate BBB function</p></list-item><list-item><label>-</label><p>dysfunctional Wnt/b-catenin signaling in AD</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">in vitro <break></break>in vitro</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B81-ijms-21-04946">81</xref>,<xref ref-type="bibr" rid="B410-ijms-21-04946">410</xref>] <break></break>[<xref ref-type="bibr" rid="B411-ijms-21-04946">411</xref>,<xref ref-type="bibr" rid="B412-ijms-21-04946">412</xref>] <break></break>reviewed by [<xref ref-type="bibr" rid="B163-ijms-21-04946">163</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Parkinson’s disease (PD)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>dopaminergic degeneration accelerates bone loss</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B89-ijms-21-04946">89</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>trauma</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">traumatic brain injury (TBI) </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>reduction of BMD following TBI</p></list-item><list-item><label>-</label><p>TBI enhances the formation of heterotopic ossification (HO)</p></list-item><list-item><label>-</label><p>TBI with concomitant fracture showed an accelerated fracture healing and enlarged callus formation, potentially caused by:</p></list-item><list-item><label>-</label><p>dominance of neuronal mechanisms and neuroinflammation</p></list-item><list-item><label>-</label><p>calvaria anabolic response mediated by cannabinoid-1 receptor</p></list-item><list-item><label>-</label><p>leptin-deficiency eliminates positive effect </p></list-item><list-item><label>-</label><p>hippocampus and calcitonin gene-related peptide (CGRP)</p></list-item><list-item><label>-</label><p>SDF-1 promotes endochondral bone repair </p></list-item><list-item><label>-</label><p>elevated levels of leptin in CSF and GH/IGF-1 in serum</p></list-item><list-item><label>-</label><p>elevated serum arachidonic acid following TBI, which promotes the expression of BGLAP and therefore osteoblasts proliferation</p></list-item><list-item><label>-</label><p>elevated serum CGRP following TBI</p></list-item><list-item><label>-</label><p>elevated secretion of CGRP following TBI</p></list-item><list-item><label>-</label><p>close association of serum leptin and callus volume</p></list-item><list-item><label>-</label><p>release of osteogenic factors into the serum following TBI</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse/rat <break></break>rat <break></break>mouse <break></break>
<break></break>mouse <break></break>mouse <break></break>mouse <break></break>rat <break></break>mouse <break></break>rabbit <break></break>rat <break></break>
<break></break>rat <break></break>rat <break></break>rat <break></break>rat </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B117-ijms-21-04946">117</xref>,<xref ref-type="bibr" rid="B118-ijms-21-04946">118</xref>] <break></break>[<xref ref-type="bibr" rid="B126-ijms-21-04946">126</xref>] <break></break>[<xref ref-type="bibr" rid="B141-ijms-21-04946">141</xref>,<xref ref-type="bibr" rid="B142-ijms-21-04946">142</xref>] <break></break>[<xref ref-type="bibr" rid="B144-ijms-21-04946">144</xref>] <break></break>[<xref ref-type="bibr" rid="B413-ijms-21-04946">413</xref>] <break></break>[<xref ref-type="bibr" rid="B414-ijms-21-04946">414</xref>] <break></break>[<xref ref-type="bibr" rid="B415-ijms-21-04946">415</xref>] <break></break>[<xref ref-type="bibr" rid="B416-ijms-21-04946">416</xref>] <break></break>[<xref ref-type="bibr" rid="B417-ijms-21-04946">417</xref>] <break></break>[<xref ref-type="bibr" rid="B418-ijms-21-04946">418</xref>] <break></break>
<break></break>
<break></break>[<xref ref-type="bibr" rid="B419-ijms-21-04946">419</xref>] <break></break>[<xref ref-type="bibr" rid="B420-ijms-21-04946">420</xref>] <break></break>[<xref ref-type="bibr" rid="B421-ijms-21-04946">421</xref>] <break></break>[<xref ref-type="bibr" rid="B422-ijms-21-04946">422</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">spinal cord injury (SCI)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>SCI serum accelerates fracture healing</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">in vitro
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B423-ijms-21-04946">423</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
<bold>Effect on Brain</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>bone</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<italic>chronic</italic>
<break></break>
<italic>disorders</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">osteoporosis </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>associated with AD, potentially caused by the disruption of the Wnt/β-catenin signaling pathway</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B424-ijms-21-04946">424</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="2" style="border-bottom:solid thin" valign="top">
<italic>genetic</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">cleidocranial dysplasia (CCD) </td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>absents of Runx2 showed bone resorption defect with reduced levels of osteoblast-produced osteocalcin in serum and brain</p></list-item><list-item><label>-</label><p>reduced brain osteocalcin was associated with enhanced anxious behavior and impaired cognitive function (as observed for CCD)</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B425-ijms-21-04946">425</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">hereditary multiple exostoses (HME)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>inactivation of <italic>Ext1</italic> resulted in exostoses as well as stereotypies and impairment of socio-communication, suggesting that mutated genes of heparan sulfate biosynthetic enzymes (incl. <italic>EXT1</italic>) are the cause for associated autism and other mental disorders</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse <break></break>mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B426-ijms-21-04946">426</xref>] <break></break>[<xref ref-type="bibr" rid="B427-ijms-21-04946">427</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<italic>trauma</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">fracture (Fx)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p>long-bone fracture exacerbates TBI and neuroinflammation, with a worsened cerebral edema and neurological recovery</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B155-ijms-21-04946">155</xref>,<xref ref-type="bibr" rid="B156-ijms-21-04946">156</xref>,<xref ref-type="bibr" rid="B428-ijms-21-04946">428</xref>]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>Effect on Brain and Bone</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<bold>brain and bone</bold>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<italic>genetic</italic>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">Coffin-Lowry syndrome (CLS)</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">
<list list-type="simple"><list-item><label>-</label><p><bold>brain</bold>: deletion of (the in CLS) mutated RSK2 is associated with impaired spatial learning and long-term spatial memory deficit</p></list-item><list-item><label>-</label><p><bold>bone</bold>: ATF4, substrate of <italic>RSK2</italic>, regulates osteoblast differentiation and activity, potentially contributing to skeletal phenotype of CLS</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">mouse <break></break>mouse</td>
<td align="left" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="top">[<xref ref-type="bibr" rid="B95-ijms-21-04946">95</xref>] <break></break>reviewed by [<xref ref-type="bibr" rid="B94-ijms-21-04946">94</xref>] <break></break>[<xref ref-type="bibr" rid="B97-ijms-21-04946">97</xref>]</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>